Catherine Hill
Adelaide Medical School
Faculty of Health and Medical Sciences
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Professor Catherine Hill is a clinical rheumatologist, epidemiologist and expert in evidence-based healthcare.
She trained in clinical rheumatology and general medicine at TQEH/RAH, research fellowship and Masters of Science (Biostats & Epidemiology) at Boston University and MD (University of Adelaide).
She leads the Rheumatology Research Group at the Basil Hetzel Institute with research expertise in population epidemiology, randomised clinical trials, qualitative research, biobanking and quality improvement. The Research Group has experts in epidemiology, statistics, biobanking, qualitative methods and evidence-based medicine. It is the South Australian hub of Australian Arthritis and Autoimmune Biobank (A3BC).
She was awarded the 2022 Parr Prize for Rheumatology Research Excellence. It is awarded every three years for outstanding contribution by a ARA member to rheumatology research; judged on quality and impact of research.
She is past President of Australian Rheumatology Association (2020-22); professional society of rheumatologists and rheumatology health professionals. She is Chair of the Education Committee of Asia Pacific League Against Rheumatism (APLAR).
She has experience and expertise in health technology assessment having been Chair of South Australian Medicines Evaluation Panel (SAMEP; 2011-2023), member of Australian Committee for Prescription Medicine (TGA, 2004-2015) and member of Pharmaceutical Benefits Advisory Committee (2016-2023).
She is a Board Member of the Australian and New Zealand Vasculitis Society as a founding Board Member. This is a collaborative organisation of physicians, scientists, and communities that focuses on research, education, and clinical practices in vasculitis.
She is a Board Member of The Hospital Research Foundation (THRF). In addition, she chairs the Clinical Governance Committee of the THRF and sits on the THRG-Arthritis Board of Governors.
As Chief Investigator of the North West Adelaide Health Study (NWAHS), she has instrumental in adding the musculoskeletal data collection to this study. Work from this study has been published as part of the Global Burden of Disease study published in the Lancet (2012), which identified musculoskeletal diseases one of the three most important diseases in terms of global disease burden.
Prof Hill is part of a national OA trials collaborative (Monash University, University of Tasmania, University of Sydney, University of WA) with current and previous NHMRC funding of interventional clinical trials for knee and hand osteoarthritis. She has collaborations with CSIRO and University of SA for innovative trials of knee OA. Previous trials have been reported in JAMA and Ann Rheum Dis. Further to this work, she is part of the European League Against Rheumatism (EULAR) Hand OA classification criteria Working group.
Giant Cell Arteritis is the most common vasculitis in the elderly that can lead to blindness and stroke. She established the South Australian Giant Cell Arteritis Registry in 2009 which has resulted in further knowledge about this condition in Australia for the first time and has resulted in both national and international collaborations; and the first Australian data regarding incidence and prevalence of this condition.
She is involved in OMERACT (Outcome Measures in Rheumatology) which is an independent initiative of international health professionals interested in outcome measures in rheumatology since 2014. She co-chairs 4 working groups for OMERACT (PMR, glucocorticoid impact, hand OA, POLOS) and is also part of the Technical Advisory Group of OMERACT.
-
Appointments
Date Position Institution name 2025 - ongoing Director of Medical Services (Workforce Performance and Governance) Central Adelaide Local Health Network 2023 - ongoing Board Member The Hospital Research Foundation 2017 - 2023 Member Pharmaceutical Benefits Advisory Committee 2016 - ongoing Clinical Professor University of Adelaide 2016 - ongoing Head, Rheumatology Research Group The University of Adelaide 2016 - ongoing Head, Rheumatology Unit The Queen Elizabeth Hospital 2015 - ongoing Staff Consultant Rheumatologist Royal Adelaide Hospital 2011 - 2022 Chair South Australian Medicines Evaluation Panel, SA Health 2010 - 2016 Clinical Associate Professor University of Adelaide 2000 - ongoing Staff Consultant Rheumatologist The Queen Elizabeth Hospital -
Awards and Achievements
Date Type Title Institution Name Country Amount 2022 Award Parr Prize for Outstanding Rheumatology Research Australian Rheumatology Association Australia - -
Language Competencies
Language Competency English Can read, write, speak, understand spoken and peer review -
Education
Date Institution name Country Title 2009 - 2009 University of Adelaide Australia Doctor of Medicine (MD) 1998 - 2000 Boston University United States Masters of Science (Epidemiology and Biostatics) 1983 - 1988 University of Adelaide Australia MBBS -
Postgraduate Training
Date Title Institution Country FRACP Royal Australasian College of Physicians Australia -
Research Interests
-
Journals
Year Citation 2025 Russell, O., Lester, S., Black, R. J., Lassere, M., Barrett, C., March, L., . . . Hill, C. L. (2025). Area-Level Socioeconomic Status Impacts Health Care Visit Frequency by Australian Patients With Inflammatory Arthritis: Results From the Australian Rheumatology Association Database. Arthritis Care and Research, 77(1), 127-135.
2025 Zeng, M., Cicuttini, F. M., Wluka, A. E., Jones, G., Hill, C. L., Ding, C., & Wang, Y. (2025). Association between medial meniscal extrusion and knee structural progression in adults with symptomatic knee osteoarthritis - a prospective cohort study. Skeletal Radiology: journal of radiology, pathology and orthopedics, 54(2), 219-228.
Scopus1 Europe PMC22025 Tieu, J., Cheah, J. T., Lyne, S., Yip, K., Ghosh, N., Richards, P., . . . Goodman, S. M. (2025). Prioritising domains of glucocorticoid therapy to measure in trials: Results from a modified delphi exercise from the OMERACT glucocorticoid impact working group. Seminars in Arthritis and Rheumatism, 71, 6 pages.
2025 Bryant, M. J., Black, R. J., & Hill, C. L. (2025). Measuring Patient Experience in Rheumatology Outpatient Care. International Journal of Rheumatic Diseases, 28(1), 3 pages.
2025 Mau, A. W. K., Keen, H. I., Hill, C. L., & Buchbinder, R. (2025). Appropriateness of lumbar spine imaging in patients presenting to the emergency department with low back pain in a Western Australian tertiary hospital. Internal Medicine Journal, 55(4), 573-580.
2025 Sweeney, A. M. T., Bridgewater, S., Orme, J., Sattui, S. E., Sharp, M., Richards, P., . . . Robson, J. C. (2025). Impact of glucocorticoids on patients' quality of life: a qualitative study assessing face validity and feasibility of the Steroid PRO in patients with inflammatory gastroenterology, respiratory and dermatology conditions. BMJ Open, 15(2), e089225.
2025 Lax, S. J., Dures, E., Bridgewater, S., Silverthorne, C. A., Lowndes, V., Richards, P., . . . Robson, J. C. (2025). Patient perspectives on the impact of appearance and weight changes attributed to systemic glucocorticoid treatment of rheumatic diseases. Rheumatology, 64(6), 3854-3862.
2025 Chin, A., Terrett, A., Kwon, M., Whittle, S., & Hill, C. (2025). Recommendations for the use of DMARDs in pregnancy and reproductive health for patients with rheumatic disease: A scoping review. Arthritis Care and Research, 9 pages.
2025 Bryant, M. J., Lester, S., Russell, O., Whittle, S., Limaye, V., Proudman, S., . . . Hill, C. L. (2025). Implementation of a novel patient reported experience measure (PREM) in rheumatology: a cross-sectional online survey of Australian rheumatology outpatients. Rheumatology International, 45(6), 10 pages.
2025 Lyne, S. A., Lester, S., Russell, O. K., Deanne, C., Dyer, K., Ninan, J., . . . Hill, C. L. (2025). Influence of socioeconomic status on access to temporal artery biopsy and rates of biopsy positivity in patients with suspected giant cell arteritis. BMC Rheumatology, 9(1), 6 pages.
2025 Bello, F., Fagni, F., Bagni, G., Hill, C. L., Mohammad, A. J., Moiseev, S., . . . Emmi, G. (2025). Arterial and venous thrombosis in systemic and monogenic vasculitis. Nature Reviews Rheumatology, 21(6), 355-369.
2025 Xue, M., Lin, H., Lynch, T., Chand, V., Sinnathurai, P., Thomas, R., . . . March, L. (2025). Th Cell Phenotypes and Their Correlations with Disease Activity in Patients with Rheumatoid Arthritis.. Journal of clinical medicine, 14(12), 4220.
2025 Terrett, A. M., Damodaran, A., Burnet, S., Singh-Grewal, D., Buchbinder, R., Glover, J., . . . Hill, C. L. (2025). The rheumatology workforce in Australia: current and projected shortfalls. Internal Medicine Journal, 8 pages.
2025 Lyon, A., Lester, S., Stanhope, J., Lynch, T., Black, R., Barrett, C., . . . Hill, C. (2025). Dual-energy x-ray absorptiometry (DEXA) and anti-osteoporotic medication use in Australian patients with early rheumatoid arthritis (RA) using data from the Australian Rheumatology Association Database (ARAD). Internal Medicine Journal, 9 pages.
2024 Lax, S. J., Dures, E., Bridgewater, S., Silverthorne, C., Lowndes, V., Richards, P., . . . Robson, J. (2024). Impact of glucocorticoids on appearance and sense of self in rheumatic diseases. RHEUMATOLOGY, 63(Supplement_1), 1 page.
2024 Janagan, S., Lim, K. W., Bhogal, R., Bridgewater, S., Silverthorne, C., Richards, P., . . . Robson, J. C. (2024). HEALTH-RELATED QUALITY OF LIFE IN PATIENTS RECEIVING GLUCOCORTICOIDS FOR A RHEUMATIC DISEASE AND ASSOCIATED FACTORS : A CROSS-SECTIONAL STUDY. RHEUMATOLOGY, 63(Supplement_1), 2 pages.
2024 Laslett, L. L., Scheepers, L. E. J. M., Antony, B., Wluka, A. E., Cai, G., Hill, C. L., . . . Jones, G. (2024). Krill Oil for Knee Osteoarthritis: A Randomized Clinical Trial. JAMA, 331(23), 1997-2006.
Scopus9 Europe PMC82024 Dartnell, J., Cox, D., Dawda, P., & Hill, C. (2024). Quality use of medicines: who owns it now?. Australian Prescriber, 47(3), 72-74.
Scopus1 Europe PMC12024 Robinson, L., Hamden, M., Griggs, K., Simon, S., Hill, C., Limaye, V., & Proudman, S. (2024). Tocilizumab use in giant cell arteritis: comparing Pharmaceutical Benefits Scheme eligible and ineligible cases in South Australia. Internal Medicine Journal, 54(7), 1228-1232.
2024 Xue, M., Lin, H., Lynch, T., Bereza-Malcolm, L., Sinnathurai, P., Thomas, R., . . . March, L. (2024). Exploring the association between circulating endothelial protein C receptor and disease activity of rheumatoid arthritis in a pilot study. Rheumatology Advances in Practice, 8(3), rkae096-1-rkae096-9.
Scopus1 Europe PMC12024 Major, T. J., Takei, R., Matsuo, H., Leask, M. P., Sumpter, N. A., Topless, R. K., . . . Merriman, T. R. (2024). Correction to: A genome-wide association analysis reveals new pathogenic pathways in gout (Nature Genetics, (2024), 56, 11, (2392-2406), 10.1038/s41588-024-01921-5). Nature Genetics, 56(11), 2577.
Scopus12024 Hoon, E., Edwards, J., Robinson, P., Rowett, D., Stocks, N., Keen, H. I., & Hill, C. L. (2024). How is gout currently managed, and is there interest in changing the way we deliver care? A qualitative exploratory study. Australian journal of general practice, 53(11), 864-871.
2024 Bryant, M. J., Black, R. J., Lester, S., Chand, V., Barrett, C., Buchbinder, R., . . . Hill, C. L. (2024). Australian adaptation and external validation of Commissioning for Quality in Rheumatoid Arthritis-RA-Patient Reported Experience Measure (CQRA-RA-PREM). Rheumatology Advances in Practice, 8(4), 9 pages.
Scopus2 Europe PMC22024 Major, T. J., Takei, R., Matsuo, H., Leask, M. P., Sumpter, N. A., Topless, R. K., . . . Merriman, T. R. (2024). A genome-wide association analysis reveals new pathogenic pathways in gout. Nature Genetics, 56(11), 2392-2406.
Scopus22 Europe PMC102024 Mittinty, M. M., Mittinty, M. N., Buchbinder, R., Lassere, M., Chand, V., Whittle, S., . . . Hill, C. (2024). Interpersonal Process of Dyadic Coping in Rheumatoid Arthritis: A Perspective From the Australian Rheumatology Association Database. Journal of Rheumatology, 51(9), 862-869.
Scopus2 Europe PMC12024 Lyne, S. A., Yip, K., Vasiliou, V. S., Katz, D. A., Richards, P., Tieu, J., . . . Hill, C. L. (2024). Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases. Seminars in Arthritis and Rheumatism, 64, 7 pages.
Scopus12024 Lim, J., Dures, E., Bailey, L. F., Almeida, C., Ruediger, C., Hill, C. L., . . . MacKie, S. L. (2024). Jaw claudication and jaw stiffness in giant cell arteritis: secondary analysis of a qualitative research dataset. Rheumatology Advances in Practice, 8(1), 6 pages.
Scopus3 Europe PMC12024 Pisaniello, H. L., Lester, S. E., Russell, O., Black, R., Tieu, J., Richards, B., . . . Whittle, S. L. (2024). The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD). Annals of the Rheumatic Diseases, 83(10), 1400-1402.
2024 Ciobanu, L. G., Baryshnikova, N. V., Jawahar, M. C., Toben, C. G., Sokolenko, E., Arnet, V. K., . . . Clark, S. R. (2024). Pre-COVID life expectancy, mortality, and burden of diseases for adults 70 years and older in Australia: a systematic analysis for the Global Burden of Disease 2019 Study. The Lancet Regional Health. Western Pacific, 47, 101092-1-101092-14.
Scopus1 Europe PMC12024 Haugen, I. K., Felson, D. T., Abhishek, A., Berenbaum, F., Bierma-Zeinstra, S., Dziedzic, K. S., . . . Kloppenburg, M. (2024). 2023 EULAR classification criteria for hand osteoarthritis. Annals of the Rheumatic Diseases, 83(11), 1428-1435.
Scopus10 Europe PMC102024 Chin, A., Adams, R., Gill, T., & Hill, C. (2024). Gout Knowledge: A Survey of Australian Outpatients with Gout. Open Access Rheumatology: Research and Reviews, Volume 16, 1-7.
2024 Benavent, D., Carmona, L., Lopez-Olivo, M. A., Hill, C. L., Westrich-Robertson, T., Goel, N., . . . Suarez-Almazor, M. E. (2024). Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set. Seminars in Arthritis and Rheumatism, 64, 152343.
Scopus1 Europe PMC12024 Cai, G., Laslett, L. L., Thompson, M., Cicuttini, F., Hill, C., Wluka, A. E., . . . Aitken, D. (2024). Effect of Intravenous Zoledronic Acid on Total Knee Replacement in Patients With Symptomatic Knee Osteoarthritis and Without Severe Joint Space Narrowing: A Prespecified Secondary Analysis of a Two-Year, Multicenter, Double-Blind, Placebo-Controlled Clinical Trial. Arthritis and Rheumatology, 76(7), 1047-1053.
Scopus4 Europe PMC42024 Morrisroe, K., Hansen, D., Stevens, W., Ross, L., Sahhar, J., Ngian, G. -S., . . . Nikpour, M. (2024). Predictors and prognosis of pulmonary hypertension complicating interstitial lung disease in systemic sclerosis. Rheumatology, keae166.
2024 Whittaker, G. A., Hill, C. L., Bradbury, L. A., Millner, J. R., Cliffe, H., Bonanno, D. R., . . . Menz, H. B. (2024). Nursing and allied health workforce in Australian public rheumatology departments is inadequate: a cross-sectional observational study. Rheumatology International, 44(5), 901-908.
Scopus2 Europe PMC22024 Maxwell, L. J., Jones, C., Bingham, C. O., Boers, M., Boonen, A., Choy, E., . . . Beaton, D. E. (2024). Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets. Seminars in Arthritis and Rheumatism, 66, 152423.
Scopus10 Europe PMC82024 Naghavi, M., Ong, K. L., Aali, A., Ababneh, H. S., Abate, Y. H., Abbafati, C., . . . Murray, C. J. L. (2024). Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 403(10440), 2100-2132.
Scopus892 Europe PMC6902024 Khursheed, T., Ovseiko, P., Dyball, S., Nakashima, R., Gonzalez, A. M. A., Babini, A., . . . Gupta, L. (2024). Coalition for Health and Gender Equity (CHANGE)—a protocol for a global cross-sectional survey of health and gender equity in rheumatology. Rheumatology Advances in Practice, 8(2), 5 pages.
Scopus1 Europe PMC22024 Callisto, A., Hansen, D., Walker, J., Ngian, G. S., Apostolopoulos, D., Liew, D., . . . Proudman, S. (2024). Impact of the COVID-19 Pandemic on Health Care Access and Diagnosis of Pulmonary Arterial Hypertension Among Patients With Systemic Sclerosis. Arthritis Care and Research, 76(1), 81-87.
Scopus2 WoS1 Europe PMC32024 Ndosi, M., Almeida, C., Dawson, J., Dures, E., Greenwood, R., Bromhead, A., . . . Robson, J. C. (2024). Validation of a patient-reported outcome measure for giant cell arteritis. Rheumatology United Kingdom, 63(1), 181-189.
Scopus2 WoS1 Europe PMC22023 Fairley, J. L., Hansen, D., Ross, L., Proudman, S., Sahhar, J., Ngian, G. -S., . . . Australian Scleroderma Interest Group. (2023). Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis.. Arthritis Research and Therapy, 25(1), 1-13.
Scopus13 WoS1 Europe PMC52023 Owen, C. E., Yates, M., Liew, D. F. L., Poon, A. M. T., Keen, H. I., Hill, C. L., & Mackie, S. L. (2023). Imaging of giant cell arteritis – recent advances. Best Practice and Research: Clinical Rheumatology, 37(1), 101827.
Scopus4 Europe PMC12023 Lyon, A., Quinlivan, A., Lester, S., Barrett, C., Whittle, S. L., Rowett, D., . . . Hill, C. L. (2023). Vaccination Rates, Perceptions, and Information Sources Used by People With Inflammatory Arthritis. ACR Open Rheumatology, 5(2), 1-9.
Scopus5 WoS2 Europe PMC32023 Morrisroe, K., Hansen, D., Stevens, W., Ross, L., Sahhar, J., Ngian, G. -S., . . . Nikpour, M. (2023). Progressive pulmonary fibrosis and its impact on survival in systemic sclerosis-related interstitial lung disease. RHEUMATOLOGY, 63(7), 1-8.
Scopus7 WoS1 Europe PMC42023 Wang, Y., Jones, G., Keen, H. I., Hill, C. L., Wluka, A. E., Kasza, J., . . . Cicuttini, F. M. (2023). Methotrexate to treat hand osteoarthritis with synovitis (METHODS): an Australian, multisite, parallel-group, double-blind, randomised, placebo-controlled trial. The Lancet, 402(10414), 1764-1772.
Scopus39 Europe PMC312023 Bridgewater, S., Ndosi, M., Dawson, J., Richards, P., Silverthorne, C., Dures, E., . . . Robson, J. C. (2023). Validation of a new glucocorticoid-specific Patient-Reported Outcome Questionnaire (the Steroid PRO). Annals of the Rheumatic Diseases, 83(3), 394-400.
Scopus3 Europe PMC22023 Black, R. J., Cross, M., Haile, L. M., Culbreth, G., Steinmetz, J., Hagins, H., . . . March., L. M. (2023). Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. LANCET RHEUMATOLOGY, 5(10), E594-E610.
Scopus238 WoS82023 Pisaniello, H. L., Lester, S., Russell, O., Black, R., Tieu, J., Richards, B., . . . Hill, C. L. (2023). Trajectories of self-reported pain-related health outcomes and longitudinal effects on medication use in rheumatoid arthritis: a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD). RMD Open, 9(3), e002962.
Scopus6 Europe PMC42023 Lyne, S. A., Ruediger, C., Lester, S., Kaur, G., Stamp, L., Shanahan, E. M., & Hill, C. L. (2023). Clinical phenotype and complications of large vessel giant cell arteritis: A systematic review and meta-analysis. Revue Du Rhumatisme Edition Francaise, 90(5), 552-564.
2023 Safiri, S., Nejadghaderi, S. A., Noori, M., Sullman, M. J. M., Collins, G. S., Kaufman, J. S., . . . Kolahi, A. A. (2023). The burden of low back pain and its association with socio-demographic variables in the Middle East and North Africa region, 1990–2019. BMC Musculoskeletal Disorders, 24(1), 59.
Scopus9 Europe PMC62023 Bridgewater, S., Shepherd, M. A., Dawson, J., Richards, P., Silverthorne, C., Ndosi, M., . . . Robson, J. C. (2023). Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: international development of a glucocorticoid treatment-specific patient-reported outcome measure.. Rheumatology (Oxford), 62(11), 3565-3575.
Scopus5 WoS2 Europe PMC42023 Lyne, S. A., Ruediger, C., Lester, S., Kaur, G., Stamp, L., Shanahan, E. M., & Hill, C. L. (2023). Clinical phenotype and complications of large vessel giant cell arteritis: a systematic review and meta-analysis. Joint Bone Spine, 90(4), 9 pages.
Scopus13 WoS1 Europe PMC72023 Jee, A. S., Stewart, I., Youssef, P., Adelstein, S., Lai, D., Hua, S., . . . Nguyen, M. A. (2023). A Composite Serum Biomarker Index for the Diagnosis of Systemic Sclerosis–Associated Interstitial Lung Disease: A Multicenter, Observational Cohort Study. Arthritis and Rheumatology, 75(8), 1424-1433.
Scopus16 WoS1 Europe PMC132023 Black, R. J., Lester, S., Tieu, J., Sinnathurai, P., Barrett, C., Buchbinder, R., . . . Hill, C. L. (2023). Mortality estimates and excess mortality in rheumatoid arthritis. Rheumatology, 62(11), 3576-3583.
Scopus26 WoS4 Europe PMC172023 Wang, Y., Pontoh, E., Hussain, S., Lim, Y., Jones, G., Hill, C., . . . Cicuttini, F. (2023). Association between popliteal artery wall thickness and structural progression in patients with symptomatic knee osteoarthritis. Rheumatology, 62(4), 1645-1651.
Scopus2 Europe PMC22023 Arnold, J. B., Halstead, J., Martín-Hervás, C., Grainger, A. J., Keenan, A. -M., Hill, C. L., . . . Redmond, A. C. (2023). Bone marrow lesions and MRI-detected structural abnormalities in people with midfoot pain and osteoarthritis: a cross-sectional study. Arthritis Care and Research, 75(5), 1113-1122.
Scopus5 WoS1 Europe PMC42023 Russell, O., Lester, S., Black, R. J., & Hill, C. L. (2023). Socioeconomic Status and Medication Use in Rheumatoid Arthritis: A Scoping Review. Arthritis Care and Research, 75(1), 92-100.
Scopus10 WoS1 Europe PMC42022 Fletcher, A., Lassere, M., March, L., Hill, C., Barrett, C., Carroll, G., & Buchbinder, R. (2022). Patterns of biologic and targeted-synthetic disease-modifying antirheumatic drug use in rheumatoid arthritis in Australia. Rheumatology, 61(10), 3939-3951.
Scopus8 WoS2 Europe PMC72022 Haugen, I. K., Felson, D., Abhishek, A., Berenbaum, F., Edwards, J. J., Herrero Beaumont, G., . . . Kloppenburg, M. (2022). Development of radiographic classification criteria for hand osteoarthritis: a methodological report (Phase 2). Rmd Open, 8(1), 10 pages.
Scopus10 WoS2 Europe PMC52022 Putman, M., Kennedy, K., Sirotich, E., Liew, J. W., Sattui, S. E., Moni, T. T., . . . Simard, J. F. (2022). COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. Lancet Rheumatology, 4(4), e237-e240.
Scopus34 WoS22 Europe PMC292022 Khoo, T., Hill, C. L., Hoon, E., & Whittle, S. (2022). Patient Perspectives of Disease Activity, Medications and Substance Use in People with Fibromyalgia. Open Access Rheumatology: Research and Reviews, 14, 87-95.
Scopus1 Europe PMC12022 Morrisroe, K., Hansen, D., Stevens, W., Sahhar, J., Ngian, G. S., Hill, C., . . . Nikpour, M. (2022). Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survival. Arthritis Research and Therapy, 24(1), 10 pages.
Scopus10 WoS4 Europe PMC112022 Lim, Y., Cicuttini, F., Wluka, A., Jones, G., Hill, C., Forbes, A., . . . Wang, Y. (2022). Effect of atorvastatin on skeletal muscles of patients with knee osteoarthritis: Post-hoc analysis of a randomised controlled trial. Frontiers in Medicine, 9, 939800-1-939800-9.
Scopus2 Europe PMC22022 Cai, G., Laslett, L. L., Bowes, M. A., Conaghan, P. G., Cicuttini, F., Wluka, A. E., . . . Aitken, D. (2022). Effect of zoledronic acid with or without methylprednisolone on 3D bone area and bone shape in patients with symptomatic knee osteoarthritis: A post-hoc analysis of the ZAP2 trial. Seminars in Arthritis and Rheumatism, 56, 8 pages.
Scopus1 Europe PMC12022 Stamp, L. K., Grainger, R., Frampton, C., Drake, J., & Hill, C. L. (2022). Effect of omega-three supplementation on serum urate and gout flares in people with gout; a pilot randomized trial. BMC Rheumatology, 6(1), 8 pages.
Scopus8 WoS22022 Stonehouse, W., Benassi-Evans, B., Bednarz, J., Vincent, A. D., Hall, S., & Hill, C. L. (2022). Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial.. The American journal of clinical nutrition, 116(3), 672-685.
Scopus46 WoS10 Europe PMC342022 Quinlivan, A., Lester, S., Barrett, C., Whittle, S., Rowett, D., Black, R., . . . Hill, C. (2022). Attitudes of Australians with inflammatory arthritis to biologic therapy and biosimilars. Rheumatology Advances in Practice, 6(3), rkac099-1-rkac099-7.
Scopus5 WoS1 Europe PMC52022 Tieu, J., Lester, S., Raymond, W., Keen, H. I., Hill, C. L., & Nossent, J. (2022). Mortality and cause of death in patients with ANCA-associated vasculitis and polyarteritis nodosa in Australia - A population-based study. Rheumatology United Kingdom, 61(3), 1062-1071.
Scopus11 WoS1 Europe PMC92022 Keen, H. I., Barrett, C., & Hill, C. (2022). Improving knowledge and data about the medical workforce underpins healthy communities and doctors. Medical Journal of Australia, 216(1), 53.
2022 Tieu, J., Lester, S., Raymond, W., Keen, H., Hill, C. L., & Nossent, J. (2022). Cancer in anti-neutrophil cytoplasm antibody-associated vasculitis and polyarteritis nodosa in Australia: a population-based study. ACR Open Rheumatology, 4(3), 223-230.
Scopus1 Europe PMC22022 Robson, J. C., Grayson, P. C., Ponte, C., Suppiah, R., Craven, A., Judge, A., . . . Berglin, E. (2022). 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis. Arthritis and Rheumatology, 74(3), 393-399.
Scopus125 Europe PMC842022 Grayson, P. C., Ponte, C., Suppiah, R., Robson, J. C., Craven, A., Judge, A., . . . Berglin, E. (2022). 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis. Arthritis and Rheumatology, 74(3), 386-392.
Scopus89 Europe PMC592022 Suppiah, R., Robson, J. C., Grayson, P. C., Ponte, C., Craven, A., Khalid, S., . . . Berglin, E. (2022). 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic Polyangiitis. Arthritis and Rheumatology, 74(3), 400-406.
Scopus105 Europe PMC812022 Lalor, A. F., Brooker, J. E., Rozbroj, T., Whittle, S. L., Hill, C. L., Rowett, D., . . . O'Connor, D. A. (2022). Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies. Seminars in Arthritis and Rheumatism, 55, 151988-1-151988-13.
Scopus4 WoS2 Europe PMC42022 Schwetlik, S. N., Baldock, K. L., Hill, C. L., & Ferrar, K. (2022). Chronic Stress and Arthritis: A Scoping Review. Arthritis Care and Research, 74(6), 982-996.
Scopus16 WoS6 Europe PMC92022 Singh, A., Molina-Garcia, P., Hussain, S., Paul, A., Das, S. K., Leung, Y. Y., . . . Antony, B. (2022). Efficacy and safety of colchicine for the treatment of osteoarthritis: a systematic review and meta-analysis of intervention trials. Clinical Rheumatology, 42(3), 889-902.
Scopus10 WoS2 Europe PMC52022 Tsakas, J. J., Liew, D. F. L., Adams, C. L., Hill, C. L., Proudman, S., Whittle, S., . . . Robinson, P. C. (2022). Attitudes and practices in the laboratory monitoring of conventional synthetic disease modifying anti-rheumatic drugs by rheumatologists and rheumatology trainees. BMC Rheumatology, 6(1), 59-1-59-8.
2022 McMaster, C., Liew, D. F. L., Lester, S., Rischin, A., Black, R. J., Chand, V., . . . Hill, C. L. (2022). COVID-19 vaccine hesitancy in inflammatory arthritis patients: serial surveys from a large longitudinal national Australian cohort. Rheumatology, 62(4), 1-7.
Scopus3 WoS3 Europe PMC22022 Cai, G., Jones, G., Cicuttini, F. M., Wluka, A. E., Wang, Y., Hill, C., . . . Aitken, D. (2022). Study protocol for a randomised controlled trial of diacerein versus placebo to treat knee osteoarthritis with effusion-synovitis (DICKENS). Trials, 23(1), 768-1-768-16.
Scopus8 WoS1 Europe PMC72022 Pisaniello, H. L., Whittle, S. L., Lester, S., Menz, F., Metcalf, R., McWilliams, L., . . . Proudman, S. (2022). Using the derived 28-joint disease activity score patient-reported components (DAS28-P) index as a discriminatory measure of response to disease-modifying anti-rheumatic drug therapy in early rheumatoid arthritis. BMC Rheumatology, 6(1), 11 pages.
Scopus8 WoS2 Europe PMC72022 Grayson, P. C., Ponte, C., Suppiah, R., Robson, J. C., Gribbons, K. B., Judge, A., . . . Hočevar, A. (2022). 2022 American College of Rheumatology/EULAR Classification Criteria for Takayasu Arteritis. Arthritis and Rheumatology, 74(12), 1872-1880.
Scopus42 Europe PMC222022 Shanahan, E. M., Gill, T. K., Briggs, E., Hill, C. L., Bain, G., & Morris, T. (2022). Suprascapular nerve block for the treatment of adhesive capsulitis: a randomised double-blind placebo-controlled trial.. RMD Open, 8(2), 8 pages.
Scopus9 Europe PMC82022 Lyne, S. A., Ruediger, C., Lester, S., Chapman, P. T., Shanahan, E. M., Hill, C. L., & Stamp, L. (2022). Giant cell arteritis: A population-based retrospective cohort study exploring incidence and clinical presentation in Canterbury, Aotearoa New Zealand. Frontiers in Medicine, 9, 1-9.
Scopus9 WoS1 Europe PMC62022 Ruediger, C., Ninan, J., Dyer, K., Lyne, S., Tieu, J., Black, R. J., . . . Hill, C. L. (2022). Diagnosis of giant cell arteritis by temporal artery biopsy is associated with biopsy length. Frontiers in Medicine, 9, 6 pages.
Scopus3 Europe PMC32022 Khoo, T., Sidhu, N., Marine, F., Lester, S., Quinlivan, A., Rowett, D., . . . Hill, C. L. (2022). Perceptions towards biologic and biosimilar therapy of patients with rheumatic and gastroenterological conditions. BMC Rheumatology, 6(1), 10 pages.
Scopus4 Europe PMC12022 Ponte, C., Grayson, P. C., Robson, J. C., Suppiah, R., Gribbons, K. B., Judge, A., . . . Cid, M. C. (2022). 2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis. Arthritis and Rheumatology, 74(12), 1881-1889.
Scopus105 Europe PMC642022 Khursheed, T., Ovseiko, P. V., Harifi, G., Badsha, H., Cheng, Y. K., Hill, C. L., . . . Gupta, L. (2022). Gender equity in rheumatology leadership in the Asia-Pacific. Rheumatology Advances in Practice, 6(3).
Scopus92022 Goggi, J. L., Hartimath, S. V., Khanapur, S., Ramasamy, B., Chin, Z. F., Cheng, P., . . . Robins, E. G. (2022). Imaging Memory T-Cells Stratifies Response to Adjuvant Metformin Combined with αPD-1 Therapy. International Journal of Molecular Sciences, 23(21), 10 pages.
Scopus5 Europe PMC42021 Farquhar, H., Vargas-Santos, A. B., Pisaniello, H. L., Fisher, M., Hill, C., Gaffo, A. L., & Stamp, L. K. (2021). Efficacy and safety of urate-lowering therapy in people with kidney impairment: A GCAN-initiated literature review. Rheumatology Advances in Practice, 5(1), 13 pages.
Scopus11 WoS7 Europe PMC82021 Robson, J., Mackie, S., & Hill, C. (2021). Patient Reported Outcomes in Large Vessel Vasculitides. Current Rheumatology Reports, 23(2), 6 pages.
Scopus2 WoS1 Europe PMC22021 Robson, J. C., Almeida, C., Dawson, J., Bromhead, A., Dures, E., Guly, C., . . . Hill, C. (2021). Patient perceptions of health-related quality of life in giant cell arteritis; international development of a disease-specific Patient-Reported Outcome Measure.. Rheumatology (Oxford, England), 60(10), 4671-4680.
Scopus13 Europe PMC112021 Lambert, R., Burgess, N., Hillock, N., Gailer, J., Hissaria, P., Merlin, T., . . . Hill, C. (2021). South Australian Medicines Evaluation Panel in review: providing evidence-based guidance on the use of high-cost medicines in the South Australian public health system. Australian Health Review, 45(2), 207-213.
2021 Wang, Y., Jones, G., Hill, C., Wluka, A. E., Forbes, A. B., Tonkin, A., . . . Cicuttini, F. M. (2021). Effect of atorvastatin on knee cartilage volume in patients with symptomatic knee osteoarthritis: results from a randomised placebo-controlled trial. Arthritis and Rheumatology, 73(11), 2035-2043.
Scopus20 WoS3 Europe PMC172021 Pathmanathan, K., Robinson, P. C., Hill, C. L., & Keen, H. I. (2021). The prevalence of gout and hyperuricaemia in Australia: An updated systematic review. Seminars in Arthritis and Rheumatism, 51(1), 121-128.
Scopus49 WoS18 Europe PMC322021 Monti, S., Craven, A., Klersy, C., Montecucco, C., Caporali, R., Watts, R., . . . Gaffo, A. L. (2021). Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes. Rheumatology United Kingdom, 60(2), 617-628.
Scopus34 Europe PMC252021 Pisaniello, H. L., Fisher, M. C., Farquhar, H., Vargas-Santos, A. B., Hill, C. L., Stamp, L. K., & Gaffo, A. L. (2021). Efficacy and safety of gout flare prophylaxis and therapy use in people with chronic kidney disease: a Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)-initiated literature review. Arthritis Research and Therapy, 23(1), 18 pages.
Scopus27 WoS13 Europe PMC192021 Tam, L. S., Tanaka, Y., Handa, R., Li, Z., Lorenzo, J. P., Louthrenoo, W., . . . Haq, S. A. (2021). Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic. International Journal of Rheumatic Diseases, 24(6), 733-745.
Scopus28 WoS20 Europe PMC212021 Safiri, S., Kolahi, A. A., Cross, M., Hill, C., Smith, E., Carson-Chahhoud, K., . . . Buchbinder, R. (2021). Prevalence, Deaths, and Disability-Adjusted Life Years Due to Musculoskeletal Disorders for 195 Countries and Territories 1990–2017. Arthritis and Rheumatology, 73(4), 702-714.
Scopus217 WoS92 Europe PMC1722021 Rischin, A., Liew, D., Black, R., Fletcher, A., Buchbinder, R., Lassere, M., . . . Hill, C. (2021). Healthcare access and attitudes towards telehealth during the early phase of the COVID ‐19 pandemic among an Australian cohort with inflammatory arthritis. Internal Medicine Journal, 51(5), 788-792.
Scopus4 WoS3 Europe PMC42021 Davis, C. R., Ruediger, C. D., Dyer, K. A., Lester, S., Graf, S. W., Kroon, F. P. B., . . . Hill, C. L. (2021). Colchicine is not effective for reducing osteoarthritic hand pain compared to placebo: a randomised, placebo-controlled trial (COLAH). Osteoarthritis and Cartilage, 29(2), 208-214.
Scopus31 WoS11 Europe PMC202021 Venter, G., Tieu, J., Black, R., Lester, S., Leonardo, N., Whittle, S. L., . . . Hill, C. L. (2021). PERSPECTIVES OF GLUCOCORTICOID USE IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS. ACR Open Rheumatology, 3(4), 231-238.
Scopus13 WoS7 Europe PMC92021 Khadra, Y., Walker, J. G., Hakendorf, P., Proudman, S., Rischmueller, M., Hill, C. L., . . . Roberts-Thomson, P. J. (2021). Scleroderma renal crisis: observations from the South Australian Scleroderma Register. Internal Medicine Journal, 51(2), 235-242.
Scopus1 WoS12021 Arnold, J. B., Halstead, J., Grainger, A. J., Keenan, A. -M., Hill, C. L., & Redmond, A. C. (2021). Foot and leg muscle weakness in people with midfoot osteoarthritis. Arthritis Care and Research, 73(6), 772-780.
Scopus18 WoS10 Europe PMC152021 Wiese, M. D., Hopkins, A. M., King, C., Wechalekar, M. D., Lee, A., Spargo, L., . . . Proudman, S. M. (2021). Precision Medicine With Leflunomide: Consideration of the DHODH Haplotype and Plasma Teriflunomide Concentration and Modification of Outcomes in Patients With Rheumatoid Arthritis. Arthritis Care and Research, 73(7), 983-989.
Scopus9 WoS4 Europe PMC32021 Fairley, J., Hansen, D., Proudman, S., Sahhar, J., Ngian, G. -S., Walker, J., . . . Nikpour, M. (2021). Clinical characteristics and survival in systemic sclerosis-mixed connective tissue disease and systemic sclerosis-overlap syndrome. Arthritis Care and Research, 73(5), 732-741.
Scopus18 WoS9 Europe PMC142021 McKenzie, B. J., Whittle, S. L., Johnston, R. V., Hill, C. L., Pardo Pardo, J., Glennon, V., . . . Buchbinder, R. (2021). Long-term glucocorticoids for rheumatoid arthritis. Cochrane Database of Systematic Reviews, 2021(12), 17 pages.
Scopus2 WoS12021 Hill, C. L. (2021). Tapering and withdrawal in patients with rheumatoid arthritis in stable remission. Lancet Rheumatology, 3(11), e739-e741.
2021 Hill, C. L., Rowett, D., & Dartnell, J. (2021). Improving the quality use of highly specialised drugs. Australian Prescriber, 44(5), 144-145.
2021 Bryant, M. J., Schubert, J. P., Black, R. J., & Hill, C. L. (2021). Patient-Reported Experience Measures in outpatient rheumatology care: A systematic review. Rheumatology Advances in Practice, 5(3), 10 pages.
Scopus6 Europe PMC42021 Wang, Y., Teichtahl, A. J., Jones, G., Keen, H. I., Hill, C. L., Wluka, A. E., . . . Cicuttini, F. M. (2021). METHODS - A randomised controlled trial of METhotrexate to treat Hand Osteoarthritis with Synovitis: study protocol for a randomised controlled trial. BMC Musculoskeletal Disorders, 22(1), 953-1-953-11.
Scopus3 WoS1 Europe PMC42021 Sattui, S. E., Conway, R., Putman, M. S., Seet, A. M., Gianfrancesco, M. A., Beins, K., . . . Perez Alamino, R. (2021). Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study. The Lancet Rheumatology, 3(12), e855-e864.
Scopus52 WoS36 Europe PMC342021 Glennon, V., Whittle, S. L., Hill, C. L., Johnston, R. V., Avery, J. C., Grobler, L., . . . Buchbinder, R. (2021). Short-term glucocorticoids for flares in people with rheumatoid arthritis receiving disease-modifying anti-rheumatic drugs (DMARDs). Cochrane Database of Systematic Reviews, 2021(11), 16 pages.
Scopus52021 Hoa, S., Bernatsky, S., Baron, M., Proudman, S., Stevens, W., Sahhar, J., . . . Zochling, J. (2021). Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis. Chest, 160(6), 2158-2162.
Scopus7 WoS3 Europe PMC52021 Cai, G., Aitken, D., Laslett, L. L., Hill, C., Wluka, A. E., March, L., . . . Jones, G. (2021). The association between change in bone marrow lesion size and change in tibiofemoral cartilage volume and knee symptoms. Rheumatology, 60(6), 2791-2800.
Scopus14 WoS5 Europe PMC102021 Adams, L., Lester, S., Hoon, E., van der Haak, H., Proudman, C., Hall, C., . . . Hill, C. L. (2021). Patient satisfaction and acceptability with telehealth at specialist medical outpatient clinics during the COVID-19 pandemic in Australia.. Internal medicine journal, 51(7), 1028-1037.
Scopus38 WoS20 Europe PMC322021 Tieu, J., Cheah, J. T., Black, R. J., Christensen, R., Ghosh, N., Richards, P., . . . Hill, C. L. (2021). Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set. Seminars in Arthritis and Rheumatism, 51(5), 1139-1145.
Scopus13 WoS1 Europe PMC62021 Jones, B., Flurey, C. A., Proudman, S., Ferreira, R. J. O., Voshaar, M., Hoogland, W., . . . Boers, M. (2021). Considerations and priorities for incorporating the patient perspective on remission in rheumatoid arthritis: An OMERACT 2020 special interest group report. Seminars in Arthritis and Rheumatism, 51(5), 1108-1112.
Scopus9 WoS7 Europe PMC52021 Stamp, L. K., Farquhar, H., Pisaniello, H. L., Vargas-Santos, A. B., Fisher, M., Mount, D. B., . . . Gaffo, A. L. (2021). Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities. Nature Reviews Rheumatology, 17(10), 633-641.
Scopus53 WoS23 Europe PMC392021 Twohig, H., Owen, C., Muller, S., Mallen, C. D., Mitchell, C., Hider, S., . . . Mackie, S. L. (2021). Outcomes measured in polymyalgia rheumatica and measurement properties of instruments considered for the OMERACT core outcome set: A systematic review. Journal of Rheumatology, 48(6), 883-893.
Scopus16 WoS9 Europe PMC112021 New-Tolley, J., Reynolds, A. C., Appleton, S. L., Gill, T. K., Lester, S., Adams, R. J., & Hill, C. L. (2021). Sleep disorders and gout in Australian adults. BMC Rheumatology, 5(1), 1-7.
Scopus7 WoS1 Europe PMC52021 Stanton, T. R., Braithwaite, F. A., Butler, D., Moseley, G. L., Hill, C., Milte, R., . . . Bennell, K. (2021). The EPIPHA-KNEE trial: Explaining Pain to target unhelpful pain beliefs to Increase PHysical Activity in KNEE osteoarthritis – a protocol for a multicentre, randomised controlled trial with clinical- and cost-effectiveness analysis. BMC Musculoskeletal Disorders, 22(1), 738-1-738-22.
Scopus5 WoS1 Europe PMC32021 Bruera, S., Carmona, L., Lopez-Olivo, M. A., Westrich-Robertson, T., March, L., Negron, J. B., . . . Suarez-Almazor, M. E. (2021). Development of a patient-centered core domain set for prospective observational longitudinal outcome studies in rheumatoid arthritis: an OMERACT initiative. Seminars in Arthritis and Rheumatism, 51(5), 1113-1116.
Scopus5 WoS32021 Mirza, S. Z., Cheah, J. T. L., Ghosh, N., Robson, J. C., Hill, C. L., Singh, J., . . . Goodman, S. M. (2021). The Patients' Perspective of Important Glucocorticoid Effects: A Nominal Group Study among Patients with Systemic Lupus Erythematosus and Myositis. Journal of Clinical Rheumatology, 27(6), 232-238.
Scopus8 WoS2 Europe PMC42021 Kroon, F. P. B., van der Heijde, D., Maxwell, L. J., Beaton, D. E., Abishek, A., Berenbaum, F., . . . Kloppenburg, M. (2021). Core outcome measurement instrument selection for physical function in hand osteoarthritis using the OMERACT Filter 2.1 process. Seminars in Arthritis and Rheumatism, 51(6), 1311-1319.
Scopus5 WoS1 Europe PMC42021 Sattui, S. E., Liew, J. W., Kennedy, K., Sirotich, E., Putman, M., Moni, T. T., . . . Sparks, J. A. (2021). Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: Results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. RMD Open, 7(3), 1-10.
Scopus139 WoS97 Europe PMC1022021 Rasch, L., Boers, M., Lems, W., van Schaardenburg, D., Proudman, S., Hill, C. L., . . . van Tuyl, L. (2021). Patient perspective on remission in rheumatoid arthritis: Validation of patient reported outcome instruments to measure absence of disease activity. Seminars in Arthritis and Rheumatism, 51(6), 1360-1369.
Scopus3 WoS1 Europe PMC22021 Hausmann, J. S., Kennedy, K., Simard, J. F., Liew, J. W., Sparks, J. A., Moni, T. T., . . . Richards, D. P. (2021). Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases. The Lancet Rheumatology, 3(10), e707-e714.
Scopus46 WoS32 Europe PMC372021 Maxwell, L. J., Beaton, D. E., Boers, M., D'Agostino, M. A., Conaghan, P. G., Grosskleg, S., . . . Wells, G. A. (2021). The evolution of instrument selection for inclusion in core outcome sets at OMERACT: Filter 2.2. Seminars in Arthritis and Rheumatism, 51(6), 1320-1330.
Scopus37 WoS15 Europe PMC202021 Austin, K., Dures, E., Almeida, C., Cramp, F., Guly, C. M., Hill, C. L., . . . Robson, J. C. (2021). Patient perceptions of physical activity after a diagnosis of Giant Cell Arteritis: analysis of multinational qualitative data. Arthritis Care & Research, 74(1), 99-106.
Scopus1 WoS1 Europe PMC12021 Bhushan, V., Lester, S., Briggs, L., Hijjawi, R., Shanahan, E. M., Pontifex, E., . . . Wechalekar, M. D. (2021). Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis. Frontiers in Medicine, 8, 11 pages.
Scopus11 WoS4 Europe PMC42020 Stanton, T. R., Karran, E. L., Butler, D. S., Hull, M. J., Schwetlik, S. N., Braithwaite, F. A., . . . Bennell, K. (2020). A pain science education and walking program to increase physical activity in people with symptomatic knee osteoarthritis: A feasibility study. PAIN Reports, 5(5), e830-1-e830-13.
Scopus21 WoS122020 Brown, Z., Metcalf, R., Bednarz, J., Spargo, L., Lee, A., Hill, C., . . . Proudman, S. (2020). Modifiable Lifestyle Factors Associated With Response to Treatment in Early Rheumatoid Arthritis. Acr Open Rheumatology, 2(6), 371-377.
Scopus7 WoS5 Europe PMC72020 Yates, M., Owen, C. E., Muller, S., Graham, K., Neill, L., Twohig, H., . . . Hill, C. L. (2020). Feasibility and Face Validity of Outcome Measures for Use in Future Studies of Polymyalgia Rheumatica: An OMERACT Study. Journal of Rheumatology, 47(9), 1379-1384.
Scopus10 WoS5 Europe PMC62020 Keen, H. I., Robinson, P. C., Dalbeth, N., & Hill, C. (2020). Time to recognise gout as a chronic disease. Medical Journal of Australia, 212(6), 285-285.e1.
Scopus4 WoS3 Europe PMC32020 Reynolds, A. C., Marshall, N. S., Hill, C. L., & Adams, R. J. (2020). Systematic review of the efficacy of commonly prescribed pharmacological treatments for primary treatment of sleep disturbance in patients with diagnosed autoimmune disease. Sleep Medicine Reviews, 49, 16 pages.
Scopus4 WoS4 Europe PMC32020 Laslett, L. L., Antony, B., Wluka, A. E., Hill, C., March, L., Keen, H. I., . . . Jones, G. (2020). KARAOKE: Krill oil versus placebo in the treatment of knee osteoarthritis: protocol for a randomised controlled trial. Trials, 21(1), 79.
Scopus14 Europe PMC82020 Shanahan, E. M., Glaezter, K., Gill, T., Hill, C., Graf, S., & Allcroft, P. (2020). A case series of suprascapular nerve block (with an historical comparator) for shoulder pain in motor neurone disease.. Palliat Med, 34(8), 269216320929553.
Scopus5 WoS3 Europe PMC32020 Leonardo, N., Lester, S., Graham, M., Barett, C., Whittle, S., Rowett, D., . . . Hill, C. L. (2020). Selection and perception of methotrexate treatment information in people with rheumatoid arthritis. International Journal of Rheumatic Diseases, 23(6), 805-812.
Scopus20 WoS13 Europe PMC142020 Fletcher, A., Lassere, M., March, L., Hill, C., Carroll, G., Barrett, C., & Buchbinder, R. (2020). Oral Complementary Medicine Use among People with Inflammatory Arthritis: An Australian Rheumatology Association Database Analysis. International Journal of Rheumatology, 2020, 9 pages.
Scopus6 WoS62020 Reid, A. B., Wiese, M., McWilliams, L., Metcalf, R., Hall, C., Lee, A., . . . Proudman, S. M. (2020). Repeat serological testing for anti-citrullinated peptide antibody after commencement of therapy is not helpful in patients with seronegative rheumatoid arthritis. Internal Medicine Journal, 50(7), 818-822.
Scopus3 WoS3 Europe PMC22020 Ryan, J., Tieu, J., Bose, B., Francis, R., Gingold, M., Goh, L., . . . Kitching, R. (2020). Formation of the Australia and New Zealand Vasculitis Society to improve the care of patients with Vasculitis in Australian and New Zealand. Internal Medicine Journal, 50(7), 781-783.
Scopus2 WoS1 Europe PMC12020 Safiri, S., Kolahi, A. A., Smith, E., Hill, C., Bettampadi, D., Mansournia, M. A., . . . Cross, M. (2020). Global, regional and national burden of osteoarthritis 1990-2017: A systematic analysis of the Global Burden of Disease Study 2017. Annals of the Rheumatic Diseases, 79(6), 819-828.
Scopus866 WoS509 Europe PMC6162020 Ruediger, C., Nguyen, L., Black, R., Proudman, S., & Hill, C. (2020). Efficacy of Methotrexate in Polymyalgia Rheumatica in routine rheumatology clinical care.. Internal medicine journal, 50(9), 1067-1072.
Scopus7 WoS1 Europe PMC32020 Cai, G., Aitken, D., Laslett, L. L., Pelletier, J. P., Martel-Pelletier, J., Hill, C., . . . Jones, G. (2020). Effect of Intravenous Zoledronic Acid on Tibiofemoral Cartilage Volume among Patients with Knee Osteoarthritis with Bone Marrow Lesions: A Randomized Clinical Trial. JAMA - Journal of the American Medical Association, 323(15), 1456-1466.
Scopus84 WoS48 Europe PMC622020 Cheah, J. T., Robson, J. C., Black, R. J., Goodman, S. M., Lester, S., Mackie, S. L., & Hill, C. L. (2020). The patient's perspective of the adverse effects of glucocorticoid use: A systematic review of quantitative and qualitative studies. From an OMERACT working group. Seminars in Arthritis and Rheumatism, 50(5), 996-1005.
Scopus24 WoS11 Europe PMC172020 Patel, S., Morrisroe, K., Proudman, S., Hansen, D., Sahhar, J., Sim, M. R., . . . Australian Scleroderma Interest Group. (2020). Occupational silica exposure in an Australian systemic sclerosis cohort. Rheumatology, 59(12), 3900-3905.
Scopus27 WoS11 Europe PMC132020 Beleigoli, A. M., Appleton, S. L., Gill, T. K., Hill, C. L., & Adams, R. J. (2020). Association of metabolic phenotypes, grip strength and diabetes risk: The 15-year follow-up of The North West Adelaide Health Study, Australia.. Obes Res Clin Pract, 14(6), 536-541.
Scopus4 WoS4 Europe PMC32020 Gill, T. K., Shanahan, E. M., Tucker, G. R., Buchbinder, R., & Hill, C. L. (2020). Shoulder range of movement in the general population: age and gender stratified normative data using a community-based cohort. BMC Musculoskeletal Disorders, 21(1), 676-1-676-9.
Scopus52 WoS15 Europe PMC292020 Stevens, D., Appleton, S., Vincent, A. D., Melaku, Y., Martin, S., Gill, T., . . . Wittert, G. (2020). Associations of OSA and Nocturnal Hypoxemia with Strength and Body Composition in Community Dwelling Middle Aged and Older Men. Nature and Science of Sleep, 12, 959-968.
Scopus9 WoS2 Europe PMC42020 McCradden, M. D., Joshi, S., Anderson, J. A., Mazwi, M., Goldenberg, A., & Shaul, R. Z. (2020). Patient safety and quality improvement: Ethical principles for a regulatory approach to bias in healthcare machine learning. Journal of the American Medical Informatics Association, 27(12), 2024-2027.
Scopus69 Europe PMC372020 Morrisroe, K., Hansen, D., Huq, M., Stevens, W., Sahhar, J., Ngian, G. -S., . . . Nikpour, M. (2020). Incidence, risk factors and outcomes of cancer in systemic sclerosis. Arthritis Care and Research, 72(11), 1625-1635.
Scopus45 WoS25 Europe PMC222020 Morrisroe, K., Stevens, W., Sahhar, J., Ngian, G. -S., Ferdowsi, N., Hansen, D., . . . Nikpour, M. (2020). The clinical and economic burden of systemic sclerosis related interstitial lung disease.. Rheumatology (Oxford, England), 59(8), 1878-1888.
Scopus25 WoS20 Europe PMC142019 Proudman, C., Lester, S. E., Gonzalez-Chica, D. A., Gill, T. K., Dalbeth, N., & Hill, C. L. (2019). Gout, flares, and allopurinol use: A population-based study. Arthritis Research and Therapy, 21(1), 1-8.
Scopus25 WoS16 Europe PMC182019 Ninan, J. V., Lester, S., & Hill, C. L. (2019). Diagnosis and management of giant cell arteritis: an Asia-Pacific perspective. International Journal of Rheumatic Diseases, 22(S1), 28-40.
Scopus11 WoS8 Europe PMC72019 Cai, G., Laslett, L. L., Aitken, D., Cicuttini, F., March, L., Hill, C., . . . Jones, G. (2019). Zoledronic acid plus methylprednisolone versus zoledronic acid or placebo in symptomatic knee osteoarthritis: a randomized controlled trial. Therapeutic Advances in Musculoskeletal Disease, 11, 1-12.
Scopus11 WoS6 Europe PMC62019 Aydin, S., Robson, J., Sreih, A., Hill, C., Alibaz-Oner, F., Mackie, S., . . . Merkel, P. (2019). Update on outcome measure development in large-vessel vasculitis: Report from OMERACT 2018. Journal of Rheumatology, 46(9), 1198-1201.
Scopus20 WoS11 Europe PMC122019 Black, R. J., Richards, B., Lester, S., Buchbinder, R., Barrett, C., Lassere, M., . . . Hill, C. L. (2019). Factors associated with commencing and ceasing opioid therapy in patients with rheumatoid arthritis. Seminars in Arthritis and Rheumatism, 49(3), 351-357.
Scopus13 WoS6 Europe PMC72019 Melaku, Y. A., Gill, T. K., Appleton, S. L., Hill, C., Boyd, M. A., & Adams, R. J. (2019). Sociodemographic, lifestyle and metabolic predictors of all-cause mortality in a cohort of community-dwelling population: An 18-year follow-up of the North West Adelaide Health Study. BMJ Open, 9(8), e030079.
Scopus4 WoS3 Europe PMC32019 Hoon, E., Ruediger, C., Gill, T., Black, R., & Hill, C. (2019). A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis. Open Access Rheumatology : Research and Reviews, 11, 189-198.
Scopus10 WoS5 Europe PMC62019 Nguyen, A. D., Crowhurst, T., Lester, S., Dobson, R., Bartholomeusz, D., & Hill, C. (2019). The utility of fluorine-18-fluorodeoxyglucose positron emission tomography in the diagnosis and monitoring of large vessel vasculitis: A South Australian retrospective audit. International Journal of Rheumatic Diseases, 22(8), 1378-1382.
Scopus5 WoS6 Europe PMC32019 Sinnathurai, P., Bartlett, S. J., Halls, S., Hewlett, S., Orbai, A. M., Buchbinder, R., . . . March, L. (2019). Investigating Dimensions of Stiffness in Rheumatoid and Psoriatic Arthritis: The Australian Rheumatology Association Database Registry and OMERACT Collaboration. The Journal of rheumatology, 46(11), 1462-1469.
Scopus5 WoS3 Europe PMC42019 Owen, C. E., Yates, M., Twohig, H., Muller, S., Neill, L. M., Harrison, E., . . . Mackie, S. L. (2019). Toward a core outcome measurement set for polymyalgia rheumatica: Report from the OMERACT 2018 special interest group. Journal of Rheumatology, 46(10), 1360-1364.
Scopus6 WoS4 Europe PMC42019 Ying Chan, F. L., Lester, S., Whittle, S. L., & Hill, C. L. (2019). The utility of ESR, CRP and platelets in the diagnosis of GCA. BMC Rheumatology, 3(1), 7 pages.
Scopus42 WoS26 Europe PMC262019 Gates, L. S., Arden, N. K., Hannan, M. T., Roddy, E., Gill, T. K., Hill, C. L., . . . Golightly, Y. M. (2019). Prevalence of foot pain across an international consortium of population based cohorts. Arthritis care & research, 71(5), 661-670.
Scopus32 WoS13 Europe PMC232019 Cheah, J. T. L., Black, R. J., Robson, J. C., Navarro-Millán, I. Y., Young, S. R., Richards, P., . . . Hill, C. L. (2019). Toward a core domain set for glucocorticoid impact in inflammatory rheumatic diseases: The OMERACT 2018 glucocorticoid impact working group. Journal of Rheumatology, 46(9), 1179-1182.
Scopus10 WoS8 Europe PMC52019 Ramiro, S., Page, M. J., Whittle, S. L., Huang, H., Verhagen, A. P., Beaton, D. E., . . . Buchbinder, R. (2019). The OMERACT core domain set for clinical trials of shoulder disorders. The Journal of Rheumatology, 46(8), 969-975.
Scopus34 WoS22 Europe PMC272019 Andersen, K., Cheah, J., March, L., Bartlett, S., Beaton, D., Bingham, C., . . . Simon, L. (2019). Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT premeeting toward consensus on core sets for randomized controlled trials. Journal of Rheumatology, 46(8), 1053-1058.
Scopus9 WoS7 Europe PMC52019 Craig, E. T., Orbai, A. M., Mackie, S., Bartlett, S. J., Bingham, C. O., Goodman, S., . . . Halls, S. (2019). Advancing stiffness measurement in rheumatic disease: report from the stiffness special interest group at OMERACT 2018. Journal of Rheumatology, 46(10), 1374-1378.
Scopus7 WoS5 Europe PMC52019 Blacketer, C., Gill, T., Taylor, A., & Hill, C. (2019). Prevalence and healthcare usage of knee pain in South Australia: a population‐based study. INTERNAL MEDICINE JOURNAL, 49(9), 1105-1110.
Scopus5 WoS2 Europe PMC22019 Brown, Z., Metcalf, R., Bednarz, J., Stavrou, C., Spargo, L., James, M., & Proudman, S. (2019). Modifiable Factors Associated with Response to Treatment in Early Rheumatoid Arthritis. ARTHRITIS & RHEUMATOLOGY, 71, 3 pages.
WoS12019 Johns, C. S., Kiely, D. G., Rajaram, S., Hill, C., Thomas, S., Karunasaagarar, K., . . . Swift, A. J. (2019). Diagnosis of pulmonary hypertension with cardiac MRI: Derivation and validation of regression models. Radiology, 290(1), 61-68.
Scopus53 Europe PMC422019 Barker, N., Fidock, B., Johns, C. S., Kaur, H., Archer, G., Rajaram, S., . . . Garg, P. (2019). A systematic review of right ventricular diastolic assessment by 4D flow CMR. BioMed Research International, 2019, 6074984-1-6074984-8.
Scopus24 Europe PMC202019 Morrisroe, K., Stevens, W., Sahhar, J., Ngian, G. -S., Ferdowsi, N., Hansen, D., . . . Nikpour, M. (2019). The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia. BMC Pulmonary Medicine, 19(1), 226-1-226-11.
Scopus7 WoS6 Europe PMC42019 Morrisroe, K., Stevens, W., Sahhar, J., Ngian, G. -S., Ferdowsi, N., Hill, C. L., . . . Nikpour, M. (2019). Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden. Arthritis Research and Therapy, 21(1), 299-1-299-12.
Scopus46 WoS30 Europe PMC232019 Staples, M. P., March, L., Hill, C., Lassere, M., & Buchbinder, R. (2019). Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: An update from the Australian Rheumatology Association Database (ARAD) prospective cohort study. BMC Rheumatology, 3(1), 7 pages.
Scopus15 WoS122018 Dumas, A., Toutain, S., Hill, C., & Simmat-Durand, L. (2018). Warning about drinking during pregnancy: Lessons from the French experience. Reproductive Health, 15(1), 20.
Scopus25 Europe PMC122018 Chin, M., Johns, C., Currie, B. J., Weatherley, N., Hill, C., Elliot, C., . . . Swift, A. J. (2018). Pulmonary Artery Size in Interstitial Lung Disease and Pulmonary Hypertension: Association with Interstitial Lung Disease Severity and Diagnostic Utility. Frontiers in Cardiovascular Medicine, 5.
Scopus392018 Quadery, S. R., Swift, A. J., Billings, C. G., Thompson, A. A. R., Elliot, C. A., Hurdman, J., . . . Kiely, D. G. (2018). The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension. European Respiratory Journal, 52(3), 1800589.
Scopus92 Europe PMC662018 Currie, B. J., Johns, C., Chin, M., Charalampopolous, T., Elliot, C. A., Garg, P., . . . Swift, A. J. (2018). CT derived left atrial size identifies left heart disease in suspected pulmonary hypertension: Derivation and validation of predictive thresholds. International Journal of Cardiology, 260, 172-177.
Scopus19 Europe PMC172018 Sinnathurai, P., Buchbinder, R., Hill, C., Lassere, M., & March, L. (2018). Comorbidity in psoriatic arthritis and rheumatoid arthritis. Internal Medicine Journal, 48(11), 1360-1368.
Scopus26 WoS21 Europe PMC182018 Lee, J. L., Sinnathurai, P., Buchbinder, R., Hill, C., Lassere, M., & March, L. (2018). Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study. Arthritis Research and Therapy, 20(1), 171-1-171-9.
Scopus104 WoS81 Europe PMC642018 Khoo, T., Caughey, G., Hill, C., & Limaye, V. (2018). Proton pump inhibitors are not associated with inflammatory myopathies: A case control study. Muscle and Nerve, 58(6), 855-857.
Scopus4 WoS3 Europe PMC22018 Bourne, A. M., Johnston, R. V., Cyril, S., Briggs, A. M., Clavisi, O., Duque, G., . . . Buchbinder, R. (2018). Scoping review of priority setting of research topics for musculoskeletal conditions. BMJ Open, 8(12), e023962-1-e023962-9.
Scopus33 WoS23 Europe PMC272018 Morrisroe, K., Nakayama, A., Soon, J., Arnold, M., Barnsley, L., Barrett, C., . . . Buchbinder, R. (2018). EVOLVE: The Australian Rheumatology Association’s ‘top five’ list of investigations and interventions doctors and patients should question. Internal Medicine Journal, 48(2), 135-143.
Scopus15 WoS12 Europe PMC132018 McLean, J., Brumby-Rendell, O., Lisle, R., Brazier, J., Dunn, K., Gill, T., . . . Leith, J. (2018). Asymptomatic population reference values for three knee patient-reported outcomes measures: evaluation of an electronic data collection system and implications for future international, multi-centre cohort studies. Archives of Orthopaedic and Trauma Surgery, 138(5), 611-621.
Scopus5 WoS4 Europe PMC32018 Appleton, S., Gill, T., Taylor, A., McEvoy, D., Shi, Z., Hill, C., . . . Adams, R. (2018). Influence of gender on associations of obstructive sleep Apnea symptoms with chronic conditions and quality of life. International Journal of Environmental Research and Public Health, 15(5), 12 pages.
Scopus39 WoS26 Europe PMC282018 Caughey, G. E., Gabb, G., Ronson, S., Ward, M., Hill, C., Beukelman, T. G., & Limaye, V. (2018). Association of Statin Exposure with Histologically-Confirmed Idiopathic Inflammatory Myositis in an Australian Population. JAMA Internal Medicine, 178(9), 1224-1229.
Scopus21 WoS16 Europe PMC142018 Pisaniello, H., Lester, S., Gonzalez-Chica, D., Stocks, N., Longo, M., Sharplin, G., . . . Hill, C. (2018). Gout prevalence and predictors of urate-lowering therapy use: Results from a population-based study. Arthritis Research and Therapy, 20(1), 10 pages.
Scopus40 WoS31 Europe PMC222018 Aitken, D., Laslett, L. L., Cai, G., Hill, C., March, L., Wluka, A. E., . . . Jones, G. (2018). A protocol for a multicentre, randomised, double-blind, placebo-controlled trial to compare the effect of annual infusions of zoledronic acid to placebo on knee structural change and knee pain over 24 months in knee osteoarthritis patients - ZAP2. BMC Musculoskeletal Disorders, 19(1), 217.
Scopus27 WoS19 Europe PMC202017 Wilsdon, T. D., & Hill, C. L. (2017). Managing the drug treatment of rheumatoid arthritis. Australian Prescriber, 40(2), 51-58.
Scopus51 WoS42 Europe PMC232017 Proudman, S. M., Huq, M., Stevens, W., Wilson, M. E., Sahhar, J., Baron, M., . . . Hij, A. (2017). What have multicentre registries across the world taught us about the disease features of systemic sclerosis?. Journal of Scleroderma and Related Disorders, 2(3), 169-182.
Scopus23 WoS202017 Appleton, C. T., Hawker, G. A., Hill, C. L., & Pope, J. E. (2017). Editorial: “Weighing in” on the Framingham Osteoarthritis Study: Measuring Biomechanical and Metabolic Contributions to Osteoarthritis. Arthritis and Rheumatology, 69(6), 1127-1130.
Scopus12 WoS11 Europe PMC102017 Morrisroe, K., Stevens, W., Huq, M., Sahhar, J., Ngian, G. S., Zochling, J., . . . Walker, J. (2017). Validity of the PROMIS-29 in a large Australian cohort of patients with systemic sclerosis. Journal of Scleroderma and Related Disorders, 2(3), 188-195.
Scopus12 WoS82017 Black, R. J., Robson, J. C., Goodman, S. M., Hoon, E., Lai, L. Y. H., Simon, L. S., . . . Hill, C. L. (2017). A patient-reported outcome measure for effect of glucocorticoid therapy in adults with inflammatory diseases is needed: report from the OMERACT 2016 special interest group. Journal of Rheumatology, 44(11), 1754-1758.
Scopus22 WoS15 Europe PMC152017 van Tuyl, L. H. D., Sadlonova, M., Hewlett, S., Davis, B., Flurey, C., Goel, N., . . . Boers, M. (2017). The patient perspective on absence of disease activity in rheumatoid arthritis: a survey to identify key domains of patient-perceived remission. ANNALS OF THE RHEUMATIC DISEASES, 76(5), 7 pages.
Scopus72 WoS58 Europe PMC532017 Ninan, J., Lester, S., & Hill, C. (2017). Giant cell arteritis: beyond temporal artery biopsy and steroids. Internal Medicine Journal, 47(11), 1228-1240.
Scopus20 WoS16 Europe PMC172017 Hillock, N. T., Heard, S., Kichenadasse, G., Hill, C. L., & Andrews, J. (2017). Infliximab for ipilimumab-induced colitis: A series of 13 patients. Asia-Pacific Journal of Clinical Oncology, 13(5), e284-e290.
Scopus35 WoS19 Europe PMC192017 Gill, T. K., Menz, H. B., Landorf, K. B., Arnold, J. B., Taylor, A. W., & Hill, C. L. (2017). Identification of clusters of foot pain location in a community sample. Arthritis Care and Research, 69(12), 1903-1908.
Scopus8 WoS4 Europe PMC52017 Halls, S., Sinnathurai, P., Hewlett, S., Mackie, S. L., March, L., Bartlett, S. J., . . . Orbai, A. -M. (2017). Stiffness Is the Cardinal Symptom of Inflammatory Musculoskeletal Diseases, Yet Still Variably Measured: Report from the OMERACT 2016 Stiffness Special Interest Group.. The Journal of rheumatology, 44(12), 1904-1910.
Scopus13 WoS10 Europe PMC92017 Wechalekar, M., Quinn, S., Lester, S., Metcalf, R., Shanahan, E., Walker, J., . . . Proudman, S. (2017). A treat-to-target strategy preserves work capacity in a rheumatoid arthritis inception cohort treated with combination conventional DMARD therapy. Journal of Clinical Rheumatology, 23(3), 131-137.
Scopus7 WoS7 Europe PMC72017 Morrisroe, K., Stevens, W., Sahhar, J., Rabusa, C., Nikpour, M., Proudman, S., . . . Zochling, J. (2017). Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme. Arthritis Research and Therapy, 19(1), 42-1-42-10.
Scopus73 WoS64 Europe PMC492017 Boulos, D., Ngian, G., Rajadurai, A., Elford, K., Stevens, W., Proudman, S., . . . Sahhar, J. (2017). Long-term efficacy and tolerability of mycophenolate mofetil therapy in diffuse scleroderma skin disease. International Journal of Rheumatic Diseases, 20(4), 481-488.
Scopus18 WoS10 Europe PMC92017 Morrisroe, K., Stevens, W., Huq, M., Sahhar, J., Ngian, G., Zochling, J., . . . ustralian Scleroderma Interest Group (ASIG). (2017). Validity of the Workers Productivity and Activity Impairment Questionnaire: Specific Health Problem (WPAI:SHP) in patients with systemic sclerosis. Clinical and Experimental Rheumatology, 35(4 Suppl. 106), S130-S137.
Scopus11 WoS4 Europe PMC142017 Walsh, T. P., Arnold, J. B., Gill, T. K., Evans, A. M., Yaxley, A., Hill, C. L., & Shanahan, E. M. (2017). Foot pain severity is associated with the ratio of visceral to subcutaneous fat mass, fat-mass index and depression in women. Rheumatology International, 37(7), 1175-1182.
Scopus13 WoS8 Europe PMC102017 Morrisroe, K., Stevens, W., Huq, M., Prior, D., Sahhar, J., Ngian, G., . . . Walker, J. (2017). Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension. Arthritis Research and Therapy, 19(1), 122.
Scopus60 WoS51 Europe PMC432017 Black, R., Lester, S., Buchbinder, R., Barrett, C., Lassere, M., March, L., . . . Hill, C. (2017). Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry. Arthritis Research and Therapy, 19(1), 253-1-253-8.
Scopus36 WoS27 Europe PMC242017 Morrisroe, K., Stevens, W., Sahhar, J., Ngian, G., Rabusa, C., Ferdowsi, N., . . . Nikpour, M. (2017). Quantifying the direct public health care cost of systemic sclerosis. Medicine, 96(48), e8503-1-e8503-11.
Scopus18 WoS12 Europe PMC122017 De Smit, E., Clarke, L., Sanfilippo, P. G., Merriman, T. R., Brown, M. A., Hill, C. L., & Hewitt, A. W. (2017). Geo-epidemiology of temporal artery biopsy-positive giant cell arteritis in Australia and New Zealand: is there a seasonal influence?. RMD Open, 3(2), e000531-1-e000531-8.
WoS15 Europe PMC162017 González-Chica, D., Hill, C., Gill, T., Hay, P., Haag, D., & Stocks, N. (2017). Individual diseases or clustering of health conditions? Association between multiple chronic diseases and health-related quality of life in adults. Health and Quality of Life Outcomes, 15(1), 244-1-244-9.
Scopus26 WoS17 Europe PMC262017 Mackie, S. L., Twohig, H., Neill, L. M., Harrison, E., Shea, B., Black, R. J., . . . Hill, C. L. (2017). The OMERACT core domain set for outcome measures for clinical trials in polymyalgia rheumatica. Journal of Rheumatology, 44(10), 1515-1521.
Scopus37 WoS26 Europe PMC272017 Rasch, L. A., Boers, M., Hill, C. L., Voshaar, M., Hoogland, W., De Wit, M., . . . Van Tuyl, L. H. D. (2017). Validating rheumatoid arthritis remission using the patients' perspective: Results from a special interest group at OMERACT 2016. Journal of Rheumatology, 44(12), 1889-1893.
Scopus15 WoS13 Europe PMC92017 Gill, T. K., & Hill, C. L. (2017). The accuracy of self-report in rheumatic diseases. Journal of Rheumatology, 44(8), 1109-1111.
Scopus6 WoS6 Europe PMC52017 Black, R. J., Goodman, S. M., Ruediger, C., Lester, S., Mackie, S. L., & Hill, C. L. (2017). A survey of glucocorticoid adverse effects and benefits in rheumatic diseases: The patient perspective. Journal of Clinical Rheumatology, 23(8), 416-420.
Scopus24 WoS19 Europe PMC152017 McLean, J. M., Cappelletto, G., Clarnette, J., Hill, C. L., Gill, T., Mandziak, D., & Leith, J. (2017). Normal population reference values for the Oxford and Harris Hip Scores - electronic data collection and its implications for clinical practice.. Hip Int, 27(4), 389-396.
Scopus21 WoS9 Europe PMC172017 Li, J., Appleton, S., Gill, T., Vakulin, A., Wittert, G., Antic, N., . . . Hill, C. (2017). Association of musculoskeletal joint pain with obstructive sleep apnea, daytime sleepiness, and poor sleep quality in men. Arthritis Care & Research, 69(5), 742-747.
Scopus24 WoS17 Europe PMC102017 Maundrell, A., Lester, S., Rischmueller, M., Hill, C., Cleland, L. G., Blumbergs, P., . . . Limaye, V. (2017). The PTPN22 gene is associated with idiopathic inflammatory myopathy. Muscle and Nerve, 55(2), 270-273.
Scopus4 WoS4 Europe PMC22017 Hoon, E., Smith, K., Black, J., Burnet, S., Hill, C., & Gill, T. (2017). Take Charge of Pain: Evaluating a community-targeted self-management education program for people with musculoskeletal pain. Health Promotion Journal of Australia, 28(1), 77-80.
Scopus5 WoS3 Europe PMC22016 Gill, T., Menz, H., Landorf, K., Arnold, J., Taylor, A., & Hill, C. (2016). Predictors of foot pain in the community: the North West Adelaide health study. Journal of Foot and Ankle Research, 9(1), 23-1-23-8.
Scopus16 WoS13 Europe PMC142016 Black, R. J., Hill, C. L., Lester, S., & Dixon, W. G. (2016). The association between systemic glucocorticoid use and the risk of cataract and glaucoma in patients with rheumatoid arthritis: a systematic review and meta- analysis. PLoS ONE, 11(11), e0166468.
Scopus41 WoS26 Europe PMC262016 Hill, C. L., Black, R. J., Nossent, J. C., Ruediger, C., Nguyen, L., Ninan, J. V., & Lester, S. (2016). Risk of mortality in patients with giant cell arteritis: a systematic review and meta-analysis. Seminars in Arthritis and Rheumatism, 46(4), 513-519.
Scopus64 WoS52 Europe PMC372016 Tieu, J., Lester, S., Whittle, S., Peh, C. A., Goldblatt, F., Proudman, S., . . . Hill, C. (2016). RITUXIMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS: A REVIEW OF USE IN SOUTH AUSTRALIA. INTERNAL MEDICINE JOURNAL, 46, 35. 2016 Milman, N., Whittle, S., Hill, C., El Sayad, J., & Wells, G. (2016). Methotrexate for polymyalgia rheumatica. Cochrane Database of Systematic Reviews, 2016(5), 9 pages.
2016 Milman, N., Hill, C., Whittle, S., El Sayad, J., & Wells, G. (2016). Methotrexate for giant cell arteritis. Cochrane Database of Systematic Reviews, 2016(5), 9 pages.
Scopus12016 Rasheed, H., Phipps-Green, A. J., Topless, R., Smith, M. D., Hill, C., Lester, S., . . . Merriman, T. R. (2016). Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout. Rheumatology, 55(8), 1421-1430.
Scopus17 WoS10 Europe PMC142016 Soon, J., Buchbinder, R., Close, J., Hill, C., Allan, S., & Turnour, C. (2016). Identifying low-value care: the Royal Australasian College of Physicians’ EVOLVE initiative. Medical Journal of Australia, 204(5), 180-181.e1.
Scopus18 WoS16 Europe PMC112016 De Smit, E., Kearns, L. S., Clarke, L., Dick, J., Hill, C. L., & Hewitt, A. W. (2016). Heterogeneity of Human Research Ethics Committees and Research Governance Offices across Australia: An observational study. AUSTRALASIAN MEDICAL JOURNAL, 9(2), 33-39.
WoS18 Europe PMC122016 Ting, K., Lester, S., Dunstan, E., & Hill, C. (2016). Association between histological features and clinical features of patients with biopsy positive giant cell arteritis. Clinical and Experimental Rheumatology, 34(3), S40-S43.
Scopus7 WoS62016 Ninan, J., Lester, S., & Hill, C. (2016). Giant cell arteritis. Best Practice and Research: Clinical Rheumatology, 30(1), 169-188.
Scopus34 WoS23 Europe PMC222016 Ting, K., Gill, T., Keen, H., Tucker, G., & Hill, C. (2016). Prevalence and associations of gout and hyperuricaemia: results from an Australian population-based study. Internal Medicine Journal, 46(5), 566-573.
Scopus51 WoS38 Europe PMC352016 van Tuyl, L., Sadlonova, M., Davis, B., Flurey, C., Goel, N., Hewlett, S., . . . Boers, M. (2016). Remission in Rheumatoid Arthritis: Working Toward Incorporation of the Patient Perspective at OMERACT 12. Journal of Rheumatology, 43(1), 203-207.
Scopus25 WoS22 Europe PMC162016 Owen, C., Ngian, G., Elford, K., Moore, O., Stevens, W., Nikpour, M., . . . Sahhar, J. (2016). Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort study. Clinical and Experimental Rheumatology, 34(5 (Suppl.100)), 170-176.
Scopus45 WoS31 Europe PMC212016 Lester, S., Hewitt, A., Ruediger, C., Bradbury, L., De Smit, E., Wiese, M., . . . Hill, C. (2016). PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis. RMD Open, 2(1), e000246-1-e000246-3.
Scopus8 WoS10 Europe PMC52016 Li, J., Wittert, G., Vincent, A., Atlantis, E., Shi, Z., Appleton, S., . . . Adams, R. (2016). Muscle grip strength predicts incident type 2 diabetes: population-based cohort study. Metabolism: Clinical and Experimental, 65(6), 883-892.
Scopus86 WoS71 Europe PMC692016 Walsh, T., Gill, T., Evans, A., Yaxley, A., Shanahan, E., & Hill, C. (2016). Association of fat mass and adipokines with foot pain in a community cohort. Arthritis Care and Research, 68(4), 526-533.
Scopus17 WoS14 Europe PMC132016 Wechalekar, M., Lester, S., Hill, C., Lee, A., Rischmueller, M., Smith, M., . . . Proudman, S. (2016). Active foot synovitis in patients with rheumatoid arthritis: unstable remission status, radiographic progression, and worse functional outcomes in patients with foot synovitis in apparent remission. Arthritis Care and Research, 68(11), 1616-1623.
Scopus34 WoS32 Europe PMC242016 Hill, C., March, L., Aitken, D., Lester, S., Battersby, R., Hynes, K., . . . Jones, G. (2016). Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose. Annals of the Rheumatic Diseases, 75(1), 23-29.
Scopus113 WoS71 Europe PMC832016 Helliwell, T., Brouwer, E., Pease, C., Hughes, R., Hill, C., Neill, L., . . . Mackie, S. (2016). Development of a provisional core domain set for polymyalgia rheumatica: Report from the OMERACT 12 Polymyalgia Rheumatica Working Group. Journal of Rheumatology, 43(1), 182-186.
Scopus26 WoS19 Europe PMC182016 Arnold, J., Wong, D., Jones, R., Hill, C., & Thewlis, D. (2016). Lateral Wedge Insoles for Reducing Biomechanical Risk Factors for Medial Knee Osteoarthritis Progression: A Systematic Review and Meta-Analysis.. Arthritis care & research, 68(7), 936-951.
Scopus55 WoS36 Europe PMC292016 Chen, J., Hill, C., Lester, S., Ruediger, C., Battersby, R., Jones, G., . . . March, L. (2016). Supplementation with omega-3 fish oil has no effect on bone mineral density in adults with knee osteoarthritis: a 2-year randomized controlled trial. Osteoporosis International, 27(5), 1897-1905.
Scopus23 WoS20 Europe PMC182016 Hill, C., Lester, S. E., & Jones, G. (2016). Response to 'Low-dose versus high-dose fish oil for pain reduction and function improvement in patients with knee osteoarthritis' by Chen et al. Annals of the Rheumatic Diseases, 75(1), e8.
Scopus3 WoS5 Europe PMC12016 Gill, T., Tucker, G., Avery, J., Shanahan, E., Menz, H., Taylor, A., . . . Hill, C. (2016). The use of self-report questions to examine the prevalence of musculoskeletal problems: a test-retest study. BMC Musculoskeletal Disorders, 17(1), 100-1-100-10.
Scopus9 WoS9 Europe PMC72016 Crook, A. M., Turkova, A., Musiime, V., Bwakura-Dangarembizi, M., Bakeera-Kitaka, S., Nahirya-Ntege, P., . . . Sculpher, M. J. (2016). Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy. BMC Medicine, 14(1), 50.
Scopus33 Europe PMC322015 Wu, C., Yan, B., & Shao, P. (2015). Exploring taxiing take-off control for unmanned aerial vehicle (UAV) based on fuzzy control. Xibei Gongye Daxue Xuebao Journal of Northwestern Polytechnical University, 33(1), 33-39.
Scopus92015 Rajaram, S., Swift, A. J., Condliffe, R., Johns, C., Elliot, C. A., Hill, C., . . . Kiely, D. G. (2015). CT features of pulmonary arterial hypertension and its major subtypes: A systematic CT evaluation of 292 patients from the ASPIRE Registry. Thorax, 70(4), 382-387.
Scopus94 Europe PMC552015 Wechalekar, M. D., Lester, S., Rischmueller, M., Hill, C., & Proudman, S. (2015). Foot Synovitis in Patients with Rheumatoid Arthritis in Apparent Remission Is Associated with Unstable Remission Status, Radiographic Progression and Worse Long-Term Functional Outcomes. ARTHRITIS & RHEUMATOLOGY, 67, 2 pages. 2015 Wang, Y., Tonkin, A., Jones, G., Hill, C., Ding, C., Wluka, A. E., . . . Cicuttini, F. M. (2015). Does statin use have a disease modifying effect in symptomatic knee osteoarthritis? Study protocol for a randomised controlled trial. Trials, 16(1), 584-1-584-10.
Scopus25 WoS22 Europe PMC162015 Wodkowski, M., Hudson, M., Proudman, S., Walker, J., Stevens, W., Nikpour, M., . . . Fritzler, M. J. (2015). Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects. Autoimmunity, 48(8), 542-551.
Scopus31 WoS26 Europe PMC202015 Quinlivan, A., Thakkar, V., Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., . . . Nikpour, M. (2015). Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Internal Medicine Journal, 45(11), 1134-1140.
Scopus21 WoS20 Europe PMC142015 Mackie, S., Koduri, G., Hill, C., Wakefield, R., Hutchings, A., Loy, C., . . . Wyatt, J. (2015). Accuracy of musculoskeletal imaging for the diagnosis of polymyalgia rheumatica: systematic review. RMD Open, 1(1), e000100-1-e000100-15.
Scopus62 WoS40 Europe PMC372015 Hill, C., Appleton, S., Black, J., Hoon, E., Rudd, R., Adams, R., & Gill, T. (2015). Role of health literacy in self-reported musculoskeletal disorders. Arthritis, 2015, 607472-1-607472-6.
WoS10 Europe PMC102015 Wodkowski, M., Hudson, M., Proudman, S., Walker, J., Stevens, W., Nikpour, M., . . . Salazar, G. (2015). Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: Evidence of an association with interstitial lung disease and worse survival. Clinical and Experimental Rheumatology, 33(4 (suppl.91)), 131-135.
Scopus64 WoS44 Europe PMC392015 Patterson, K., Roberts-Thomson, P., Lester, S., Tan, J., Hakendorf, P., Rischmueller, M., . . . Walker, J. (2015). Interpretation of an extended autoantibody profile in a well-characterized Australian systemic sclerosis (Scleroderma) cohort using principal components analysis. Arthritis and Rheumatology, 67(12), 3234-3244.
Scopus102 WoS81 Europe PMC622015 Ting, K., Hill, C., & Whittle, S. (2015). Quality of reporting of interventional animal studies in rheumatology: a systematic review using the ARRIVE guidelines. International Journal of Rheumatic Diseases, 18(5), 488-494.
Scopus35 WoS28 Europe PMC242015 Graf, S., Whittle, S., Wechalekar, M., Moi, J., Barrett, C., Hill, C., . . . Zochling, J. (2015). Australian and New Zealand recommendations for the diagnosis and management of gout: Integrating systematic literature review and expert opinion in the 3e Initiative. International Journal of Rheumatic Diseases, 18(3), 341-351.
Scopus52 WoS32 Europe PMC322015 Merriman, T. R., Phipps-Green, A., Topless, R., Smith, M. D., Hill, C., Lester, S., . . . Rasheed, H. (2015). Association of the Apolipoprotein A1-C3-A4 Gene Cluster with the Risk of Gout: Evidence for a Causal Role in Gout. ARTHRITIS & RHEUMATOLOGY, 67, 2 pages. 2015 Murray, D. D., Suzuki, K., Law, M., Trebicka, J., Neuhaus, J., Wentworth, D., . . . Hill, C. (2015). Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: a case control study. PLoS ONE, 10(10), e0139981-1-e0139981-23.
Scopus8 WoS9 Europe PMC62014 Morrisroe, K., Stevens, W., Nandurkar, H., Prior, D., Thakkar, V., Roddy, J., . . . Nikpour, M. (2014). The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis. Clinical and Experimental Rheumatology, 32(6 Suppl. 86), S133-S137.
Scopus29 WoS21 Europe PMC152014 Lester, S., Hewitt, A., Bradbury, L., De Smit, E., Harrison, A., Jones, G., . . . Hill, C. L. (2014). PTPN22 rs2476601 and Susceptibility to Biopsy Proven Giant Cell Arteritis (GCA) in an Australian Sample.. ARTHRITIS & RHEUMATOLOGY, 66, S341. 2014 Ting, K., Lester, S., & Hill, C. L. (2014). Association Between Histological Features and Clinical Features of Patients with Biopsy Positive Giant Cell Arteritis.. ARTHRITIS & RHEUMATOLOGY, 66, S345-S346. 2014 Mackie, S., Koduri, G., Hill, C. L., Hutchings, A., Wakefield, R. J., Dasgupta, B., & Wyatt, J. (2014). The Use of Imaging in the Diagnosis of Polymyalgia Rheumatica: Systematic Literature Review and Meta-Analysis. ARTHRITIS & RHEUMATOLOGY, 66, S1211. 2014 Dunstan, E., Lester, S., Rischmueller, M., Chan, H., Hewitt, A., & Hill, C. (2014). TLR4 polymorphism is not associated with biopsy proven giant cell arteritis. Clinical and Experimental Rheumatology, 32(SUPPL.82), S26-S29.
Scopus4 WoS4 Europe PMC42014 Cremin, K., Leo, P., Harris, J., De Smit, E., Bradbury, L., McKelvie, P., . . . Hewitt, A. (2014). Utility of temporal artery biopsy samples for genome-wide analysis of giant cell arteritis. Genes and Immunity, 15(5), 338-340.
Scopus1 WoS12014 Black, R. J., Spargo, L., Schultz, C., Chatterton, B., Cleland, L., Lester, S., . . . Proudman, S. M. (2014). Decline in hand bone mineral density indicates increased risk of erosive change in early rheumatoid arthritis. Arthritis Care & Research, 66(4), 515-522.
Scopus14 WoS14 Europe PMC102014 Gill, T., Hill, C., Shanahan, E., Taylor, A., Appleton, S., Grant, J., . . . Adams, R. (2014). Vitamin D levels in an Australian population. BMC Public Health, 14(Sep), 1001-1-1001-11.
Scopus69 WoS61 Europe PMC432014 Gill, T., Shanahan, E., Allison, D., Alcorn, D., & Hill, C. (2014). Prevalence of abnormalities on shoulder MRI in symptomatic and asymptomatic older adults. International Journal of Rheumatic Diseases, 17(8), 863-871.
Scopus56 WoS38 Europe PMC432014 Cross, M., Smith, E., Hoy, D., Nolte, S., Ackerman, I., Fransen, M., . . . March, L. (2014). The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study. Annals of the Rheumatic Diseases, 73(7), 1323-1330.
Scopus2633 WoS2028 Europe PMC19822014 Dunstan, E., Lester, S., Rischmueller, M., Dodd, T., Black, R., Ahern, M., . . . Hill, C. (2014). Epidemiology of biopsy-proven giant cell arteritis in South Australia. Internal Medicine Journal, 44(1), 32-39.
Scopus58 WoS46 Europe PMC442013 Gill, T., Shanahan, E., Taylor, A., Buchbinder, R., & Hill, C. (2013). Shoulder pain in the community: an examination of associative factors using a longitudinal cohort study. Arthritis Care & Research, 65(12), 2000-2007.
Scopus17 WoS14 Europe PMC112013 Appleton, S., Seaborn, C., Visvanathan, R., Hill, C., Gill, T., Taylor, A., & Adams, R. (2013). Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype. Diabetes Care, 36(8), 2388-2394.
Scopus405 WoS349 Europe PMC3052013 Appleton, S., Neo, C., Hill, C., Douglas, K., & Adams, R. (2013). Untreated hypertension: prevalence and patient factors and beliefs associated with under-treatment in a population sample. Journal of Human Hypertension, 27(7), 453-462.
Scopus18 WoS9 Europe PMC132013 Ng, K., Quinn, S., Gill, T., Hill, C., & Shanahan, E. (2013). Impact of the new national health standard for rail safety workers on ischaemic heart disease risk factors in train drivers. Internal Medicine Journal, 43(6), 650-655.
Scopus4 WoS2 Europe PMC12013 Limaye, V., Luke, C., Tucker, G., Hill, C., Lester, S., Blumbergs, P., & Roberts-Thomson, P. (2013). The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis. Rheumatology International, 33(4), 965-971.
Scopus61 WoS49 Europe PMC442013 Dunstan, E., Lester, S., Black, R., Rischmueller, M., Chan, H., Hewitt, A., & Hill, C. (2013). No association between FCγR3B copy number variation and susceptibility to biopsy-proven giant cell arteritis. Arthritis, 2013, 514914-1-514914-4.
WoS1 Europe PMC12013 Black, R., Roach, D., Rischmueller, M., Lester, S., & Hill, C. (2013). The use of temporal artery ultrasound in the diagnosis of giant cell arteritis in routine practice. International Journal of Rheumatic Diseases, 16(3), 352-357.
Scopus17 WoS14 Europe PMC122013 Gill, T., & Hill, C. (2013). Smoking and osteoarthritis. International Journal of Rheumatic Diseases, 16(6), 766-767.
Scopus3 WoS2 Europe PMC22013 Adams, R., Piantadosi, C., Ettridge, K., Miller, C., Wilson, C., Tucker, G., & Hill, C. (2013). Functional health literacy mediates the relationship between socio-economic status, perceptions and lifestyle behaviors related to cancer risk in an Australian population. Patient Education and Counseling, 91(2), 206-212.
Scopus83 WoS51 Europe PMC592013 Haynes, R., Jiang, L., Hopewell, J. C., Li, J., Chen, F., Parish, S., . . . Peto, R. (2013). HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: Trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment. European Heart Journal, 34(17), 1279-1291.
Scopus6192013 Valkhoff, V. E., Sturkenboom, M. C. J. M., Hill, C., Van Zanten, S. V., & Kuipers, E. J. (2013). Low-dose acetylsalicylic acid use and the risk of upper gastrointestinal bleeding: A meta-analysis of randomized clinical trials and observational studies. Canadian Journal of Gastroenterology, 27(3), 159-167.
Scopus32 Europe PMC192013 Dunstan, E., Lester, S., Rischmueller, M., Dodd, T., Ahern, M., Cleland, L., . . . Hill, C. (2013). EPIDEMIOLOGY OF BIOPSY-PROVEN GIANT CELL ARTERITIS (GCA) IN SOUTH AUSTRALIA. INTERNAL MEDICINE JOURNAL, 43, 21. 2013 Swift, A. J., Rajaram, S., Hurdman, J., Hill, C., Davies, C., Sproson, T. W., . . . Kiely, D. G. (2013). Noninvasive estimation of pa pressure, flow, and resistance with CMR imaging: Derivation and prospective validation study from the aspire registry. Jacc Cardiovascular Imaging, 6(10), 1036-1047.
Scopus134 Europe PMC982013 Rajaram, S., Swift, A. J., Davies, C., Hill, C., Jenkins, D., Goddard, M., . . . Kiely, D. G. (2013). Primary pulmonary artery sarcoma and coexisting chronic thromboembolic pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine, 188(5), e7-e8.
Scopus7 Europe PMC62013 Rajaram, S., Swift, A. J., Telfer, A., Hurdman, J., Marshall, H., Lorenz, E., . . . Kiely, D. G. (2013). 3D contrast-enhanced lung perfusion MRI is an effective screening tool for chronic thromboembolic pulmonary hypertension: Results from the ASPIRE Registry. Thorax, 68(7), 677-678.
Scopus136 Europe PMC752013 Hurdman, J., Condliffe, R., Elliot, C. A., Swift, A., Rajaram, S., Davies, C., . . . Kiely, D. G. (2013). Pulmonary hypertension in COPD: Results from the ASPIRE registry. European Respiratory Journal, 41(6), 1292-1301.
Scopus209 Europe PMC1432013 Smyth, W., Fielding, E., Beattie, E., Gardner, A., Moyle, W., Franklin, S., . . . MacAndrew, M. (2013). A survey-based study of knowledge of Alzheimer's disease among health care staff. BMC Geriatrics, 13(1), 8 pages.
Scopus123 Europe PMC772012 Rajaram, S., Swift, A. J., Capener, D., Telfer, A., Davies, C., Hill, C., . . . Wild, J. M. (2012). Lung morphology assessment with balanced steady-state free precession MR imaging compared with CT. Radiology, 263(2), 569-577.
Scopus50 Europe PMC342012 Hurdman, J., Condliffe, R., Elliot, C. A., Davies, C., Hill, C., Wild, J. M., . . . Kiely, D. G. (2012). ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a. European Respiratory Journal, 39(4), 945-955.
Scopus382 Europe PMC2862012 Swift, A. J., Rajaram, S., Marshall, H., Condliffe, R., Capener, D., Hill, C., . . . Kiely, D. G. (2012). Black blood MRI has diagnostic and prognostic value in the assessment of patients with pulmonary hypertension. European Radiology, 22(3), 695-702.
Scopus41 Europe PMC242012 Rajaram, S., Swift, A. J., Capener, D., Telfer, A., Davies, C., Hill, C., . . . Wild, J. M. (2012). Diagnostic accuracy of contrast-enhanced MR angiography and unenhanced proton MR imaging compared with CT pulmonary angiography in chronic thromboembolic pulmonary hypertension. European Radiology, 22(2), 310-317.
Scopus69 Europe PMC432012 Black, R., Roach, D., Lester, S., Rischmueller, M., & Hill, C. (2012). THE USE OF TEMPORAL ARTERY ULTRASOUND IN THE DIAGNOSIS OF GIANT CELL ARTERITIS AT THE QUEEN ELIZABETH HOSPITAL. INTERNAL MEDICINE JOURNAL, 42, 24. 2012 Hungin, P. A. S., Hill, C., Molloy-Bland, M., & Raghunath, A. (2012). Systematic Review: Patterns of Proton Pump Inhibitor Use and Adherence in Gastroesophageal Reflux Disease. Clinical Gastroenterology and Hepatology, 10(2), 109-116.
Scopus35 Europe PMC292012 Rajaram, S., Swift, A. J., Capener, D., Elliot, C. A., Condliffe, R., Davies, C., . . . Kiely, D. G. (2012). Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease. Journal of Rheumatology, 39(6), 1265-1274.
Scopus77 WoS61 Europe PMC562012 Adams, R., Piantadosi, C., Appleton, S., Hill, C., Visvanathan, R., Wilson, D., & McEvoy, R. (2012). Investigating obstructive sleep apnoea: will the health system have the capacity to cope? A population study. Australian Health Review, 36(4), 424-429.
Scopus24 WoS15 Europe PMC182012 Lester, S., Rischmueller, M., Tan, L., Wormald, P., Zalewski, P., Hamilton-Bruce, M., . . . Hill, C. (2012). Sicca symptoms and their association with chronic rhinosinusitis in a community sample. The Open Rheumatology Journal, 6(1), 170-174.
Scopus8 Europe PMC62012 Gill, T., Taylor, A., Hill, C., & Phillips, P. (2012). Osteoporosis in the community. Sensitivity of self-reported estimates and medication use of those diagnosed with the condition. Bone & Joint Research, 1(5), 93-98.
Scopus4 WoS3 Europe PMC52012 Black, R., Lester, S., Dunstan, E., Shahram, F., Nadji, A., Bayat, N., . . . Davatchi, F. (2012). Fc-gamma receptor 3B copy number variation is not a risk factor for Behçet’s disease. International Journal of Rheumatology, 2012, 1-4.
Scopus5 WoS7 Europe PMC52012 Graf, S., Lester, S., Nossent, J., Hill, C., Proudman, S., Lee, A., & Rischmueller, M. (2012). Low copy number of the FCGR3B gene and rheumatoid arthritis: a case-control study and meta-analysis. Arthritis Research & Therapy, 14(1), 1-7.
Scopus34 WoS33 Europe PMC312012 Wechalekar, M., Lester, S., Proudman, S., Cleland, L., Whittle, S., Rischmueller, M., & Hill, C. (2012). Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement. Arthritis and Rheumatism, 64(5), 1316-1322.
Scopus49 WoS43 Europe PMC352012 Shanahan, E., Shanahan, K., Hill, C., Ahern, M., & Smith, M. (2012). Safety and acceptability of suprascapular nerve block in rheumatology patients. Clinical Rheumatology, 31(1), 145-149.
Scopus21 WoS17 Europe PMC142012 Vos, T., Flaxman, A., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., . . . Murray, C. (2012). Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380(9859), 2163-2196.
Scopus6662 WoS4478 Europe PMC48612012 Murray, C., Vos, T., Lozano, R., Naghavi, M., Flaxman, A., Michaud, C., . . . Lopez, A. (2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380(9859), 2197-2223.
Scopus7189 WoS5798 Europe PMC53012012 Ngian, G., Stevens, W., Prior, D., Gabbay, E., Roddy, J., Tran, A., . . . Nikpour, M. (2012). Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study. Arthritis Research & Therapy, 14(R213), 1-9.
Scopus79 WoS66 Europe PMC592012 Tran, H., Lewis, M., Tan, L. W., Lester, S., Baker, L., Ng, J., . . . Lang, C. (2012). Immunolocalization of NLRP3 inflammasome in normal murine airway epithelium and changes following induction of ovalbumin-induced airway inflammation. Journal of Allergy, Online(819176), 1-13.
Europe PMC412012 Gill, T. K., & Hill, C. L. (2012). Socioeconomic factors and total joint replacement: comment on the article by Mnatzaganian et al. Arthritis and Rheumatism, 64(4), 1299-1300.
2011 Nikpour, M., Proudman, S., Byron, J., Zochling, J., Roddy, J., Sahhar, J., . . . Stevens, W. (2011). MORTALITY AND CAUSES OF DEATH IN AN AUSTRALIAN SYSTEMIC SCLEROSIS COHORT. INTERNAL MEDICINE JOURNAL, 41, 12. 2011 Hissaria, P., Lester, S., Hakendorf, P., Woodman, R., Patterson, K., Hill, C., . . . Roberts-Thomson, P. (2011). Survival in scleroderma: Results from the population-based South Australian Register. Internal Medicine Journal, 41(5), 381-390.
Scopus62 WoS54 Europe PMC452011 Ngian, G., Nikpour, M., Byron, J., Tran, A., Roddy, J., Minson, R., . . . Proudman, S. (2011). SURVIVAL IN AUSTRALIAN PATIENTS WITH CONNECTIVE TISSUE DISEASE-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION. INTERNAL MEDICINE JOURNAL, 41, 12.
WoS22011 Hill, C., Appleton, S., Gill, T., Black, J., & Adams, R. (2011). BURDEN OF LOW HEALTH LITERACY IN MUSCULOSKELETAL DISEASE: RESULTS OF A SOUTH AUSTRALIAN POPULATION SURVEY. INTERNAL MEDICINE JOURNAL, 41, 34. 2011 Menz, H., Gill, T., Taylor, A., & Hill, C. (2011). Age and gender differences in disabling foot pain using different definitions of the manchester foot pain and disability index. BMC Musculoskeletal Disorders, 12(243), 1-9.
Scopus15 WoS12 Europe PMC142011 Ninan, J., Nguyen, A., Cole, A., Rischmueller, M., Dodd, T., Roberts-Thomson, P., & Hill, C. (2011). Mortality in patients with biopsy-proven giant cell arteritis: A South Australian population-based study. Journal of Rheumatology, 38(10), 2215-2217.
Scopus48 WoS46 Europe PMC342011 Massy-Westropp, N., Gill, T., Taylor, A., Bohannon, R., & Hill, C. (2011). Hand grip strength: age and gender stratified normative data in a population-based study. BMC Research Notes, 4(127), 1-5.
Scopus542 Europe PMC3582011 Adams, R., Appleton, S., Gill, T., Taylor, A., Wilson, D., & Hill, C. (2011). Cause for concern in the use of non-steroidal anti-inflammatory medications in the community - a population-based study. BMC Family Practice, 12(1), 70-1-70-8.
Scopus64 WoS45 Europe PMC462011 Hill, C., Lester, S., Taylor, A., Shanahan, M., & Gill, T. (2011). Factor structure and validity of the shoulder pain and disability index in a population-based study of people with shoulder symptoms. BMC Musculoskeletal Disorders, 12(8), 1-6.
Scopus58 WoS48 Europe PMC352011 Cole, A., Gill, T., Taylor, A., & Hill, C. (2011). Prevalence and associations of hand pain in the community: results from a population-based study. Scandinavian Journal of Rheumatology, 40(2), 145-149.
Scopus10 WoS8 Europe PMC72011 García Rodríguez, L. A., Cea Soriano, L., Hill, C., & Johansson, S. (2011). Increased risk of stroke after discontinuation of acetylsalicylic acid: A UK primary care study. Neurology, 76(8), 740-746.
Scopus982011 Lau, J. Y., Sung, J., Hill, C., Henderson, C., Howden, C. W., & Metz, D. C. (2011). Systematic review of the epidemiology of complicated peptic ulcer disease: Incidence, recurrence, risk factors and mortality. Digestion, 84(2), 102-113.
Scopus360 Europe PMC2642011 Condliffe, R., Radon, M., Hurdman, J., Davies, C., Hill, C., Akil, M., . . . Kiely, D. G. (2011). CT pulmonary angiography combined with echocardiography in suspected systemic sclerosis-associated pulmonary arterial hypertension.. Rheumatology Oxford England, 50(8), 1480-1486.
Scopus34 Europe PMC222011 Harrison, L., Babiker, A., Castro, H., Compagnucci, A., Fiscus, S., Giaquinto, C., . . . De Bortoli, C. (2011). First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial. Lancet Infectious Diseases, 11(4), 273-283.
Scopus1222010 Tavel, J. A., Babiker, A., Carey, C., Fisher, M., Fox, L., Gey, D., . . . Himmich, H. (2010). Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: The STALWART study. Plos One, 5(2), e9334.
Scopus16 Europe PMC122010 Hill, C. L., Cole, A., Rischmueller, M., Dodd, T., Coleman, M., Tucker, G., & Roberts-Thomson, P. (2010). Risk of cancer in patients with biopsy-proven giant cell arteritis (vol 49, pg 756, 2010). RHEUMATOLOGY, 49(11), 2230.
2010 Adams, R., Appleton, S., Cole, A., Gill, T., Taylor, A., & Hill, C. (2010). Oral complementary medicine and alternative practitioner use varies across chronic conditions and attitudes to risk. Journal of Clinical Epidemiology, 2(1), 251-260.
Scopus8 Europe PMC62010 Katikireddi, V., Whittle, S., & Hill, C. (2010). Tumour necrosis factor inhibitors and risk of serious infection in rheumatoid arthritis. International Journal of Rheumatic Diseases, 13(1), 12-26.
Scopus22 WoS19 Europe PMC142010 D'Onise, R., Shanahan, E., Gill, T., & Hill, C. (2010). Does leisure time physical activity protect against shoulder pain at work?. Occupational Medicine-oxford, 60(5), 383-388.
Scopus13 WoS11 Europe PMC72010 Hill, C., Schultz, C., Wu, R., Chatterton, B., & Cleland, L. (2010). Measurement of hand bone mineral density in early rheumatoid arthritis using dual energy X-ray absorptiometry. International Journal of Rheumatic Diseases, 13(3), 230-234.
Scopus12 WoS10 Europe PMC82010 Hill, C., Gill, T., Shanahan, E., & Taylor, A. (2010). Prevalence and correlates of shoulder pain and stiffness in a population-based study: the North West Adelaide Health Study. International Journal of Rheumatic Diseases, 13(3), 215-222.
Scopus79 WoS66 Europe PMC572010 Gill, T., Hill, C., Adams, R., Broderick, D., Black, J., & Taylor, A. (2010). "I know I have arthritis but I don't know what type". Understanding and knowledge of this chronic condition. BMC Musculoskeletal Disorders, 11(1), 174-181.
Scopus14 WoS14 Europe PMC92010 Cox, S., Limaye, V., Hill, C., Blumbergs, P., & Roberts-Thomson, P. (2010). Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features. International Journal of Rheumatic Diseases, 13(2), 117-124.
Scopus44 WoS36 Europe PMC312010 Hill, C., Cole, A., Rischmueller, M., Dodd, T., Coleman, M., Tucker, G., & Roberts-Thomson, P. (2010). Risk of cancer in patients with biopsy-proven giant cell arteritis. Rheumatology, 49(4), 756-759.
Scopus20 WoS20 Europe PMC162010 Wechalekar, M. D., Rischmueller, M., Whittle, S., Burnet, S., & Hill, C. L. (2010). Prolonged remission of chronic reactive arthritis treated with three infusions of infliximab. Journal of Clinical Rheumatology, 16(2), 79-80.
Scopus19 WoS14 Europe PMC132009 Hill, C. L., Cole, A., Lester, S., & Whittle, S. L. (2009). Steroid sparing drug treatments for giant cell arteritis. Cochrane Database of Systematic Reviews, (1).
Scopus22009 Whittle, S. L., Cole, A., Lester, S., & Hill, C. L. (2009). Steroid sparing drug treatments for polymyalgia rheumatica. Cochrane Database of Systematic Reviews, (1).
2009 Adams, R., Appleton, S., Hill, C., Dodd, M., Findlay, C., & Wilson, D. (2009). Risks associated with low functional health literacy in an Australian population. Medical Journal of Australia, 191(10), 530-534.
Scopus124 WoS100 Europe PMC852009 Adams, R., Appleton, S., Hill, C., Ruffin, R., & Wilson, D. (2009). Inadequate health literacy is associated with increased asthma morbidity in a population sample. Journal of Allergy and Clinical Immunology, 124(3), 601-603.
Scopus40 WoS35 Europe PMC272009 Adams, R., Tucker, G., Price, K., Hill, C., Appleton, S., Wilson, D., . . . Ruffin, R. (2009). Self-reported adverse events in health care that cause harm: a population-based survey. Medical Journal of Australia, 190(9), 484-488.
Scopus13 WoS11 Europe PMC102009 Adams, R., Stocks, N., Wilson, D., Hill, C., Gravier, S., Kickbusch, I., & Beilby, J. (2009). Health literacy: a new concept for general practice?. Australian Family Physician, 38(3), 144-147.
Scopus108 WoS75 Europe PMC512009 Adams, R., Appleton, S., Hill, C., Wilson, D., Taylor, A., Chittleborough, C., . . . Ruffin, R. (2009). Independent Association of HbA₁c and Incident Cardiovascular Disease in People Without Diabetes. Obesity, 17(3), 559-563.
Scopus41 WoS37 Europe PMC362009 Cole, A., Gill, T., Shanahan, E., Phillips, P., Taylor, A., & Hill, C. (2009). Is diabetes associated with shoulder pain or stiffness? Results from a population based study. Journal of Rheumatology, 36(2), 371-377.
Scopus41 WoS29 Europe PMC332009 Hill, C., Gill, T., Appleton, S., Cleland, L., Taylor, A., & Adams, R. (2009). The use of fish oil in the community: results of a population-based study. Rheumatology, 48(4), 441-442.
Scopus10 WoS7 Europe PMC62009 El-Serag, H., Hill, C., & Jones, R. (2009). Systematic review: The epidemiology of gastro-oesophageal reflux disease in primary care, using the UK general practice research database. Alimentary Pharmacology and Therapeutics, 29(5), 470-480.
Scopus73 Europe PMC532009 Hungin, A. P. S., Hill, C., & Raghunath, A. (2009). Systematic review: Frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsia. Alimentary Pharmacology and Therapeutics, 30(4), 331-342.
Scopus54 Europe PMC492009 Mihaylova, B., Briggs, A., Hlatky, M., Armitage, M., Parish, S., Gray, A., . . . Brown, M. (2009). Statin cost-effectiveness in the United States for people at different vascular risk levels. Circulation Cardiovascular Quality and Outcomes, 2(2), 65-72.
Scopus67 Europe PMC502009 Hagger, D., Condliffe, R., Woodhouse, N., Elliot, C. A., Armstrong, I. J., Davies, C., . . . Kiely, D. G. (2009). Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension. Rheumatology, 48(9), 1137-1142.
Scopus74 Europe PMC582008 Cressey, T. R., Green, H., Khoo, S., Treluyer, J. M., Compagnucci, A., Saidi, Y., . . . Rosso, R. (2008). Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children. Clinical Infectious Diseases, 46(10), 1601-1608.
Scopus17 Europe PMC122008 Walker, A. S., Mugyenyi, P., Kityo, C., Ssali, F., Tumukunde, D., Otim, T., . . . Bwakaga, H. (2008). Twenty-four-week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine/lamivudine as first-line antiretroviral therapy: A randomized double-blind trial (NORA). Tropical Medicine and International Health, 13(1), 6-16.
Scopus23 Europe PMC172008 Meade, T., Sleight, P., Collins, R., Armitage, J., Parish, S., Barton, J., . . . Donnelly, R. (2008). SLCO1B1 variants and statin-induced myopathy - A genomewide study. New England Journal of Medicine, 359(8), 789-799.
Scopus1823 WoS1474 Europe PMC12132008 Massy-Westropp, N., Johnston, R., & Hill, C. (2008). Post-operative therapy for metacarpophalangeal arthroplasty.. Cochrane database of systematic reviews (Online), (1). 2008 Hill, C. L., Lu, T. Y., Cervelli, M., & Mathew, T. (2008). Failure of rasburicase therapy in recurrent acute gout with tophi. International Journal of Rheumatic Diseases, 11(3), 315-317.
Scopus6 WoS32008 Menz, H., Gill, T., Taylor, A., & Hill, C. (2008). Predictors of podiatry utilisation in Australia: the north west Adelaide health study. Journal of Foot and Ankle Research, 1(8), 1-7.
Scopus25 WoS14 Europe PMC192008 Hill, C., Gill, T., Menz, H., & Taylor, A. (2008). Prevalence and correlates of foot pain in a population-based study: the North West Adelaide health study. Journal of Foot and Ankle Research, 1(2), 1-7.
Scopus266 WoS216 Europe PMC1922008 Adams, R., Tucker, G., Hugo, G., Hill, C., & Wilson, D. (2008). Projected future trends of hospital service use for selected obesity-related conditions. Obesity Research & Clinical Practice, 2(2), 133-141.
Scopus15 WoS13 Europe PMC142008 Lu, T., Hill, C., Pontifex, E., & Roberts-Thomson, P. (2008). Breast cancer and systemic sclerosis: A clinical description of 21 patients in a population-based cohort study. Rheumatology International, 28(9), 895-899.
Scopus32 WoS20 Europe PMC162008 Massy-Westropp, N., Johnston, R., & Hill, C. (2008). Post-operative therapy for metacarpophalangeal arthroplasty. The Cochrane Database of Systematic Reviews, 2009(1), 1-14.
Scopus8 WoS2 Europe PMC12008 Hill, C., & Nash, P. (2008). Tumour necrosis factor inhibitors. Australian Prescriber, 31(3), 61.
2007 Hill, C., Gill, T., Taylor, A., Daly, A., DalGrande, E., & Adams, R. (2007). Psychological factors and quality of life in arthritis: a population-based study. Clinical Rheumatology, 26(7), 1049-1054.
Scopus41 WoS31 Europe PMC272007 Pontifex, E., Hill, C., & Roberts-Thomson, P. (2007). Risk factors for lung cancer in patients with scleroderma: a nested case-control study. Annals of the Rheumatic Diseases, 66(4), 551-553.
Scopus68 WoS52 Europe PMC372007 Hill, C., Hunter, D., Niu, J., Clancy, M., Guermazi, A., Genant, H., . . . Felson, D. (2007). Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Annals of the Rheumatic Diseases, 66(12), 1599-1603.
Scopus439 WoS368 Europe PMC3632007 Hill, C., Buchbinder, R., & Osborne, R. (2007). Quality of reporting of randomized clinical trials in abstracts of the 2005 annual meeting of the american college of rheumatology. Journal of Rheumatology, 34(12), 2476-2480.
Scopus23 WoS22 Europe PMC172007 Proudman, S., Keen, H., Stamp, L., Lee, A., Goldblatt, F., Ayres, O., . . . Cleland, L. (2007). Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Seminars in Arthritis and Rheumatism, 37(2), 99-111.
Scopus64 WoS62 Europe PMC532007 van Beek, E. J. R., Hill, C., Woodhouse, N., Fichele, S., Fleming, S., Howe, B., . . . Taylor, C. J. (2007). Assessment of lung disease in children with cystic fibrosis using hyperpolarized 3-Helium MRI: Comparison with Shwachman score, Chrispin-Norman score and spirometry. European Radiology, 17(4), 1018-1024.
Scopus90 Europe PMC572007 Puddy, E., & Hill, C. (2007). Interpretation of the chest radiograph. Continuing Education in Anaesthesia Critical Care and Pain, 7(3), 71-75.
Scopus382006 McMahon, C. J., Dodd, J. D., Hill, C., Woodhouse, N., Wild, J. M., Fichele, S., . . . Masterson, J. B. (2006). Hyperpolarized 3helium magnetic resonance ventilation imaging of the lung in cystic fibrosis: Comparison with high resolution CT and spirometry. European Radiology, 16(11), 2483-2490.
Scopus86 Europe PMC642006 Lu, T., Pink, J., Whitten, L., Hill, C., Adams, R., & Gibb, C. (2006). A champion-driven pathway towards quality improvement in the medical management of osteoporotic fractures. Medical Journal of Australia, 185(6), 341-342.
Scopus2 WoS1 Europe PMC22006 Lu, T. Y. T., & Hill, C. (2006). Managing patients taking tumour necrosis factor inhibitors. Australian Prescriber, 29(3), 67-70.
Scopus42006 Plint, A. C., Moher, D., Morrison, A., Schulz, K., Altman, D. G., Hill, C., & Gaboury, I. (2006). Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Medical Journal of Australia, 185(5), 263-267.
Scopus742 WoS613 Europe PMC5512005 Keen, H. I., Pile, K., & Hill, C. L. (2005). The prevalence of underpowered randomized clinical trials in rheumatology. Journal of Rheumatology, 32(11), 2083-2088.
Scopus40 WoS33 Europe PMC212005 Mihaylova, B., Briggs, A., Armitage, J., Parish, S., Gray, A., Collins, R., . . . Sandercock, P. (2005). Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: Economic analysis of a randomised trial in 20 536 individuals. Lancet, 365(9473), 1779-1785.
Scopus103 Europe PMC732005 Bayat, N., Keen, H. I., & Hill, C. L. (2005). Randomized clinical trials of osteoarthritis: A review. APLAR Journal of Rheumatology, 8(3), 171-176.
Scopus42005 Hill, C. L., Seo, G. S., Gale, D., Totterman, S., Gale, M. E., & Felson, D. T. (2005). Cruciate ligament integrity in osteoarthritis of the knee. Arthritis and Rheumatism, 52(3), 794-799.
Scopus133 WoS112 Europe PMC1032005 Koumellis, P., Van Beek, E. J. R., Woodhouse, N., Fichele, S., Swift, A. J., Paley, M. N. J., . . . Wild, J. M. (2005). Quantitative analysis of regional airways obstruction using dynamic hyperpolarized 3He MRI - Preliminary results in children with cystic fibrosis. Journal of Magnetic Resonance Imaging, 22(3), 420-426.
Scopus86 Europe PMC652004 Hill, C., & van Beek, E. J. R. (2004). MRI of the chest: Present and future. Imaging, 16(1), 61-70.
Scopus42004 Hill, C. L. (2004). Leflunomide-induced peripheral neuropathy: Rapid resolution with cholestyramine wash-out [3]. Rheumatology, 43(6), 809.
Scopus9 WoS72004 Crow, Y. J., Massey, R. F., Innes, J. R., Pairaudeau, P. W., Hill, C. A. R., Woods, C. G., . . . Winter, R. M. (2004). Congenital glaucoma and brain stem atrophy as features of Aicardi-Goutières syndrome. American Journal of Medical Genetics, 129 A(3), 303-307.
Scopus35 Europe PMC212004 Hill, C. L. (2004). Increased risk of cancer in patients with scleroderma: no risk in patients with morphoea? Reply. ANNALS OF THE RHEUMATIC DISEASES, 63(5), 612.
2004 Wollina, U., & Hill, C. L. (2004). Increased risk of cancer in patients with scleroderma: No risk in patients with morphoea? [14] (multiple letters). Annals of the Rheumatic Diseases, 63(5), 611-612.
Scopus3 Europe PMC12003 Felson, D. T., McLaughlin, S., Goggins, J., LaValley, M. P., Gale, M. E., Totterman, S., . . . Gale, D. (2003). Bone Marrow Edema and Its Relation to Progression of Knee Osteoarthritis. Annals of Internal Medicine, 139(5 I), 330-I33.
Scopus627 WoS547 Europe PMC4642003 Hill, C. L., Nguyen, A. M., Roder, D., & Roberts-Thomson, P. (2003). Risk of cancer inpatients with scleroderma: A population based cohort study. Annals of the Rheumatic Diseases, 62(8), 728-731.
Scopus194 WoS154 Europe PMC1232003 Iyngkaran, P., Limaye, V., Hill, C., Henderson, D., Pile, K. D., & Rischmueller, M. (2003). Rheumatoid vasculitis following influenza vaccination [7]. Rheumatology, 42(7), 907-909.
Scopus29 WoS27 Europe PMC202003 Hill, C. L., Gale, D. R., Chaisson, C. E., Skinner, K., Kazis, L., Gale, M. E., & Felson, D. T. (2003). Periarticular Lesions Detected on Magnetic Resonance Imaging: Prevalence in Knees With and Without Symptoms. Arthritis and Rheumatism, 48(10), 2836-2844.
Scopus98 WoS81 Europe PMC722003 Hill, C. (2003). Alcohol and cancer risk. Gerontologie Et Societe, 105(2), 59-67.
Scopus72002 Hill, C. L., LaValley, M. P., & Felson, D. T. (2002). Discrepancy between published report and actual conduct of randomized clinical trials. Journal of Clinical Epidemiology, 55(8), 783-786.
Scopus93 WoS87 Europe PMC772002 Hill, C. L., LaValley, M. P., & Felson, D. T. (2002). Secular changes in the quality of published randomized clinical trials in rheumatology. Arthritis and Rheumatism, 46(3), 779-784.
Scopus40 WoS36 Europe PMC302002 Buchbinder, R., & Hill, C. L. (2002). Malignancy in patients with inflammatory myopathy. Current Rheumatology Reports, 4(5), 415-426.
Scopus90 Europe PMC602001 Felson, D. T., Chaisson, C. E., Hill, C. L., Totterman, S. M. S., Gale, M. E., Skinner, K. M., . . . Gale, D. R. (2001). The association of bone marrow lesions with pain in knee osteoarthritis. Annals of Internal Medicine, 134(7), 541-549.
Scopus847 WoS711 Europe PMC6232001 The Association of Bone Marrow Lesions with Pain in Knee Osteoarthritis (2001). Annals of Internal Medicine, 134(7), I-93.
2001 Hill, C. L., Zhang, Y., Sigurgeirsson, B., Pukkala, E., Mellemkjaer, L., Airio, A., . . . Felson, D. T. (2001). Frequency of specific cancer types in dermatomyositis and polymyositis: A population-based study. Lancet, 357(9250), 96-100.
Scopus1007 WoS715 Europe PMC5812001 Hill, C. L., & Felson, D. T. (2001). Cancer types in dermatomyositis and polymyositis - Reply. LANCET, 357(9266), 1443.
2001 Hill, C. L., Gale, D. G., Chaisson, C. E., Skinner, K., Kazis, L., Gale, M. E., & Felson, D. T. (2001). Knee effusions, popliteal cysts, and synovial thickening: Association with knee pain in osteoarthritis. Journal of Rheumatology, 28(6), 1330-1337.
Scopus348 WoS304 Europe PMC2342001 Maddison, P., Hill, C. L., & Felson, D. T. (2001). Cancer types in dermatomyositis and polymyositis [3] (multiple letters). Lancet, 357(9266), 1443.
Scopus2 Europe PMC91999 Hill, C. L., Parsons, J., Taylor, A., & Leach, G. (1999). Health related quality of life in a population sample with arthritis. Journal of Rheumatology, 26(9), 2029-2035.
Scopus92 WoS82 Europe PMC651997 Hill, C. L., Leach, G., & Taylor, A. (1997). The SF-36 health status survey in a population sample with arthritis in South Australia.. ARTHRITIS AND RHEUMATISM, 40(9), 488. 1997 Hill, C. L., Cleland, L. G., Schultz, C., Chatterton, B. E., & Pile, K. D. (1997). Measurement of hand bone mineral density in early rheumatoid arthritis using dual energy x-ray absorptiometry (DEXA). ARTHRITIS AND RHEUMATISM, 40(9), 1756. 1996 Hill, C., Romas, E., & Kirkham, B. (1996). Use of sequential DTPA clearance and high resolution computerized tomography in monitoring interstitial lung disease in dermatomyositis. British Journal of Rheumatology, 35(2), 164-166.
Scopus14 Europe PMC51996 Hill, C., Roberts-Thomson, P., Pollard, A., Gillis, D., & Kirkham, B. (1996). Clinical associations of anti-lamin autoantibodies.. Australian and New Zealand Journal of Medicine, 26(2), 162-166.
Scopus5 WoS5 Europe PMC31995 Hill, C., Pile, K., Henderson, D., & Kirkham, B. (1995). Neurological side effects in two patients receiving gold injections for rheumatoid arthritis. Rheumatology, 34(10), 989-990.
Scopus11 WoS7 Europe PMC21995 HILL, C., ZEITZ, C., & KIRKHAM, B. (1995). Dermatomyositis with lung involvement in a patient treated with simvastatin. Australian and New Zealand Journal of Medicine, 25(6), 745-746.
Scopus54 WoS47 Europe PMC39 -
Book Chapters
Year Citation 2014 Hill, C., Graf, S., & Fitridge, R. (2014). Vasculitides and Fibromuscular dysplasia. In R. Fitridge (Ed.), Oxford Textbook of Vascular Surgery. 1995 Cleland, L., Hill, G., & James, M. (1995). Diet and arthritis. In Bailliere's Clinical Rheumatology (Vol. 9, pp. 771-785). Bailliere Tindall.
DOI Scopus26 WoS19 Europe PMC8 -
Conference Papers
Year Citation 2024 Lax, S. J., Dures, E., Bridgewater, S., Silverthorne, C., Lowndes, V., Richards, P., . . . Robson, J. (2024). IMPACT OF GLUCOCORTICOIDS ON APPEARANCE AND SENSE OF SELF IN RHEUMATIC DISEASES. In RHEUMATOLOGY Vol. 63 (pp. I122). OXFORD UNIV PRESS. 2024 Khoo, T., Sidhu, N., Marine, F., Lester, S., Quinlivan, A., Rowett, D., . . . Hill, C. L. (2024). Adult Medicine-South AustraliaPERCEPTIONS TOWARDS BIOLOGIC AND BIOSIMILARTHERAPY OF PATIENTS WITH RHEUMATIC ANDGASTROENTEROLOGICAL CONDITIONS. In INTERNAL MEDICINE JOURNAL Vol. 54 (pp. 5). WILEY.
DOI2024 Hill, C., Kwon, M., Chin, A., Lester, S., & Whittle, S. (2024). DMARD MONITORING IN RHEUMATOID ARTHRITIS: A SCOPING REVIEW OF INTERNATIONAL/NATIONAL GUIDELINES. In ANNALS OF THE RHEUMATIC DISEASES Vol. 83 (pp. 2 pages). ELSEVIER.
DOI2023 Lim, J., Dures, E., Bailey, L., Almeida, C., Ruediger, C., Hill, C., . . . Mackie, S. L. (2023). JAW CLAUDICATION - DOES THE TEXTBOOK DESCRIPTION NEED UPDATING?. In RHEUMATOLOGY Vol. 62 (pp. 2 pages). ENGLAND, Manchester: OXFORD UNIV PRESS. 2023 Robinson, L., Hamden, M., Griggs, K., Hill, C., Limaye, V., & Proudman, S. (2023). USE OF TOCILIZUMAB FOR GIANT CELL ARTERITIS IN PATIENTS WHO DO NOT MEET CRITERIA FOR PBS-SUBSIDIZED THERAPY. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 28). WILEY. 2023 Dartnell, J., Brown, S., Barrett, C., Hardy, L., Buchbinder, R., Whittle, S., . . . Hill, C. (2023). COLLECTIVE IMPACT APPROACH FOR MORE EFFECTIVE KNOWLEDGE TRANSLATION. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 53). WILEY. 2023 Bridgewater, S., Ndosi, M., Dawson, J., Richards, P., Silverthorne, C., Dures, E., . . . Robson, J. C. (2023). A COMMON MEASURE OF THE IMPACT OF GLUCOCORTICOIDS IN PATIENTS WITH INFLAMMATORY AND AUTOIMMUNE CONDITIONS - THE STEROID PRO: A CROSS-CULTURAL VALIDATION STUDY WITH RASCH MODELS. In RHEUMATOLOGY Vol. 62 (pp. 1 page). ENGLAND, Manchester: OXFORD UNIV PRESS. 2023 Yang, V., Ninan, J., Liew, D., Keen, H., Hill, C., & Leung, J. (2023). Variations in Approach to the Diagnosis and Management of Polymyalgia Rheumatica Among Australian Rheumatologists. In ARTHRITIS & RHEUMATOLOGY Vol. 75 (pp. 521-522). WILEY. 2023 Bryant, M. J., Munt, R., Black, R. J., Reynolds, A., & Hill, C. L. (2023). Joining forces to understand what matters most: qualitative insights into the patient experience of outpatient rheumatology care. In Rheumatology Advances in Practice Vol. 7 (pp. 10 pages). England: OXFORD UNIV PRESS.
DOI Scopus6 Europe PMC42023 Ninan, J., Ruediger, C., Dyer, K. A., Dodd, T., Black, R. J., Lyne, S., . . . Hill, C. L. (2023). Incidence of biopsy-proven giant cell arteritis (GCA) in South Australia 2014–2020. In Frontiers in Medicine Vol. 10 (pp. 5 pages). Switzerland: FRONTIERS MEDIA SA.
DOI Scopus22022 Khoo, T., Lester, S., Hill, C., Whittle, S., Black, R., Tieu, J., & Rischmueller, M. (2022). CONNECTIVE TISSUE DISEASE RELATED INTERSTITIAL LUNG DISEASE IN A RHEUMATOLOGY CLINIC POPULATION. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 35). WILEY. 2022 Chin, A., Lester, S., Khoo, T., Burnet, S., Tieu, J., Rischmueller, M., . . . Hill, C. (2022). LYMPHOPAENIA IN RHEUMATOID ARTHRITIS (RA): A SINGLE CENTRE AUDIT. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 29). WILEY. 2022 Callisto, A., Hansen, D., Walker, J., Ngian, G. -S., Nikpour, M., Liew, D., . . . Proudman, S. (2022). IMPACT OF THE COVID-19 PANDEMIC ON HEALTHCARE ACCESS AND ATTITUDES TOWARDS TELEHEALTH AMONG AUSTRALIAN PATIENTS WITH SYSTEMIC SCLEROSIS. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 37). WILEY. 2022 Russell, O., Khoo, T., Hill, C., Whittle, S., Tieu, J., Lyne, S., & Burnet, S. (2022). AN EXPERIENCE OF THE FIRST PUBLIC RURAL RHEUMATOLOGY CLINIC IN SOUTH AUSTRALIA (SA). In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 35). WILEY. 2022 Ye, M. J., Sinnathurai, P., Hill, C., Barrett, C., Hardy, L., Buchbinder, R., . . . Quyen, D. (2022). ENGAGING CLINICIANS AND CONSUMERS IN THE DESIGN AND IMPLEMENTATION OF A NATIONAL EDUCATION PROGRAM FOR INFLAMMATORY ARTHRITIS. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 31). WILEY. 2022 Russell, O., Lester, S., Black, R., Lassere, M., Barrett, C., March, L., . . . Hill, C. (2022). EFFECT OF SOCIOECONOMIC STATUS (SES) ON OPIOID AND GLUCOCORTICOID USE IN AUSTRALIAN RHEUMATOID ARTHRITIS (RA) PATIENTS: A MEDICINE DISPENSING ANALYSIS USING DATA FROM THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE (ARAD). In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 39-40). WILEY. 2022 Lynch, T., Sinnathurai, P., Buchbinder, R., Hill, C., Russell, O., Lester, S., . . . March, L. (2022). PREDICTORS OF DISCORDANT PRESCRIPTION MEDICATION SELF-REPORT IN THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE (ARAD) COHORT. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 39). WILEY. 2022 Russell, O., Lester, S., Black, R., Lassere, M., Barrett, C., March, L., . . . Hill, C. (2022). THE EFFECT OF AREA-LEVEL SOCIOECONOMIC STATUS (SES) ON FUNCTIONAL STATUS IN AUSTRALIAN RHEUMATOID ARTHRITIS (RA) PATIENTS: DATA FROM THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE (ARAD). In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 11). WILEY. 2022 Hill, C., Damodaran, A., Burnet, S., Singh-Grewal, D., Buchbinder, R., Rudd, T., . . . Keen, H. I. (2022). AUSTRALIAN RHEUMATOLOGY ASSOCIATION: RESULTS OF 2021 WORKFORCE SURVEY. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 7-8). WILEY.
WoS12022 Bridgewater, S., Shepherd, M. A., Dawson, J., Richards, P., Silverthorne, C., Ndosi, M., . . . Robson, J. C. (2022). PATIENTS' PERCEPTIONS OF GLUCOCORTICOID THERAPY IMPACT ON HEALTH-RELATED QUALITY OF LIFE DURING TREATMENT FOR RHEUMATIC DISEASES: INTERNATIONAL DEVELOPMENT OF A TREATMENT-SPECIFIC PATIENT-REPORTED OUTCOME MEASURE (THE STEROID PRO). In RHEUMATOLOGY Vol. 61 (pp. I65-+). SCOTLAND, Glasgow: OXFORD UNIV PRESS. 2022 Naureen, G., Scott, D., Sanders, K. M., Vogrin, S., Busija, L., Lim, K., . . . Brennan-Olsen, S. L. (2022). Development and Validation of a Self-Reported Vitamin D Prediction Tool for Australian Adults aged >=50 Years. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 37 (pp. 185). WILEY. 2022 Merriman, T., Matsuo, H., Takei, R., Leask, M., Topless, R., Shirai, Y., . . . Major, T. (2022). A Genome-Wide Association Analysis of 2,622,830 Individuals Reveals New Pathogenic Pathways in Gout. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 3338-3341). PA, Philadelphia: WILEY. 2021 Sattui, S., Conway, R., Putman, M., Seet, A., Beins, K., Hill, C., . . . Robinson, P. (2021). Outcomes of COVID-19 Infection in Patients with Primary Systemic Vasculitis and Polymyalgia Rheumatica: Results from the COVID-19 Global Rheumatology Alliance Physician Registry. In ARTHRITIS & RHEUMATOLOGY Vol. 73 (pp. 1982-1985). ELECTR NETWORK: WILEY. 2021 Fletcher, A., March, L., Lassere, M., Hill, C., Barrett, C., Carroll, G., . . . Buchbinder, R. (2021). Australian Psoriatic Arthritis (PsA) Biologic Disease-modifying Antirheumatic Drug (bDMARD) Treatment Pathways Using Sankey Diagrams and Predictive Analysis: A Combined Australian Rheumatology Association Database (ARAD) and Pharmaceutical Benefits Scheme (PBS) Analysis. In ARTHRITIS & RHEUMATOLOGY Vol. 73 (pp. 400-402). ELECTR NETWORK: WILEY. 2021 Keen, H., Raymond, W., Lester, S., Preen, D., Inderjeeth, C., Hill, C., & Nossent, J. (2021). All-cause Mortality in a Hospital Ascertained Cohort with Giant Cell Arteritis: A Longitudinal Population-level Data Linkage Cohort Study. In ARTHRITIS & RHEUMATOLOGY Vol. 73 (pp. 2914-2915). ELECTR NETWORK: WILEY. 2021 Laslett, L. L., Scheepers, L. E., Antony, B. S., Wluka, A. E., Hill, C. L., March, L., . . . Jones, G. (2021). EFFICACY OF KRILL OIL IN THE TREATMENT OF KNEE OSTEOARTHRITIS: A 24-WEEK MULTICENTRE RANDOMISED DOUBLE-BLIND CONTROLLED TRIAL. In OSTEOARTHRITIS AND CARTILAGE Vol. 29 (pp. S10-S11). ELSEVIER SCI LTD. 2021 Russell, O., Lester, S., Black, R., & Hill, C. (2021). SOCIOECONOMIC STATUS (SES) AND MEDICATION USE IN RHEUMATOID ARTHRITIS (RA): A SCOPING REVIEW. In ANNALS OF THE RHEUMATIC DISEASES Vol. 80 (pp. 1098-1099). ELECTR NETWORK: BMJ PUBLISHING GROUP.
DOI2021 Kelty, E., Nossent, J., Raymond, W., Robinson, P., Hill, C., Inderjeeth, C., . . . Keenon, H. (2021). COSTS AND FACTORS AFFECTING HEALTH SERVICE UTILISATION IN PATIENTS WITH GOUT: A LONGITUDINAL, POPULATION-LEVEL LINKED DATA STUDY IN WESTERN AUSTRALIA. In ANNALS OF THE RHEUMATIC DISEASES Vol. 80 (pp. 852-853). BMJ PUBLISHING GROUP.
DOI2021 Fletcher, A., March, L., Lassere, M., Hill, C., Barreett, C., Carroll, G., & Buchbinder, R. (2021). AUSTRALIAN PSORIATIC ARTHRITIS (PsA) BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG (bDMARD) TREATMENT PATHWAYS: A COMBINED AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE (ARAD) AND PHARMACEUTICAL BENEFITS SCHEME (PBS) ANALYSIS. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 31-32). WILEY. 2021 Sidhu, N., Marine, F., Lester, S., Quinlivan, A., Rowett, D., Buchbinder, R., & Hill, C. (2021). COMPARISON OF RHEUMATOLOGY AND GASTROENTEROLOGY PATIENT PERCEPTIONS TOWARDS BIOLOGIC AND BIOSIMILAR THERAPY. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 8-9). WILEY. 2021 Berezovskaya, S., Cicuttini, F., Hussain, S. M., Jones, G., Hill, C., Wluka, A., . . . Wang, Y. (2021). CORRELATES OF VASTUS MEDIALIS CROSS-SECTIONAL AREA IN ADULTS WITH SYMPTOMATIC KNEE OSTEOARTHRITIS. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 31). WILEY. 2021 Hains, I., Sinnathurai, P., Hill, C., Barrett, C., Pulver, L., Rudd, T., . . . Sheppard, J. (2021). WHAT DO RHEUMATOLOGISTS THINK AND DO IN THE MANAGEMENT OF INFLAMMATORY ARTHRITIS: A BASELINE SURVEY. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 49). WILEY. 2021 Davis, C., Ruediger, C., Dyer, K., Lester, S., Murphy, K., & Hill, C. (2021). COMPARISON OF DIETARY OILS IN OSTEOARTHRITIS: A FEASIBILITY STUDY. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 27). WILEY. 2021 Shanahan, E., Briggs, E., Gill, T., Hill, C., & Morris, T. (2021). Suprascapular Nerve Block for the Treatment of Adhesive Capsulitis. In ARTHRITIS & RHEUMATOLOGY Vol. 73 (pp. 3309-3310). ELECTR NETWORK: WILEY. 2021 Ruediger, C., Ninan, J., Dyer, K., Lyne, S., Dodd, T., Lester, S., & Hill, C. (2021). DIAGNOSIS OF GIANT CELL ARTERITIS (GCA) IS ASSOCIATED WITH TEMPORAL ARTERY BIOPSY LENGTH IN SOUTH AUSTRALIA (SA). In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 19). WILEY. 2021 Mittinty, M., Mittinty, N. M., Buchbinder, R., Lassere, M., Chand, V., March, L., & Hill, C. (2021). A PERSPECTIVE ON DYADIC COPING FROM THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE (ARAD). In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 34). WILEY. 2021 Black, R., Lester, S., Tieu, J., Sinnathurai, P., Barrett, C., Buchbinder, R., . . . Hill, C. L. (2021). MORTALITY ASSOCIATED WITH RHEUMATOID ARTHRITIS IN AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE PARTICIPANTS. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 37-38). WILEY. 2021 Lyon, A., Quinlivan, A., Lester, S., Barrett, C., Whittle, S., Marine, F., . . . Hill, C. (2021). VACCINATION RATES, PERCEPTIONS AND INFORMATION SOURCES UTILISED BY AUSTRALIAN PATIENTS WITH INFLAMMATORY ARTHRITIS. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 15). WILEY. 2021 Sheppard, J., Dartnell, J., Granger, R., Sinnathurai, P., Buchbinder, R., Hill, C., . . . Hayward, K. (2021). INITIATING A NATIONAL CONSORTIUM APPROACH TO SUPPORT OPTIMAL USE OF bDMARDs. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 22-23). WILEY. 2021 Johnson, J., Lynch, L., Gordon, M., Whittle, S., & Hill, C. (2021). EXPLORING OPIOID USE IN THE CONTEXT OF RHEUMATOLOGY DISEASE IN AN OUTPATIENT SETTING. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 24-25). WILEY. 2021 Bhushan, V., Lester, S., Briggs, L., Hijjawi, R., Shanahan, E. M., Pontifex, E., . . . Wechalekar, M. D. (2021). REAL-LIFE RETENTION RATES AND REASONS FOR SWITCHING OF BIOLOGICAL DMARDs in RA, PsA AND AS. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 41). WILEY. 2021 Ye, J., Marson, A., Sinnathurai, P., Pulver, L., Barrett, C., Hill, C., . . . Dartnell, J. (2021). PATTERNS OF USE OF b/tsDMARDs AND OTHER MEDICATIONS FOR PATIENTS WITH RHEUMATOID ARTHRITIS: A RETROSPECTIVE STUDY USING PBS DATA. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 23). WILEY. 2021 Khoo, T., Hill, C., Hoon, E., & Whittle, S. (2021). MEDICATION USE, COMORBIDITIES AND DISEASE ACTIVITY OF PATIENTS WITH FIBROMYALGIA IN A HOSPITAL OUTPATIENT CLINIC. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 48). WILEY. 2021 Berezovskaya, S., Cicuttini, F., Hussain, S., Hill, C., Jones, G., Wluka, A., . . . Wang, Y. (2021). CORRELATES OF VASTUS MEDIALIS CROSS-SECTIONAL AREA IN ADULTS WITH SYMPTOMATIC KNEE OSTEOARTHRITIS. In OSTEOARTHRITIS AND CARTILAGE Vol. 29 (pp. S272-S273). ELSEVIER SCI LTD. 2020 Davis, C., Ruediger, C., Dyer, K., Lester, S., Graf, S., Kroon, F. P. B., . . . Hill, C. (2020). COLCHICINE IS NOT EFFECTIVE FOR REDUCING OSTEOARTHRITIC HAND PAIN COMPARED TO PLACEBO: A RANDOMISED, PLACEBO-CONTROLLED TRIAL (COLAH). In ANNALS OF THE RHEUMATIC DISEASES Vol. 79 (pp. 793-794). ELECTR NETWORK: BMJ PUBLISHING GROUP.
DOI WoS12020 Dartnell, J., Elliott, J., Buchbinder, R., Hill, C., Barrett, C., Marine, F., . . . de Wever, J. (2020). DEVELOPING A COLLABORATIVE NATIONAL PROGRAM TO OPTIMISE USE OF BDMARDS. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 40-41). WILEY. 2020 Aitken, D., Cai, G., Laslett, L. L., Hill, C., March, L., Cicuttini, F., . . . Jones, G. (2020). A MULTICENTRE RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF ZOLEDRONIC ACID FOR KNEE OSTEOARTHRITIS - THE ZAP2 TRIAL. In OSTEOARTHRITIS AND CARTILAGE Vol. 28 (pp. S79-S80). Vienna, AUSTRIA: ELSEVIER SCI LTD.
WoS12020 Wang, Y., Jones, G., Hill, C., Wluka, A., Forbes, A., Ding, C., . . . Cicuttini, F. (2020). EFFECT OF ATORVASTATIN ON KNEE STRUCTURE AND PAIN IN PATIENTS WITH KNEE OSTEOARTHRITIS: A RANDOMISED CONTROLLED TRIAL. In OSTEOARTHRITIS AND CARTILAGE Vol. 28 (pp. S478-S479). Vienna, AUSTRIA: ELSEVIER SCI LTD.
WoS22020 Tieu, J., Lester, S., Raymond, W., Keen, H., Hill, C., & Nossent, J. (2020). MALIGNANCY IN ANCA-ASSOCIATED VASCULITIS AND POLYARTERITIS NODOSA: AN AUSTRALIAN POPULATION-BASED STUDY. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 22). WILEY. 2020 Russell, O., Lester, M. S., Black, R., & Hill, C. (2020). SOCIOECONOMIC STATUS (SES) AND MEDICATION USE IN RHEUMATOID ARTHRITIS (RA): A SCOPING REVIEW. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 23). WILEY. 2020 Tieu, J., Lester, S., Raymond, W., Keen, H., Hill, C., & Nossent, J. (2020). MALIGNANCY IN ANCA-ASSOCIATED VASCULITIS AND POLYARTERITIS NODOSA: AN AUSTRALIAN POPULATION-BASED STUDY. In ANNALS OF THE RHEUMATIC DISEASES Vol. 79 (pp. 92-93). ELECTR NETWORK: BMJ PUBLISHING GROUP.
DOI2020 Black, R., Lester, S., Hill, C., & Dixon, W. (2020). ORAL GLUCOCORTICOID USE AND THE DEVELOPMENT OF CATARACTS AND GLAUCOMA IN PATIENTS WITH INCIDENT RHEUMATOID ARTHRITIS. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 46-47). WILEY. 2020 Austin, K., Dures, E., Almeida, C., Cramp, F., Gilbert, K., Guly, C., . . . Robson, J. (2020). PATIENT PERCEPTIONS OF PHYSICAL ACTIVITY FOLLOWING A DIAGNOSIS OF GIANT CELL ARTERITIS: A MULTINATIONAL QUALITATIVE STUDY. In RHEUMATOLOGY Vol. 59 (pp. 86). Glasgow, SCOTLAND: OXFORD UNIV PRESS. 2020 Cai, G., Aitken, D., Laslett, L. L., Hill, C., Wluka, A. E., March, L., . . . Jones, G. (2020). THE ASSOCIATION BETWEEN CHANGE IN BONE MARROW LESION SIZE AND CHANGE IN TIBIOFEMORAL CARTILAGE VOLUME AND KNEE SYMPTOMS - RESULTS FROM THE ZAP2 TRIAL. In OSTEOARTHRITIS AND CARTILAGE Vol. 28 (pp. S265). Vienna, AUSTRIA: ELSEVIER SCI LTD. 2020 Chen, T., Deng, J., & Luo, J. (2020). Adaptive Offline Quintuplet Loss for Image-Text Matching. In Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) Vol. 12358 LNCS (pp. 549-565). Glasgow, Scotland: Springer Science and Business Media Deutschland GmbH.
DOI Scopus482019 Fletcher, A., Lassere, M., March, L., Hill, C., Barrett, C., Carroll, G., & Buchbinder, R. (2019). Australian Rheumatoid Arthritis (RA) Biologic Treatment Pathways: An Australian Rheumatology Association Database (ARAD) Analysis. In ARTHRITIS & RHEUMATOLOGY Vol. 71 (pp. 3 pages). GA, Atlanta: WILEY.
WoS12018 Calderon, L., Whittle, S., Hill, C., Sayad, J., Wells, G., & Milman, N. (2018). Methotrexate for Polymyalgia Rheumatica. In JOURNAL OF RHEUMATOLOGY Vol. 45 (pp. 1025-1026). Vancouver, CANADA: J RHEUMATOL PUBL CO. 2018 Leonardo, N., Lester, S., Graham, M., Whittle, S., Rowett, D., Buchbinder, R., & Hill, C. (2018). Attitudes and Beliefs Regarding Methotrexate in Patients with Rheumatoid Arthritis: Results from Australian Rheumatology Association Database. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 2 pages). IL, Chicago: WILEY.
WoS12018 Reid, A., Wiese, M. D., Metcalf, R., Wechalekar, M. D., Lee, A., Hill, C., . . . Proudman, S. (2018). Utility of Serial ACPA Measurements in Rheumatoid Arthritis: Results of a Prospective Cohort Study. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 2 pages). IL, Chicago: WILEY. 2018 Fletcher, A., Lassere, M., Black, R., Barrett, C., Carroll, G., Lester, S., . . . Hill, C. (2018). Socioeconomic Differences in Opioid Use By People with Inflammatory Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 1 page). IL, Chicago: WILEY. 2017 Sinnathurai, P., Halls, S., Hewlett, S., Orbai, A., Bartlett, S., Buchbinder, R., . . . March, L. (2017). EXPLORING DIMENSIONS OF STIFFNESS IN RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE (ARAD) OMERACT STIFFNESS SURVEY. In INTERNAL MEDICINE JOURNAL Vol. 47 (pp. 37). WILEY. 2017 Richards, B., Black, R., Lester, S., Buchbinder, R., Lassere, M., March, L., & Hill, C. (2017). FACTORS ASSOCIATED WITH COMMENCING AND CEASING OPIOID THERAPY IN A POPULATION-BASED COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS (RA): DATA FROM THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE (ARAD). In INTERNAL MEDICINE JOURNAL Vol. 47 (pp. 32). WILEY. 2017 Stuchbery, R., Mangiola, S., Macintyre, G., Clarkson, M. J., Kowalczyk, A., Peters, J. S., . . . Corcoran, N. M. (2017). Periprostatic fat holds a field-effect transcriptional signature of cancer grade. In BJU INTERNATIONAL Vol. 120 (pp. 22). AUSTRALIA: WILEY. 2016 De Smit, E., Clarke, L., Kearns, L., Hill, C., McKelvie, P., Craig, J., . . . Hewitt, A. W. (2016). UNRAVELLING THE GENETIC ARCHITECTURE OF GIANT CELL ARTERITIS THROUGHA GENOME-WIDE ASSOCIATION STUDY. In CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY Vol. 44 (pp. 57). WILEY-BLACKWELL. 2016 Ruediger, C., Lester, S., Aitken, D., March, L., Jones, G., & Hill, C. (2016). METABOLIC SYNDROME IS ASSOCIATED WITH PROGRESSION OF BONE MARROW LESIONS IN PATIENTS WITH KNEE OSTEOARTHRITIS. In INTERNAL MEDICINE JOURNAL Vol. 46 (pp. 19). WILEY-BLACKWELL. 2016 Crowhurst, T., Dobson, R., Nguyen, L., Bartholomeusz, D., & Hill, C. (2016). ¹⁸FDG PET CT imaging in the diagnosis and monitoring of large vessel vasculitis. In Abstracts of the 46th Australian and New Zealand Society of Nuclear Medicine Annual Scientific Meeting (ANZSNM 2016), as published in Internal Medicine Journal Vol. 46 (pp. 33). Rotorua: Wiley-Blackwell.
DOI2016 De Smit, E., Clarke, L., Ngygen, K., Shuey, N., Hill, C., Anderson, L., . . . Hewitt, A. W. (2016). LONGITUDINAL EXPRESSION PROFILING OF T LYMPHOCYTES IN PATIENTS WITH ACTIVE TO QUIESCENT GIANT CELL ARTERITIS. In CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY Vol. 44 (pp. 99-100). WILEY-BLACKWELL. 2015 Van Tuyl, L. H., Sadlonova, M., Hewlett, S., Davis, B., Flurey, C., Goel, N., . . . Boers, M. (2015). THE PATIENT PERSPECTIVE ON ABSENCE OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS: A SURVEY TO IDENTIFY KEY DOMAINS OF PATIENT PERCEIVED REMISSION. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 435-436). BMJ PUBLISHING GROUP.
DOI WoS32015 Cook, J. R., Macintyre, D. A., Samara, E., Kim, S. H., Singh, N., Johnson, M. R., . . . Terzidou, V. (2015). Exogenous oxytocin modulates human myometrial microRNAs. In BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY Vol. 122 (pp. 226). WILEY-BLACKWELL. 2014 Merriman, T., Topless, R., Day, R., Kannangara, D., Williams, K., Bradbury, L., . . . Rasheed, H. (2014). ASSOCIATION OF THE TOLL-LIKE RECEPTOR 4 (TLR4) GENE WITH GOUT. In ANNALS OF THE RHEUMATIC DISEASES Vol. 73 (pp. 354). Paris, FRANCE: BMJ PUBLISHING GROUP.
DOI WoS22012 Hill, C. L., Appleton, S. L., Gill, T. K., Black, J., Rudd, R. E., & Adams, R. J. (2012). Role of health literacy in population estimates of musculoskeletal disorders. In Abstracts of the American College of Rheumatology/Association of Rheumatology Health Professionals, Annual Scientific Meeting, as published in Arthritis and Rheumatism Vol. 64 (pp. S25). Washington, DC: Wiley.
DOI2011 Hill, C. L., Jones, G., March, L., Battersby, R., Hynes, K., Fedorova, T., . . . Cleland, L. G. (2011). Fish Oil in Knee Osteoarthritis: A Two Year Randomized, Double-Blind Clinical Trial Comparing High Dose with Low Dose. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S426). Chicago, IL: WILEY. 2011 Ngian, G. -S., Stevens, W., Byron, J., Ai, T., Roddy, J. E., Minson, R., . . . Nikpour, M. (2011). Survival and Predictors of Mortality In Australian Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S332). Chicago, IL: WILEY.
WoS12011 Adams, R., Piantadosi, C., Appleton, S., Mcevoy, D., Hill, C., Visvanathan, R., & Wilson, D. (2011). Investigating obstructive sleep apnoea - Will the health system have the capacity to cope? A population study. In JOURNAL OF SLEEP RESEARCH Vol. 20 (pp. 63-64). Sydney, AUSTRALIA: WILEY-BLACKWELL. 2011 Lester, S., Rischmueller, M., Tan, L., Wormald, P., Zalewski, P., Appleton, S., . . . Hill, C. (2011). THE PREVALENCE OF SICCA SYMPTOMS, AND THEIR ASSOCIATION WITH ASTHMA AND SINUSITIS, IN A COMMUNITY SAMPLE. In INTERNAL MEDICINE JOURNAL Vol. 41 (pp. 11). WILEY-BLACKWELL. 2009 Gill, T. K., Laddipeerla, N. R., Phillips, P., Hill, C. L., & Taylor, A. W. (2009). PREVALENCE AND ASSOCIATED MEDICATION USE OF THOSE WITH OSTEOPOROSIS IN THE COMMUNITY. In OSTEOPOROSIS INTERNATIONAL Vol. 20 (pp. 181-182). Bangkok, THAILAND: SPRINGER LONDON LTD. 2006 Hill, C. L., Gill, T. K., & Taylor, A. W. (2006). Prevalence and associations of foot pain in a population-based study.. In ARTHRITIS AND RHEUMATISM Vol. 54 (pp. S322-S323). Washington, DC: WILEY-LISS. 2006 Hill, C. L., Buchbinder, R., & Osborne, R. H. (2006). Quality of reporting of randomized clinical trials (RCTs) in abstracts of the 2005 annual scientific meeting of American College of Rheumatology.. In ARTHRITIS AND RHEUMATISM Vol. 54 (pp. S534). Washington, DC: WILEY-LISS. 2005 Pontifex, E. K., Hill, C. L., & Roberts-Thomson, P. (2005). Risk factors for lung cancer in patients with scleroderma: A nested case-control study.. In ARTHRITIS AND RHEUMATISM Vol. 52 (pp. S162). San Diego, CA: WILEY-BLACKWELL. 2005 Bayat, N., Keen, H., & Hill, C. (2005). A review of osteoarthritis randomized clinical. In ANNALS OF THE RHEUMATIC DISEASES Vol. 64 (pp. 489). Vienna, AUSTRIA: BMJ PUBLISHING GROUP. 2005 Hill, C. L., Hunter, D. J., Niu, J. B., Clancy, M., Guermazi, A., Genant, H., & Felson, D. T. (2005). Changes in synovitis are associated with changes in pain in knee osteoarthritis (OA).. In ARTHRITIS AND RHEUMATISM Vol. 52 (pp. S71). San Diego, CA: WILEY-BLACKWELL.
WoS12003 Amin, S., Lavalley, M. P., Niu, J., Seo, G. S., Hill, C. L., Gale, D., . . . Felson, D. T. (2003). Complete anterior cruciate ligament (ACL) tear and risk for radiographic and symptom progression in subjects with knee osteoarthritis.. In ARTHRITIS AND RHEUMATISM Vol. 48 (pp. S70-S71). ORLANDO, FLORIDA: WILEY-LISS.
WoS12003 Hill, C. L., Gill, T., Taylor, A., Daly, A., d'Espaignet, E., & Adams, R. J. T. (2003). Psychological factors and quality of life in arthritis: A population-based study. In ARTHRITIS AND RHEUMATISM Vol. 48 (pp. S406). ORLANDO, FLORIDA: WILEY-LISS. 2003 Hill, C. L., Seo, G. S., Gale, D., Totterman, S., Gale, E., & Felson, D. T. (2003). The prevalence of cruciate ligament tears in osteoarthritis of the knee and their association with disease severity and knee pain.. In ARTHRITIS AND RHEUMATISM Vol. 48 (pp. S78). ORLANDO, FLORIDA: WILEY-LISS.
WoS12003 Keen, H. I., Pile, K., & Hill, C. L. (2003). The prevalence of under-powered randomised clinical trials in rheumatology.. In ARTHRITIS AND RHEUMATISM Vol. 48 (pp. S127). ORLANDO, FLORIDA: WILEY-LISS. 2002 Felson, D. T., McLaughlin, S., Goggins, J., LaValley, M., Gale, M. E., Totterman, S., . . . Gale, D. (2002). Bone marrow edema (BME) and its relation to x-ray progression in knee osteoarthritis (OA).. In ARTHRITIS AND RHEUMATISM Vol. 46 (pp. S558). LA, NEW ORLEANS: WILEY.
WoS32000 Hill, C. L., LaValley, M. P., & Felson, D. T. (2000). Discrepancy between reports and actual conduct of randomized controlled trials (RCT).. In ARTHRITIS AND RHEUMATISM Vol. 43 (pp. S135). LIPPINCOTT WILLIAMS & WILKINS. 1999 Hill, C. L., Gale, D., Chaisson, C. E., Johnson, S. S., & Felson, D. T. (1999). The frequency of effusions and peri-articular lesions in knee osteoarthritis (KOA) and association with pain.. In ARTHRITIS AND RHEUMATISM Vol. 42 (pp. S294). LIPPINCOTT WILLIAMS & WILKINS.
WoS11999 Hill, C. L., LaValley, M. P., Evans, S. R., & Felson, D. T. (1999). Improvement in quality but persistent methodological deficiencies in randomized clinical trials (RCT) reports in rheumatology: 1987/8 vs. 1997/8.. In ARTHRITIS AND RHEUMATISM Vol. 42 (pp. S72). LIPPINCOTT WILLIAMS & WILKINS. -
Conference Items
Year Citation 2025 Stanhope, J., Lester, S., Weinstein, P., Adams, R., Gill, T., Appleton, S., & Hill, C. (2025). Does having green or blue space within walking distance of home reduce the risk of arthritis?. Poster session presented at the meeting of Australian Rheumatology Association Annual Scientific Meeting. Adelaide. 2025 Davies, T., Stanhope, J., Park, S., Whittle, S., & Hill, C. (2025). Time from referral to initial assessment and DMARD commencement in those with suspected rheumatoid arthritis. Poster session presented at the meeting of Australian Rheumatology Association Annual Scientific Meeting. 2025 Lyon, A., Lester, S., Stanhope, J., Lynch, T., Black, R., Barrett, C., . . . Hill, C. (2025). Dual-energy x-ray absorptiometry (DEXA) and anti-osteoporotic medication use in Australian patients with early rheumatoid arthritis (RA) using data from the Australian Rheumatology Association Database (ARAD). Poster session presented at the meeting of Australian Rheumatology Association Annual Scientific Meeting. 2025 Goodwin, S., Wigg, A., Schwetlik, S., Lester, S., Stanhope, J., Dyer, K., . . . Hill, C. (2025). Bridging the gap to community care: an allied health-led, self-management group for rheumatology outpatients. Poster session presented at the meeting of Australian Rheumatology Association Annual Scientific Meeting. 2025 Ruediger, C., Dyer, K., Lyne, S., Ninan, J., Lester, S., Mishra, A., . . . Hill, C. (2025). Audit of temporal artery biopsy reporting in South Australia. Poster session presented at the meeting of Australian Rheumatology Association Annual Scientific Meeting. 2025 Chim, I., Stanhope, J., Dyer, K., Simon, S., Ruediger, C., Lyne, S., . . . Hill, C. (2025). Associations and outcomes of ocular giant cell arteritis (GCA): a sub-group analysis of the South Australian GCA Registry. Poster session presented at the meeting of Australian Rheumatology Association Annual Scientific Meeting. 2024 Stanhope, J., Weinstein, P., Lester, S., & Hill, C. (2024). Green space exposure: effects on inflammatory arthritis outcomes and the microbiome. Poster session presented at the meeting of A3BC Collaborators Meeting. Adelaide. 2024 Tuli, J., Ruediger, C., Stanhope, J., Dyer, K., Lester, S., & Hill, C. (2024). Bridging the gap: comparing inflammatory arthritis patient outcomes with Australian national standards. Poster session presented at the meeting of A3BC Collaborators Meeting. Adelaide. 2024 Lyon, A., Lester, S., Stanhope, J., Lynch, T., Black, R., Barrett, C., . . . Hill, C. (2024). -energy x-ray absorptiometry (DEXA) and anti-osteoporotic medication use in Australian patients with early rheumatoid arthritis (RA) using data from the Australian Rheumatology Association Database (ARAD). Poster session presented at the meeting of South Australian Branch of the Australian Rheumatology Association Annual Scientific Meeting. Adelaide. 2024 Davies, T., Stanhope, J., Park, S., Whittle, S., & Hill, C. (2024). Time from referral to initial assessment and DMARD commencement in those with suspected rheumatoid arthritis. Poster session presented at the meeting of South Australian Branch of the Australian Rheumatology Association Annual Scientific Meeting. Adelaide. 2024 Goodwin, S., Wigg, A., Schwetlik, S., Lester, S., Stanhope, J., Dyer, K., . . . Hill, C. (2024). Bridging the gap to community care: An allied health-led self-management group program for rheumatology outpatients. Poster session presented at the meeting of South Australian Branch of the Australian Rheumatology Association Annual Scientific Meeting. Adelaide. 2022 Bridgewater, S., Shepherd, M. A., Dawson, J., Richards, P., Silverthorne, C., Ndosi, M., . . . Robson, J. (2022). PATIENT PERCEPTIONS OF IMPACT OF GLUCOCORTICOID THERAPY IN THE RHEUMATIC DISEASES: INTERNATIONAL DEVELOPMENT OF A TREATMENT-SPECIFIC PATIENT REPORTED OUTCOME MEASURE. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. DENMARK, Copenhagen: BMJ PUBLISHING GROUP.
DOI2022 Lim, Y., Cicuttini, F., Wluka, A., Jones, G., Hill, C., Forbes, A., . . . Wang, Y. (2022). EFFECT OF ATORVASTATIN ON SKELETAL MUSCLES OF PATIENTS WITH KNEE OSTEOARTHRITIS: POST-HOC ANALYSIS OF A RANDOMISED CONTROLLED TRIAL. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2022 Fairley, J., Hansen, D., Ross, L., Proudman, S., Sahhar, J., Ngian, G. -S., . . . Nikpour, M. (2022). Clinical Characteristics and Survival of Combined Pulmonary Arterial Hypertension and Interstitial Lung Disease in Systemic Sclerosis. Poster session presented at the meeting of Abstracts of the ACR Convergence 2022, as published in Arthritis & Rheumatology. Philadelphia, PA: Wiley.
DOI2021 Pontoh, E., Cicuttini, F., Hussain, S., Jones, G., Hill, C., Wluka, A., . . . Wang, Y. (2021). ASSOCIATION BETWEEN POPLITEAL ARTERY WALL THICKNESS AND STRUCTURAL PROGRESSION IN INDIVIDUALS WITH SYMPTOMATIC KNEE OSTEOARTHRITIS. Poster session presented at the meeting of OSTEOARTHRITIS AND CARTILAGE. ELSEVIER SCI LTD. 2021 Stamp, L., Grainger, R., Frampton, C., Drake, J., & Hill, C. (2021). Effect of Omega-three Supplementation on Serum Urate and Gout Flares in People with Gout; A Pilot Randomized Trial. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. ELECTR NETWORK: WILEY. 2021 Quinlivan, A., Lester, S., Barrett, C., Whittle, S., Rowett, D., Black, R., . . . Hill, C. (2021). ATTITUDES OF AUSTRALIANS WITH INFLAMMATORY ARTHRITIS TO BIOLOGIC THERAPY AND BIOSIMILARS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2021 Pontoh, E. W., Cicuttini, F., Hussain, S. M., Jones, G., Hill, C., Wluka, A., . . . Wang, Y. (2021). ASSOCIATION BETWEEN POPLITEAL ARTERY WALL THICKNESS AND STRUCTURAL PROGRESSION IN INDIVIDUALS WITH SYMPTOMATIC KNEE OSTEOARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2021 Shanahan, E. M., Briggs, E., Gill, T., Hill, C., & Morris, T. (2021). SUPRASCAPULAR NERVE BLOCK FOR THE TREATMENT OF ADHESIVE CAPSULITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2021 Schwetlik, S. N., Baldock, K. L., Hill, C. L., Gill, T., & Ferrar, K. (2021). A CROSS-SECTIONAL ANALYSIS OF THE RELATIONSHIP BETWEEN ALLOSTATIC LOAD AND OSTEOARTHRITIS. Poster session presented at the meeting of OSTEOARTHRITIS AND CARTILAGE. ELSEVIER SCI LTD. 2021 Rischin, A., Liew, D., Black, R., Fletcher, A., Buchbinder, R., Lassere, M., . . . Hill, C. (2021). HEALTHCARE ACCESS AND ATTITUDES TOWARDS TELEHEALTH DURING THE EARLY PHASE OF THE COVID-19 PANDEMIC AMONG AN AUSTRALIAN COHORT WITH INFLAMMATORY ARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2020 Black, R., Lester, S., Ninan, J., Ruediger, C., & Hill, C. (2020). INCIDENCE AND PREVALENCE OF GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA RECORDED IN AUSTRALIAN PRIMARY CARE ELECTRONIC MEDICAL RECORDS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2020 New-Tolley, J., Reynolds, A., Appleton, S. L., Gill, T. K., Lester, S., Adams, R., & Hill, C. (2020). PREVALENCE OF GOUT AND SLEEP CONDITIONS IN AUSTRALIAN ADULTS: 2019 SLEEP HEALTH FOUNDATION NATIONAL SURVEY. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2020 Whittle, S., Hill, C., & Buchbinder, R. (2020). ARA MEMBER SURVEY TO IDENTIFY PRIORITY QUESTIONS FOR A LIVING GUIDELINE FOR THE PHARMACOLOGICAL MANAGEMENT OF RHEUMATOID ARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
WoS22020 Khoo, T., Hill, C., & Whittle, S. (2020). MEDICATION USE AND COMORBIDITIES OF PATIENTS WITH FIBROMYALGIA IN A HOSPITAL OUTPATIENT CLINIC. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2020 Lalor, A. F., Brooker, J. E., Rozbroj, T., Whittle, S., Hill, C., Rowett, D., . . . Buchbinder, R. (2020). CLINICIAN PERSPECTIVES FACTORS INFLUENCING PRESCRIBING AND USE OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN INFLAMMATORY RHEUMATIC DISORDERS FROM THE PERSPECTIVES OF CLINICIANS: A QUALITATIVE EVIDENCE SYNTHESIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2020 Venter, G., Tieu, J., Black, R., Lester, S., Leonardo, N., Whittle, S. L., . . . Hill, C. L. (2020). PERSPECTIVES OF GLUCOCORTICOID USE IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2020 Davis, C., Ruediger, C., Dyer, K., Lester, S., Graf, S., Kroon, F., . . . Hill, C. (2020). COLCHICINE IS NOT EFFECTIVE FOR REDUCING OSTEOARTHRITIC HAND PAIN COMPARED TO PLACEBO: A RANDOMISED, PLACEBO-CONTROLLED TRIAL (COLAH). Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2019 Fairley, J., Hansen, D., Proudman, S., Sahhar, J., Ngian, G. -S., Walker, J., . . . Nikpour, M. (2019). Clinical Characteristics and Survival in Systemic Sclerosis-mixed Connective Tissue Disease and Systemic Sclerosis-overlap Syndrome. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. GA, Atlanta: WILEY. 2019 Arnold, J. B., Halstead-Rastrick, J., Keenan, A. -M., Hill, C. L., & Redmond, A. C. (2019). FOOT AND LEG MUSCLE WEAKNESS IN INDIVIDUALS WITH MIDFOOT PAIN AND OSTEOARTHRITIS. Poster session presented at the meeting of OSTEOARTHRITIS AND CARTILAGE. Toronto, CANADA: ELSEVIER SCI LTD.
DOI2019 Calderon, L., Milman, N., Hill, C., Whittle, S., Sayad, J., Wells, G., & Pardo, J. (2019). Methotrexate for Giant Cell Arteritis. Poster session presented at the meeting of JOURNAL OF RHEUMATOLOGY. Montreal, CANADA: J RHEUMATOL PUBL CO. 2019 Robson, J., Almeida, C., Dawson, J., Emma, D., Bromhead, A., Mackie, S., . . . Hill, C. (2019). PATIENT PERCEPTIONS OF HEALTH RELATED QUALITY OF LIFE RELATED TO GIANT CELL ARTERITIS AND ITS TREATMENT: AN INTERNATIONAL QUALITATIVE STUDY. Poster session presented at the meeting of RHEUMATOLOGY. Philadelphia, PA: OXFORD UNIV PRESS. 2019 Black, R., Lester, S., Hill, C., & Dixon, W. (2019). THE IMPACT OF ORAL GLUCOCORTICOIDS ON THE DEVELOPMENT OF CATARACTS AND GLAUCOMA IN INCIDENT RHEUMATOID ARTHRITIS PATIENTS. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. Madrid, SPAIN: BMJ PUBLISHING GROUP.
DOI2019 Austin, K., Dures, E., Almeida, C., Cramp, F., Gilbert, K., Guly, C., . . . Robson, J. (2019). PATIENT PERCEPTIONS OF PHYSICAL ACTIVITY AFTER A DIAGNOSIS OF GIANT CELL ARTERITIS: A SECONDARY ANALYSIS OF MULTINATIONAL QUALITATIVE DATA. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. Madrid, SPAIN: BMJ PUBLISHING GROUP.
DOI2019 Yates, M., Owen, C. E., Muller, S., Graham, K., Neill, L., Twohig, H., . . . Hill, C. (2019). RESULTS OF A PATIENT SURVEY ON FEASIBILITY AND FACE VALIDITY OF OUTCOME MEASURES FOR INTENDED USE IN FUTURE STUDIES ENROLLING PARTICIPANTS WITH POLYMYALGIA RHEUMATICA. Poster session presented at the meeting of RHEUMATOLOGY. Birmingham, ENGLAND: OXFORD UNIV PRESS. 2018 Fletcher, A., Staples, M. P., Hill, C., Lassere, M., March, L., Carroll, G., . . . Buchbinder, R. (2018). Use of Oral Complementary Medicine in Inflammatory Arthritis: Data from the Australian Rheumatology Association Database (ARAD). Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. IL, Chicago: WILEY. 2018 Cai, G., Aitken, D., Laslett, L., Hill, C., March, L., Wluka, A. E., . . . Jones, G. (2018). A MULTICENTRE RANDOMISED CONTROLLED TRIAL OF ZOLEDRONIC ACID FOR OSTEOARTHRITIS OF THE KNEE WITH BONE MARROW LESIONS. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. Amsterdam, NETHERLANDS: BMJ PUBLISHING GROUP.
DOI WoS72018 Cross, M., Macara, M., Little, E., Chan, M., Little, D., Buchbinder, R., . . . March, L. (2018). EFFICACY OF ZOLEDRONATE IN TREATING OSTEONECROSIS OF THE FEMORAL HEAD: A RANDOMIZED CONTROLLED TRIAL. Poster session presented at the meeting of OSTEOARTHRITIS AND CARTILAGE. Liverpool, ENGLAND: ELSEVIER SCI LTD.
DOI WoS12018 Cross, M., Buchbinder, R., Chan, M. M., Duncan, E. L., Hill, C. L., Inderjeeth, C., . . . March, L. (2018). EFFICACY OF ZOLEDRONATE IN TREATING OSTEONECROSIS OF THE FEMORAL HEAD: A RANDOMISED CONTROLLED TRIAL. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2018 Cheah, J., Young, S., Goodman, S. M., Hill, C., Beard, S., Richards, P., . . . Navarro-Millan, I. (2018). The Impact of Chronic Glucocorticoid Use Amongst Patients with Rheumatoid Arthritis: A Qualitative Study. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. IL, Chicago: WILEY. 2018 Cheah, J., Robson, J., Black, R., Goodman, S. M., Lester, S., Mackie, S., & Hill, C. (2018). The Patient's Perspective of Glucocorticoid Use: A Systematic Literature Review of Quantitative and Qualitative Studies. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. IL, Chicago: WILEY. 2018 Robson, J. C., Almeida, C., Dawson, J., Bromhead, A., Mackie, S. L., Hill, C., . . . Dures, E. (2018). A MULTINATIONAL QUALITATIVE STUDY IN GIANT CELL ARTERITIS: PATIENT PERCEPTIONS OF DIAGNOSIS, TREATMENT, IMPACT ON HEALTH-RELATED QUALITY OF LIFE AND CONTEXTUAL FACTORS. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. Amsterdam, NETHERLANDS: BMJ PUBLISHING GROUP.
DOI WoS32018 Proudman, C., Lester, S., Gonzalez-Chica, D., Gill, T., Dalbeth, N., & Hill, C. (2018). Gout, Flares and Allopurinol Use: A Population Based Study. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. IL, Chicago: WILEY. 2018 Chan, F., Lester, S., Whittle, S., & Hill, C. (2018). THE UTILITY OF ESR, CRP AND PLATELETS IN THE DIAGNOSIS OF GCA: A SOUTH AUSTRALIAN STATEWIDE ANALYSIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2018 Russell, R. A., williams, J., Szell, C., Gould, D. V., & Hill, C. (2018). Developing a Transparent Supervisor Evaluation System. Poster session presented at the meeting of 3rd International Conference on Developments in Doctoral Education & Training. Stratford upon Avon, United Kingdom. 2017 Merriman, T. R., Cadzow, M., Merriman, M. E., Phipps-Green, A., Topless, R., Abhishek, A., . . . Major, T. (2017). A Genome-Wide Association Study of Gout in People of European Ancestry. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Diego: WILEY. 2017 Walker, J. G., Nikpour, M., Huq, M., Patterson, K., Roberts-Thomson, P., Proudman, S., . . . Fritzler, M. J. (2017). Autoantibodies to the hPOP1 and Rpp25/38 Components of the Th/to Complex Identify a Subgroup of Systemic Sclerosis (SSc) Associated Interstitial Lung Disease (ILD) and Antibodies to hPOP1 Are Associated with Reduced Survival. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Diego: WILEY. 2017 Whittle, S., Menz, F., Lester, S., Proudman, S., & Hill, C. (2017). THE DAS28-P INDEX AS A PREDICTOR OF POOR SUBJECTIVE RESPONSE TO DMARD THERAPY IN EARLY RHEUMATOID ARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
WoS12017 Ruediger, C., Nguyen, L., Black, R., Proudman, S., & Hill, C. (2017). A REVIEW OF METHOTREXATE USE IN POLYMYALGIA RHEUMATICA (PMR). Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2017 Pisaniello, H., Lester, S., Gonzalez-Chica, D., Longo, M., Sharplin, G., Dal Grande, E., . . . Hill, C. (2017). PREVALENCE AND PREDICTORS OF GOUT AND ALLOPURINOL USE, AND THEIR ASSOCIATION WITH RISK PERCEPTION: RESULTS FROM A SOUTH AUSTRALIAN POPULATION-BASED STUDY. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
WoS12017 Gabb, G. M., Caughey, G., Ronson, S., Ward, M., Hill, C. L., & Limaye, V. (2017). ASSOCIATION OF IDIOPATHIC INFLAMMATORY MYOSITIS WITH STATIN EXPOSURE: A POPULATION BASED CASE CONTROL AND ECOLOGICAL STUDY. Poster session presented at the meeting of HYPERTENSION. Hobart, AUSTRALIA: LIPPINCOTT WILLIAMS & WILKINS.
WoS12017 Wiese, M. D., Metcalf, R., Wechalekar, M. D., Spargo, L., McWilliams, L., James, M., . . . Proudman, S. (2017). Predicting Remission at 6 Months in Early Rheumatoid Arthritis Treated with Conventional Synthetic Dmards. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Diego: WILEY. 2017 Wechalekar, M. D., Lester, S., Nagpal, S., Cole, S., Peters, J., Das, A., . . . Proudman, S. (2017). Osteopontin and Leptin Are Associated with Erosive Disease in an Inception Cohort of Rheumatoid Arthritis Treated-to-Target with Combination Conventional DMARD Therapy. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Diego: WILEY. 2017 Merriman, T. R., Cadzow, M., Merriman, M., Phipps-Green, A., Topless, R., Abhishek, A., . . . Flynn, T. (2017). A GENOME-WIDE ASSOCIATION STUDY OF GOUT IN PEOPLE OF EUROPEAN ANCESTRY. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. Madrid, SPAIN: BMJ PUBLISHING GROUP.
DOI2016 Boulos, D., Rajadurai, A., Ngian, G. S., Elford, K., Stevens, W., Proudman, S., . . . Sahhar, J. (2016). LONG-TERM EFFICACY AND TOLERABILITY OF MYCOPHENOLATE MOFETIL THERAPY IN DIFFUSE SCLERODERMA SKIN DISEASE. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. London, ENGLAND: BMJ PUBLISHING GROUP.
DOI2016 Caughey, G. E., Gabb, G. M., Ronson, S., Ward, M., Hill, C. L., & Limaye, V. (2016). Association of Idiopathic Inflammatory Myositis with Statin Exposure: A Population Based Case Control Study. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY-BLACKWELL. 2016 Black, R., Goodman, S. M., Ruediger, C., Lester, S., Mackie, S., & Hill, C. (2016). Glucocorticoid Adverse Effects - the Patient Perspective. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. DC, Washington: WILEY. 2016 De Smit, E., Hill, C., Merriman, T., Cremin, K., Leo, P., McKelvie, P., . . . Hewitt, A. W. (2016). Investigation into the genetic architecture of Giant Cell Arteritis through a genome-wide association study. Poster session presented at the meeting of Abstracts of the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO 2016), as published in Investigative Ophthalmology & Visual Science. Seattle, WA: Association for Research in Vision and Ophthalmology. 2015 Ting, K., Hill, C., Gill, T., & Tucker, G. (2015). PREVALENCE AND ASSOCIATIONS OF GOUT AND HYPERURICAEMIA: RESULTS FROM AN AUSTRALIAN POPULATION-BASED STUDY. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
WoS22015 Hill, C., Black, R., Nossent, J., Ruediger, C., Ninan, J., & Lester, S. (2015). Risk of mortality in patients with giant cell arteritis: a systematic review and meta-analysis. Poster session presented at the meeting of Abstracts of the 2015 ACR/ARHP Annual Meeting, as published in Arthritis & Rheumatology. San Francisco, CA: Wiley-Blackwell.
DOI WoS12015 Murthy, S., Lester, S., March, L., Jones, G., Cleland, L., Bubicich, M., & Hill, C. (2015). SERUM CARTILAGE OLIGOMERIC MATRIX PROTEIN (COMP) IN KNEE OSTEOARTHRITIS AND THE EFFECT OF HIGH AND LOW DOSE FISH OIL ON COMP LEVELS IN FOSTAR STUDY GROUP. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2015 Walsh, T., Gill, T., Shanahan, E., & Hill, C. (2015). THE ASSOCIATION OF FAT MASS AND ADIPOKINES WITH FOOT PAIN IN A COMMUNITY COHORT. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. Adelaide, South Australia: WILEY-BLACKWELL. 2015 Gill, T., Menz, H., & Hill, C. (2015). PREVALENCE AND PREDICTORS OF FOOT PAIN: RESULTS FROM AN AUSTRALIAN COHORT STUDY. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2015 Rajadurai, A., Ngian, G., Elford, K., Stevens, W., Proudman, S., Roddy, J., . . . Sahhar, J. (2015). MYCOPHENOLATE MOFETIL IN THE TREATMENT OF SCLERODERMA-ASSOCIATED DIFFUSE SKIN DISEASE: RESULTS FROM THE AUSTRALIAN SCLERODERMA COHORT STUDY. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2015 Wechalekar, M., Lester, S., Rischmueller, M., Hill, C., & Proudman, S. (2015). FOOT SYNOVITIS IN PATIENTS IN APPARENT REMISSION IS ASSOCIATED WITH WORSE LONG-TERM FUNCTIONAL OUTCOMES. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2015 Ting, K., Whittle, S., & Hill, C. (2015). QUALITY OF REPORTING OF INTERVENTIONAL ANIMAL STUDIES IN RHEUMATOLOGY. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2015 Wodkowski, M., Hudson, M., Proudman, S., Walker, J., Stevens, W., Nikpour, M., . . . Fritzler, M. (2015). Clinical Correlates of Monospecific Anti-Ro52/TRIM21 Antibodies in a Tri-nation Cohort of 1574 Systemic Sclerosis Subjects. Poster session presented at the meeting of JOURNAL OF RHEUMATOLOGY. Quebec, CANADA: J RHEUMATOL PUBL CO. 2015 Gill, T. K., Walsh, T. P., Shanahan, E. M., & Hill, C. (2015). Association Between Musculoskeletal Pain, Fat Mass and Fat Free Mass: Results from a Population-Based Study. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Francisco: WILEY. 2015 Gill, T. K., Ting, K., Tucker, G. R., Shanahan, E. M., & Hill, C. (2015). Prevalence of Gout and Hyperuricemia and Association with Fat Mass and Fat Free Mass: Results from a Population-Based Study. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Francisco: WILEY. 2015 Gill, T. K., Shanahan, E. M., Tucker, G. R., & Hill, C. (2015). Age and Sex Stratified Normative Data for Shoulder Range of Movement. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Francisco: WILEY. 2014 Li, J., Appleton, S., Gill, T., Vakulin, A., Wittert, G., Antic, N., . . . Hill, C. (2014). Musculoskeletal pain is not associated with obstructive sleep apnoea or daytime sleepiness but is associated with poor sleep quality. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with the Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell.
DOI WoS12014 Owen, C., Ngian, G., Elford, K., Moore, O., Nikpour, M., Stevens, W., . . . Sahhar, J. (2014). Mycophenolate mofetil versus azathioprine in scleroderma-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study. Poster session presented at the meeting of Abstracts of the 2014 ACR/ARHP Annual Meeting, as published in Arthritis & Rheumatology. Boston, MA: Wiley-Blackwell.
DOI2014 Quinlivan, A., Thakkar, V., Stevens, W., Prior, D., Rabusa, C., Youssef, P., . . . Nikpour, M. (2014). Cost savings with a biomarker-based screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Poster session presented at the meeting of Abstracts of the 3rd Systemic Sclerosis World Congress, as published in Clinical and Experimental Rheumatology. Rome, Italy: Clinical and Experimental Rheumatology. 2014 Quinlivan, A., Thakkar, V., Stevens, W., Prior, D., Rabusa, C., Youssef, P., . . . Nikpour, M. (2014). Cost savings with a biomarker-based screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell.
DOI2014 Lester, S., Patterson, K., Walker, J., Charlesworth, J., Stankovich, J., Stevens, W., . . . Zochling, J. (2014). Associations between HLA DRB1 alleles and autoantibodies in systemic sclerosis. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell.
DOI2014 Owen, C., Ngian, G., Moore, O., Stevens, W., Proudman, S., Roddy, J., . . . Sahhar, J. (2014). Mycophenolate mofetil versus azathioprine in scleroderma-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell.
DOI2014 Patterson, K., Roberts-Thomson, P., Lester, S., Proudman, S., Rischmueller, M., Stevens, W., . . . Walker, J. (2014). Autoantibody associations among a well-characterized Australian systemic sclerosis (SSc) cohort. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell.
DOI2014 Wechalekar, M., Lester, S., Hill, C., Shanahan, E., Metcalf, R., Shanahan, M., & Proudman, S. (2014). Work disability in an inception cohort of early rheumatoid arthritis (RA) receiving treat-to-target therapy. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell.
DOI2014 Cross, M., Smtih, E. U., Hoy, D., Nolte, S., Ackerman, I., Fransen, M., . . . March, L. (2014). SEVERITY OF OSTEOARTHRITIS IN GLOBAL POPULATIONS. Poster session presented at the meeting of OSTEOARTHRITIS AND CARTILAGE. Paris, FRANCE: ELSEVIER SCI LTD.
DOI WoS32014 Hoon, E., Gill, T., Dent, E., Lynch, J., & Beilby, J. (2014). Profiling self-management and information seeking activities for people with MSK conditions in an Australian regional population. Poster session presented at the meeting of Proceedings of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley.
DOI2014 Rasheed, H., Topless, R., Day, R., Kannangara, D., Williams, K., Bradbury, L., . . . Merriman, T. R. (2014). Association of the Toll-like Receptor 4 (TLR4) Gene with Gout.. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. MA, Boston: WILEY. 2014 Lester, S., Dunstan, E., Hewitt, A., Bradbury, L., Brown, M., Harrison, A., . . . Hill, C. (2014). PTPN22 RS2476601 AND SUSCEPTIBILITY TO BIOPSY PROVEN GIANT CELL ARTERITIS ( GCA) IN AN AUSTRALIAN SAMPLE. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
DOI WoS12013 Dunstan, E., Lester, S., Hewitt, A., Rischmueller, M., & Hill, C. (2013). NO ASSOCIATION BETWEEN FCGR3B, TLR4 AND SOUTH AUSTRALIAN BIOPSY-PROVEN GIANT CELL ARTERITIS PATIENTS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2013 Hill, C. L., Jones, G., Lester, S., Battersby, R., Fedorova, T., Hynes, K., . . . March, L. (2013). Effect of fish oil on structural progression in knee osteoarthritis: a two year randomized, double-blind clinical trial comparing high dose with low dose. Poster session presented at the meeting of Abstracts of the 2013 ACR/ARHP Annual Meeting, as published in Arthritis & Rheumatology. San Diego, CA: Wiley-Blackwell.
DOI WoS12013 Gill, T. K., Shanahan, E. M., Allison, D., Alcorn, D., & Hill, C. L. (2013). An examination of shoulder pain using magnetic resonance imaging in older people. Poster session presented at the meeting of 77th Annual Meeting of the American College of Rheumatology / 48th Annual Meeting of the Association of Rheumatology Health Professionals, as published in Arthritis & Rheumatism. San Diego, CA: Wiley-Blackwell.
DOI2013 Gill, T., Shanahan, E., Allison, D., Alcorn, D., & Hill, C. (2013). An examination of shoulder pain using magnetic resonance imaging (MRI) in older people. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with the Rheumatology Health Professionals Association 54th Annual Scientific Meeting, as published in Internal Medicine Journal. Perth, Western Australia: Wiley-Blackwell.
DOI2013 Gill, T., Shanahan, E., Taylor, A., Appleton, S., Adams, R., & Hill, C. (2013). Vitamin D and musculoskeletal pain. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with the Rheumatology Health Professionals Association 54th Annual Scientific Meeting, as published in Internal Medicine Journal. Perth, Western Australia: Wiley-Blackwell.
DOI2012 Adams, R., Appleton, S., Gill, T., Hill, C., & Visvanathan, R. (2012). ASTHMA CONTROL IS ASSOCIATED WITH BLOOD GRANULOCYTE PATTERNS IN A POPULATION COHORT SAMPLE. Poster session presented at the meeting of RESPIROLOGY. WILEY-BLACKWELL. 2012 Appleton, S., Gill, T., Hill, C., Visvanathan, R., & Adams, R. (2012). ASTHMA AND WHEEZE ARE ASSOCIATED WITH REDUCED VITAMIN D LEVELS IN A POPULATION COHORT. Poster session presented at the meeting of RESPIROLOGY. WILEY-BLACKWELL. 2012 Black, R., Spargo, L., Shultz, C., Chatteron, B., James, M., Cleland, L., . . . Proudman, S. (2012). Decline in hand bone mineral density indicates increased risk for erosive change in early rheumatoid arthritis (RA). Poster session presented at the meeting of Abstracts for the RACP Future Directions in Health Congress 2012, as published in Internal Medicine Journal. Brisbane, Qld.: Wiley-Blackwell.
DOI2012 Graf, S., Lester, S., Nossent, H., Hill, C., Proudman, S., Lee, A., & Rischmueller, M. (2012). Low copy number of the FCGR3B gene and rheumatoid arthritis: a case control study and meta-analysis. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting, as published in Internal Medicine Journal. Canberra, ACT: Wiley-Blackwell.
DOI2011 Ngian, G., Sahhar, J., Byron, J., Proudman, S., Hill, C., Roddy, J., . . . Van Doornum, S. (2011). PREVALENCE OF CORONARY HEART DISEASE IN A COHORT OF AUSTRALIAN SCLERODERMA PATIENTS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2011 Jayaweera, S., Sahhar, J., Englert, H., Proudman, S., Hill, C., & Youssef, P. (2011). MYCOPHENOLATE MOFETIL (MMF) IN SCLERODERMA (SSc) ASSOCIATED INTERSTITIAL LUNG DISEASE (ILD) AND SKIN DISEASE - THE AUSTRALIAN EXPERIENCE. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
WoS12011 Black, R., Spargo, L., Schultz, C., Chatterton, B., James, M., Cleland, L., . . . Proudman, S. (2011). Decline in hand bone mineral density indicates increased risk for erosive change in early rheumatoid arthritis (RA). Poster session presented at the meeting of Abstracts of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 52nd Annual Scientific Meeting, as published in Internal Medicine Journal. Brisbane, Qld.: Wiley.
DOI2011 Stevens, W., Nikpour, M., Byron, J., Roddy, J., Sahhar, J., Zochling, J., . . . Proudman, S. (2011). FREQUENCY, CLINICAL CHARACTERISTICS AND RISK FACTORS FOR DIGITAL ULCERS IN SYSTEMIC SCLEROSIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
WoS3 -
Report for External Bodies
Year Citation 2024 Hill, C. L., Pulver, L. K., & Liew, D. F. L. (2024). Navigating high-cost medicines: summary of the Guiding Principles for the governance of high-cost medicines in Australian hospitals. WILEY.
DOI2021 Hill, C. (2021). Biologics and biosimilars best practice: Guiding principles for the governance of biologics and their biosimilars in Australian hospitals.
Research Funding
| 2022-2027 | MRFF Chronic Musculoskeletal Conditions in Children and Adolescents | A3BC for Kids. | Chief Investigators: March L, Whittle SL, Shrestha R, Saffery R, Thomas R, Buchbinder R, Neeland M, Lassere M, Mittinty M, Murray K, Munro J, Keen HI, Singh-Grewal D, Hill CL, Novakovic B | Five years. $2,496,875.50 |
| 2021-2025 | NHMRC Centres of Research Excellence - Clinical Research | CRE for Better Outcomes in Inflammatory Arthritis | Chief Investigators: March L, Thomas R, Lassere M, Buchbinder R, Hill CL, Keen H, Wechalekar M, Munro J, Figtree G, Schofield D | Five years. $2,500,000 |
| 2021-2024 | NIHR-NHMRC Collaborative Research Grant | Steroid-Reducing Options for ReLapsING PMR (STERLING-PMR): a pragmatic, randomised trial to compare the clinical and cost-effectiveness of adding immunosuppression to steroid-tapering treatment for patients with relapsing PMR, versus steroid-tapering. | Chief Investigators: Hill CL, Keen H, Owen C, Liew D, Manaski-Nankervis J, Stocks N, Reudiger C | Four year project grant. $890,000 |
| 2020-2025 | MRFF Preventive and Public Health Research | Healthy Choices: Co-designed community programs to enhance healthy lifestyle choices for people with chronic conditions. | Chief Investigators: Hiller S, Olds T, Maher C, Gill T, Esterman A, Khadka J, Adams R, Hill CL, Keogh J | Five years. $780,670 |
| 2020-2023 | The Hospital Research Foundation Project Grant Round | Does light treatment improve sleep and pain? | Chief Investigators: Gill T, Adams R, Hill CL, Lovato N | Three years. $129,653 |
| 2020 | The Hospital Research Foundation Allied Health Research Collaboration Grant | Rocker sole footwear for the treatment of painful midfoot osteoarthritis: a pilot randomised controlled trial. | Chief Investigators: Arnold, JB, Cooney, M, Bourke, J, Ferris, L, Hill C, Milanese S, Gill T, Walsh, T | One year. $34,000 |
| 2020 | Arthritis Australia, Australian Rheumatology Association Project Grant | The patient experience of glucocorticoids for the treatment of rheumatic diseases and the development of a patient reported outcome measure (PROM). | Hill CL, Black R, Robson J, Goodman S | One year. $15,000 |
| 2019-2021 | NHMRC Project Grant | Targeting unhelpful pain beliefs to promote physical activity in people with knee osteoarthritis: a multicentre, randomised controlled trial with cost-effectiveness analysis. | Chief Investigators: Stanton T, Moseley G, Hill CL, Ratcliffe J, Smuck M, Tomkins-Lane C. | Three year Project Grant. $1,190,000 |
| 2019 | Arthritis Australia Grant-in-aid | Comparison of dietary oils in osteoarthritis patients: a feasibility study. | Davis C, Hill CL, Ruediger C, Murphy K. | One year. $15,000 |
| 2018- 2020 |
NHMRC Project Grant DICKENS |
A randomised controlled trial of DlaCerein to treat KneE osteoarthritis with enfusioN-Synovitis |
Chief Investigators: Aitken D, Jones G, Cicuttini F, Winzenberg T, Keen H |
Three year project grant $1,309,503 |
| 2018 | Arthritis Australia Project Grant - 1147370 | Does targeting pain-related beliefs in people with knee osteoarthritis increase physical activity. | Chief Investigators: Stanton T, Moseley GL, Hill CL, Bennell K. | One year project grant. $15,000 |
| 2017- 2021 |
NHMRC Project Grant Australia and New Zealand Musculoskeletal (ANZMUSC) - 1134856 |
Clinical Trials Network | Five year project grant. $2,497,653 | |
| 2017- 2020 |
NHMRC Project Grant METHODS - 1127981 |
A randomised clinical trial of METhotrexate to treat Hand Osteoarthritis with Synovitis | Four year project grant $770,013 | |
| 2017- 2019 | 1134125 | Optimising therapy in anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis | Three year project grant $124,676 | |
| 2017 | Arthritis Australia Project Grant. | A randomised clinical trial of colchicine in inflammatory hand osteoarthritis | Chief Investigators: Hill CL, Ruediger C | One year project grant $40,000. |
| 2017 | Arthritis Australia Project Grant. | A randomised clinical trial of colchicine in inflammatory hand osteoarthritis. | Chief Investigators: Hill CL, Ruediger C. | One year project grant, co-funded by The Hospital Research Foundation. $50,000 |
| 2016- 2017 | NHMRC Project Grant 1102732 | A randomised trial of krill oil for osteoarthritis of the knee, $751,491. | Chief Investigators: Jones G, Cicuttini F, Hill CL | Two year project grant. $569,927 |
| 2014-2015 | NHMRC Project Grant 1068023 | Dissecting the great ophthalmic masquerade: The Global Giant Cell Arteritis Genomics Consortium. | Chief Investigators: Hewitt A, Hill CL, Evans D, Merriman T, Morgan A, Smith K, McKelvie P, Martin J | Two year project grant. $569,927 |
| 2013-2017 | NHMRC Project Grant 1048581. | Does statin use have a disease modifying effect in symptomatic knee osteoarthritis? A multicentre randomised, double-blind, placebo-controlled trial. | Chief Investigators: Wang Y, Cicuttini F, Tonkin A, Hill CL, Ding C. | Three year Project Grant. $971,019.95 |
| 2013-2016 | NHMRC Project Grant 1045415. | A randomised trial of zoledronic acid for osteoarthritis of the knee. | Chief Investigators: Jones G, Cicuttini F, March L, Hill CL, Dore D. | Three year project grant. $954,596.66 |
| 2016 | Arthritis Australia Project Grant. | Customising pathways to self-management support for people with osteoarthritis | Chief Investigators: Hoon E, Oliver F, Hill CL. | One year project grant. |
| 2015 | Arthritis Australia Grant. | Developing a patient reported outcome measure in polymyalgia rheumatic. | Chief Investigators: Hoon E, Hill CL, Gill TK. | One year project grant. $10,000. |
| 2014 | NHMRC Project Grant | Dissecting the great ophthalmic masquerade: The Global Giant Cell Arteritis Genomics Consortium. | Two year project grant $569,927 | |
| 2014 | Arthritis Australia Grant. | Suprascapular nerve block for the treatment of adhesive capsulitis | Chief Investigators: Shanahan EM, Hill CL, Gill TK. | One year project grant. $30,000. |
| 2013- 2015 | NHMRC Project Grant | A randomised trial of zoledronic acid for osteoarthritis of the knee. | Three year project grant. $954,596 | |
| 2013- 2015 | Does statin use have a disease modifying effect in symptomatic knee osteoarthritis? A multicentre randomised, double-blind, placebo-controlled trial | Three year project grant. $971,019 | ||
| 2013 | Arthritis Australia Grant. | Genetics of Giant Cell Arteritis. | Chief Investigators: Brown M, Hewitt A, Merriman T, Rischmueller M, Hill CL. | $25,000. |
| 2012 | Arthritis Australia Grant-in-Aid. | Pilot study of MRI in shoulder pain. | Chief Investigators: Gill TK, Hill CL, Shanahan M, Allison D. | $15,000. |
| Arthritis Australia Grant. | Association of n-3 fatty acid levels and serum COMP levels with inflammation, symptoms and cartilage volume in knee | Chief Investigators: Hill CL, Cleland LG, Jones G, March LM. | $35,000. | |
| 2009- 2014 | TQEH Research Foundation | The Health Observatory. | Chief Investigators: Adams RJ, Wilson DW, Hill CL, Visvanathan R, Ruffin RE, Wittert G | Five year program grant. $1,250,000. |
| 2008 - 2011 | NHMRC Grant No 451900. | Fish Oil in knee osteoarthritis. | Chief Investigators: Hill CL, Cleland LG, Jones G, March LM. | Three year project grant. $618,625 |
| North West Adelaide Health Study | Arthritis Subgroup. Human Services Research Initiatives (HSRIP) grant. | Co-investigators: A. Taylor, T. Gill, M. Shanahan | ||
| 2007 | NHMRC Project Grant | Fish oil in the treatment of knee osteoarthritis. | Four year project grant $702,726 | |
| 2006 | Arthritis Australia Grant-in-Aid. | Quality of Life and disability of people waiting for joint replacement surgery’. | Chief Investigators: Osborne R, Buchbinder R, Hill CL. | $15,000. |
Teaching
| Undergraduate Medical students | Year III clinical skills, Year IV rheumatology tutorials and Clinical Examiner, Year IV, Year V |
| Postgraduate basic physician trainees | Written examination preparation tutorials, Clinical examination short case and long case preparation |
| Rheumatology Advanced Trainee Supervision | Supervision of advanced trainees in rheumatology |
-
Current Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2025 Principal Supervisor Optimising transition care for adolescents with juvenile rheumatic disease in South Australia Master of Clinical Science Master Part Time Dr Gráinne Murray 2024 Co-Supervisor Neck pain epidemiology and risk factors in the Australian population Doctor of Philosophy Doctorate Full Time Miss Nasibeh Sorkhi Kojabad 2023 Principal Supervisor The influence of socioeconomic factors on medication use and health outcomes in Australians with rheumatoid arthritis Doctor of Philosophy Doctorate Part Time Dr Oscar Kenneth Russell 2022 Principal Supervisor Rheumatoid Arthritis and Exercise in Australia Master of Clinical Science Master Part Time Dr Julia New-Tolley 2021 Principal Supervisor Epidemiology, Clinical Phenotype and Treatment Implications of Giant Cell Arteritis in Australia and New Zealand Doctor of Philosophy Doctorate Part Time Suellen Anne Lyne 2017 Co-Supervisor Giant Cell Arteritis - Understanding Mechanisms of Disease, Improving the Diagnostic Certainty, and Optimising Management through Fast Track Clinics Doctor of Philosophy Doctorate Part Time Dr Jem Verghese Ninan -
Past Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2023 - 2025 Principal Supervisor Patient experience in Australian outpatient rheumatology care Doctor of Philosophy Doctorate Full Time Dr Madeleine Bryant 2018 - 2024 Principal Supervisor Understanding the Longitudinal Characteristics of Chronic Pain in Arthritis:
The Role of Intensive Longitudinal Methods in Analysing Pain and the Attributable Burden of Persistent Pain on Treatment and Health OutcomesDoctor of Philosophy Doctorate Full Time Dr Huai Leng Pisaniello 2017 - 2022 Principal Supervisor Optimising management in ANCA-associated vasculitis Doctor of Philosophy Doctorate Full Time Dr Joanna Tieu 2015 - 2019 Co-Supervisor The establishment of an automated, electronic data-collection system for the purpose of qualifying, evaluating and improving post-operative surgical outcomes and evidence-based surgery Doctor of Philosophy Doctorate Part Time Dr James Marcus McLean 2013 - 2019 Co-Supervisor The Epidemiology and Patient Perspectives of Glucocorticoid Use in Rheumatoid Arthritis and Other Inflammatory Diseases Doctor of Philosophy Doctorate Part Time Dr Rachel Joelle Black -
Other Supervision Activities
Date Role Research Topic Location Program Supervision Type Student Load Student Name 2018 - ongoing External Supervisor The association between allostatic load and osteoarthritis University of South Australia Masters by Research Master Part Time Sarah Schwetlik -
Mentoring
Date Topic Location Name 2017 - ongoing Midfoot osteoarthritis University of South Australia John Arnold
-
Board Memberships
Date Role Board name Institution name Country 2022 - ongoing Member Board Member and Medical Advisor Arthritis SA Australia 2020 - 2022 President Australian Rheumatology Association ARA Australia 2019 - ongoing Member Australian and New Zealand Vasculitis Society Australian and New Zealand Vasculitis Society Australia 2018 - 2020 Vice-President Australian Rheumatology Association ARA Australia 2016 - ongoing Secretary Australian Rheumatology Association - Australia -
Committee Memberships
Date Role Committee Institution Country 2022 - ongoing Chair Education Committee Asia Pacific League Against Rheumatism Singapore 2020 - ongoing Board Member Asia Pacific League Against Rheumatism (APLAR) COVID-19 Taskforce The Asia Pacific League of Associations for Rheumatology Singapore 2020 - ongoing Co-Chair Outcome Measures in Rheumatology (OMERACT) Hand Osteoarthritis Special Interest Group Canada 2019 - ongoing Member Hand Osteoarthritis Classification Criteria Working Group European Alliance Association of Rheumatology Switzerland 2019 - 2022 Chair Consortium Leadership Committee Value in Prescribing bDMARD Program Australia 2019 - ongoing Member Natural Therapies Expert Advisory Group Commonwealth Government Australia 2018 - 2019 Member Making Better Care Committee Central Adelaide Local Health Network Australia 2018 - 2019 Member Expert Advisory Group National Arthritis Strategy Australia 2018 - ongoing Board Member Australian & New Zealand Vasculitis Society Australian & New Zealand Vasculitis Society Australia 2018 - 2020 Chair Policy and Advocacy Committee Australian Rheumatology Association Australia 2017 - ongoing Board Member Pharmaceutical Benefits Advisory Committee Australian Government Department of Health Australia 2017 - ongoing Board Member Outcome Measures in Rheumatology (OMERACT) Technical Advisory Group Canada 2017 - ongoing Board Member Australian Arthritis and Autoimmune Biobank Collaborative (A3BC) Steering Committee Kolling Institute Australia 2017 - ongoing Board Member Research Committee & Research Trust Australian Rheumatology Association Australia 2016 - 2015 Member Scientific Review Subcommittee The Queen Elizabeth Hospital Australia 2016 - ongoing Co-Chair Outcome Measures in Rheumatology (OMERACT) Glucocorticoid Impact Working Group Canada 2016 - ongoing Co-Chair Outcome Measures in Rheumatology (OMERACT) Polymyalgia Rheumatica Special Interest Group Canada 2016 - 2020 Chair Australian Rheumatology Association Database (ARAD) Committee Australian Rheumatology Association Australia 2016 - 2020 Member ANZMUSC Scientific Advisory Committee Australia & New Zealand Musculoskeletal Clinical Trials Network Australia 2015 - 2017 Member Drug Utilisation Subcommittee Pharmaceutical Benefits Advisory Committee, Commonwealth Government Australia 2014 - 2019 Co-Chair Outcome Measures in Rheumatology (OMERACT) Patient Perspectives in RA Remission Special Interest Group Canada 2014 - 2015 President Australian Rheumatology Association (SA Branch) Australian Rheumatology Association Australia 2014 - 2014 Member NHMRC Assigners Academy National Health and Medical Research Council Australia 2013 - ongoing Member Drug and Therapeutics Committee Central Adelaide Local Health Network Australia 2013 - 2018 Member Arthritis Australia Grant Assessment Committee Arthritis Australia Australia 2011 - 2022 Chair South Australian Medicines Evaluation Panel SA Health Australia 2011 - 2015 Member NHMRC Grant Review Panel National Health and Medical Research Council Australia 2011 - ongoing Member South Australian Medicines Advisory Committee SA Health Australia 2008 - 2012 Member WHO Burden of Disease Osteoarthritis Working Group World Health Organization Switzerland 2007 - 2014 Member Epidemiology Abstract Review Panel American College of Rheumatology United States 2007 - ongoing Board Member Australian Scleroderma Interest Group (ASIG) Australian Rheumatology Association Australia 2007 - ongoing Board Member Australian Scleroderma Interest Group (ASIG) Scientific Committee Australian Rheumatology Society Australia 2006 - 2010 Chair The Queen Elizabeth Hospital Drugs and Therapeutic Committee The Queen Elizabeth Hospital Australia 2006 - 2007 President Australian Rheumatology Association (SA Branch) Australian Rheumatology Association Australia 2005 - ongoing Member Australian Rheumatology Association Database (ARAD) Committee Australian Rheumatology Association Australia 2004 - 2015 Member Australian Committee for Prescription Medicine Therapeutic Goods Administration Australia 2004 - 2013 Member The Queen Elizabeth Hospital Drugs and Therapeutic Committee The Queen Elizabeth Hospital Australia 2004 - 2005 Secretary Australian Rheumatology Association (SA Branch) Australian Rheumatology Association Australia 2003 - 2015 Member Scientific Subcommittee North West Adelaide Human Ethics Commitee Australia 2000 - 2018 Member Mortality Review Committee The Queen Elizabeth Hospital Australia -
Memberships
Date Role Membership Country 2019 - ongoing Board Member Australian and New Zealand Vasculitis Society Australia 2019 - ongoing Member Australian Institute of Company Directors Australia 2014 - ongoing Member American College of Rheumatology United States 1996 - ongoing Member Australian Rheumatology Association Australia 1996 - ongoing Member Royal Australasian College of Physicians Australia -
Editorial Boards
Date Role Editorial Board Name Institution Country 2022 - ongoing Editor Rheumatology Advances in Practice British Society for Rheumatology United Kingdom 2017 - 2020 Board Member BMC Rheumatology BMC Rheumatology United States 2017 - 2020 Editor BMC Rheumatology BMC Rheumatology United Kingdom 2013 - 2016 Board Member Arthritis Care and Research - United States 2011 - 2015 Editor Arthritis Care and Research American College of Rheumatology United States -
Review, Assessment, Editorial and Advice
Date Title Type Institution Country 2019 - 2020 Research Establishment Fellowships Grant Assessment Royal Australian College of Physicians/Australian Rheumatology Association Australia 2019 - 2019 Dutch Arthritis Foundation Grant Assessment Dutch Arthritis Foundation Netherlands 2018 - 2018 New Zealand Research Council Grant Assessment New Zealand Research Council New Zealand 2018 - 2018 Swiss National Science Foundation Grant Assessment Swiss National Science Foundation Switzerland 2018 - 2018 United Kingdom Medical Research Council Grant Assessment United Kingdom Medical Research Council United Kingdom 2007 - 2019 American College of Rheumatology Annual Scientific Meeting Conference Review American College of Rheumatology Australia
Connect With Me
External Profiles
